Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

2924 8421 43 None -10 7 Human 10.0 pEC50 = 10 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmc.2006.10.060
44398069 8421 43 None -10 7 Human 10.0 pEC50 = 10 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmc.2006.10.060
9908268 8421 43 None -10 7 Human 10.0 pEC50 = 10 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmc.2006.10.060
CHEMBL114606 8421 43 None -10 7 Human 10.0 pEC50 = 10 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmc.2006.10.060
11452022 10368 39 None -19 6 Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
6996 10368 39 None -19 6 Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
CHEMBL366208 10368 39 None -19 6 Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
25192005 14508 0 None -3 2 Human 9.8 pEC50 = 9.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1089004 14508 0 None -3 2 Human 9.8 pEC50 = 9.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
44406004 79490 10 None 5 4 Human 9.8 pEC50 = 9.8 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 337 14 4 4 2.9 CCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
CHEMBL199791 79490 10 None 5 4 Human 9.8 pEC50 = 9.8 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 337 14 4 4 2.9 CCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
25192001 14831 0 None -2 4 Human 9.7 pEC50 = 9.7 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1091103 14831 0 None -2 4 Human 9.7 pEC50 = 9.7 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
46884020 15212 0 None -30 4 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1093686 15212 0 None -30 4 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
10883396 10421 45 None 1 15 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.006
5283560 10421 45 None 1 15 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.006
911 10421 45 None 1 15 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.006
CHEMBL225155 10421 45 None 1 15 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.006
10883396 10421 45 None 1 15 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
5283560 10421 45 None 1 15 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
911 10421 45 None 1 15 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
CHEMBL225155 10421 45 None 1 15 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
76332615 112331 0 None 5 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 555 12 3 8 5.0 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(CC)(CC)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121986 112331 0 None 5 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 555 12 3 8 5.0 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(CC)(CC)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
44565714 186076 0 None -6 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 484 11 4 5 4.1 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473238 186076 0 None -6 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 484 11 4 5 4.1 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
2924 8421 43 None -10 7 Human 8.9 pEC50 = 8.9 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm050242f
44398069 8421 43 None -10 7 Human 8.9 pEC50 = 8.9 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm050242f
9908268 8421 43 None -10 7 Human 8.9 pEC50 = 8.9 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm050242f
CHEMBL114606 8421 43 None -10 7 Human 8.9 pEC50 = 8.9 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm050242f
44218130 146668 0 None -1 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 552 14 3 8 4.3 CCc1cc(-c2noc(-c3cc(CN(C)CC(C)C)cc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799355 146668 0 None -1 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 552 14 3 8 4.3 CCc1cc(-c2noc(-c3cc(CN(C)CC(C)C)cc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
10883396 10421 45 None 1 15 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2006.10.014
5283560 10421 45 None 1 15 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2006.10.014
911 10421 45 None 1 15 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2006.10.014
CHEMBL225155 10421 45 None 1 15 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2006.10.014
11222939 74349 9 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2006.10.014
44438254 74349 9 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2006.10.014
CHEMBL190006 74349 9 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2006.10.014
44591250 196533 0 None -19 4 Human 8.0 pEC50 = 8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1F 10.1016/j.bmcl.2008.11.072
CHEMBL515921 196533 0 None -19 4 Human 8.0 pEC50 = 8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1F 10.1016/j.bmcl.2008.11.072
44591266 186079 0 None -19 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 443 13 4 5 4.2 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1F 10.1016/j.bmcl.2008.11.072
CHEMBL473269 186079 0 None -19 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 443 13 4 5 4.2 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1F 10.1016/j.bmcl.2008.11.072
44422606 92348 0 None -2 5 Human 7.0 pEC50 = 7 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 329 11 3 3 3.1 CCCCCCc1ccc(OC[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL228049 92348 0 None -2 5 Human 7.0 pEC50 = 7 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 329 11 3 3 3.1 CCCCCCc1ccc(OC[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
44219525 146720 0 None -47 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799686 146720 0 None -47 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
44218450 146727 0 None -100 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(C)CC 10.1016/j.ejmech.2016.03.048
CHEMBL3799718 146727 0 None -100 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(C)CC 10.1016/j.ejmech.2016.03.048
76325739 112846 0 None -11 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 462 11 4 7 3.4 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133595 112846 0 None -11 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 462 11 4 7 3.4 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
76336567 112854 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 432 9 4 6 3.0 Cc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133602 112854 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 432 9 4 6 3.0 Cc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
76311231 112855 0 None -7 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133603 112855 0 None -7 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3780292 112855 0 None -7 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
76332957 112862 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 409 12 4 4 3.7 CCCCCCc1ccc2c(CCC(N)(CO)COP(=O)(O)O)cccc2c1 10.1039/C3MD00079F
CHEMBL3133610 112862 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 409 12 4 4 3.7 CCCCCCc1ccc2c(CCC(N)(CO)COP(=O)(O)O)cccc2c1 10.1039/C3MD00079F
45377937 90894 0 None -112 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 496 9 1 6 5.1 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CCC(C(=O)O)CC3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207780 90894 0 None -112 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 496 9 1 6 5.1 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CCC(C(=O)O)CC3)cc2)s1 10.1016/j.bmcl.2012.09.110
66655587 174415 0 None -5 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 435 6 1 4 4.8 O=C(O)CCN1CCC2(CC1)COc1cc(OCc3cc(Cl)ccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4205714 174415 0 None -5 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 435 6 1 4 4.8 O=C(O)CCN1CCC2(CC1)COc1cc(OCc3cc(Cl)ccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4301563 174415 0 None -5 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 435 6 1 4 4.8 O=C(O)CCN1CCC2(CC1)COc1cc(OCc3cc(Cl)ccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
46846906 146819 0 None -2290 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 8 1 7 4.5 CCCc1c(-c2ccccc2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1021/acs.jmedchem.6b00089
CHEMBL3800257 146819 0 None -2290 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 8 1 7 4.5 CCCc1c(-c2ccccc2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1021/acs.jmedchem.6b00089
70692256 81749 0 None -3162 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 468 8 1 4 6.1 CN(CCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1)CC(=O)O 10.1016/j.bmcl.2012.04.095
CHEMBL2032429 81749 0 None -3162 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 468 8 1 4 6.1 CN(CCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1)CC(=O)O 10.1016/j.bmcl.2012.04.095
70694327 81754 0 None -12589 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 494 6 1 4 6.8 O=C(O)CCN1CCC(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032434 81754 0 None -12589 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 494 6 1 4 6.8 O=C(O)CCN1CCC(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
11853835 111489 0 None -501 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 10 2 6 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CN1CC(C(=O)O)C1 10.1021/jm4014373
CHEMBL3105482 111489 0 None -501 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 10 2 6 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CN1CC(C(=O)O)C1 10.1021/jm4014373
46237828 15718 0 None -5 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 369 4 1 6 3.4 COc1cc(/C=C2\S/C(=N\N(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
CHEMBL1098013 15718 0 None -5 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 369 4 1 6 3.4 COc1cc(/C=C2\S/C(=N\N(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
57398845 77694 0 None -1548 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 489 9 1 7 5.9 CCc1ccccc1Oc1ccc(-c2nc(-c3sc(CN4CC(C(=O)O)C4)cc3CC)no2)cc1 10.1016/j.bmcl.2011.12.019
CHEMBL1951313 77694 0 None -1548 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 489 9 1 7 5.9 CCc1ccccc1Oc1ccc(-c2nc(-c3sc(CN4CC(C(=O)O)C4)cc3CC)no2)cc1 10.1016/j.bmcl.2011.12.019
42636433 123170 0 None -1258 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 455 7 1 6 4.7 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCC(=O)O)CC4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359846 123170 0 None -1258 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 455 7 1 6 4.7 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCC(=O)O)CC4)no2)cc1Cl 10.1021/jm5010336
44125704 123178 0 None -316 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 472 8 2 8 4.5 CC(C)Oc1ncc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359854 123178 0 None -316 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 472 8 2 8 4.5 CC(C)Oc1ncc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
25182769 13037 0 None -4073 3 Human 4.0 pEC50 = 4 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 380 6 2 5 4.3 Cc1cc(O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1081645 13037 0 None -4073 3 Human 4.0 pEC50 = 4 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 380 6 2 5 4.3 Cc1cc(O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
53319457 64164 0 None -69 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4nc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651851 64164 0 None -69 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4nc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100306h
118716139 121650 0 None -79 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 432 9 4 6 3.0 Cc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341917 121650 0 None -79 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 432 9 4 6 3.0 Cc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
46236933 15826 0 None 7 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.3 CC(C)/N=C1\S/C(=C\c2cccc(O)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098771 15826 0 None 7 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.3 CC(C)/N=C1\S/C(=C\c2cccc(O)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
16736755 64133 0 None -64 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 413 8 1 4 5.4 CCCCOc1ccc2oc(-c3ccc(CN4CC(C(=O)O)C4)cc3Cl)cc2c1 10.1021/ml100227q
CHEMBL1651714 64133 0 None -64 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 413 8 1 4 5.4 CCCCOc1ccc2oc(-c3ccc(CN4CC(C(=O)O)C4)cc3Cl)cc2c1 10.1021/ml100227q
11853576 111497 0 None -204 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 441 10 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCNCCO 10.1021/jm4014373
CHEMBL3105490 111497 0 None -204 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 441 10 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCNCCO 10.1021/jm4014373
11224984 15489 23 None -44 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1095833 15489 23 None -44 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
46236811 15747 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1 10.1021/jm100181s
CHEMBL1098201 15747 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1 10.1021/jm100181s
76325533 112545 0 None -537 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)c(C4CCCC4)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126613 112545 0 None -537 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)c(C4CCCC4)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
72793789 111173 0 None -380 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 1 5 5.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCN1CC(C(=O)O)C1 10.1021/jm4014373
CHEMBL3102986 111173 0 None -380 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 1 5 5.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCN1CC(C(=O)O)C1 10.1021/jm4014373
11363176 9923 47 None -12 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 10.1021/jm100181s
5446 9923 47 None -12 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 10.1021/jm100181s
9320 9923 47 None -12 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1096146 9923 47 None -12 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 10.1021/jm100181s
25182926 14713 0 None -173 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 451 11 3 6 3.8 O=C(O)CCNCc1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 10.1016/j.bmcl.2010.01.102
CHEMBL1090423 14713 0 None -173 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 451 11 3 6 3.8 O=C(O)CCNCc1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 10.1016/j.bmcl.2010.01.102
11852144 112352 0 None -323 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 8 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OC[C@H](O)CO 10.1021/jm401456d
CHEMBL3122006 112352 0 None -323 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 8 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OC[C@H](O)CO 10.1021/jm401456d
76318056 112319 0 None 1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 541 11 3 8 4.7 CCCc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c2c1CC(C)(C)CC2 10.1021/jm401456d
CHEMBL3121974 112319 0 None 1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 541 11 3 8 4.7 CCCc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c2c1CC(C)(C)CC2 10.1021/jm401456d
76321772 112333 0 None -2 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 553 10 3 8 4.8 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC3(CCCC3)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121988 112333 0 None -2 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 553 10 3 8 4.8 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC3(CCCC3)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
11689680 86415 0 None -3890 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.064
CHEMBL211505 86415 0 None -3890 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.064
24825338 84485 0 None -1288 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 434 7 1 5 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL208924 84485 0 None -1288 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 434 7 1 5 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.04.084
72793828 111470 0 None -109 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 439 6 2 6 5.0 Cc1cc(-c2cnc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)o2)cc(C)c1OCC(O)CO 10.1021/jm4014373
CHEMBL3105250 111470 0 None -109 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 439 6 2 6 5.0 Cc1cc(-c2cnc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)o2)cc(C)c1OCC(O)CO 10.1021/jm4014373
127046185 146795 0 None -363 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 496 11 3 9 2.8 CCc1cc(-c2noc(-c3cc(C)nc(OC4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800120 146795 0 None -363 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 496 11 3 9 2.8 CCc1cc(-c2noc(-c3cc(C)nc(OC4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
24825338 84485 0 None -1288 3 Human 7.0 pEC50 = 7.0 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 434 7 1 5 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL208924 84485 0 None -1288 3 Human 7.0 pEC50 = 7.0 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 434 7 1 5 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
1160618 37580 1 None 2 2 Human 7.0 pEC50 = 7.0 Functional
PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]
ChEMBL 389 6 0 6 4.9 O=C(CSc1nnc(-c2ccco2)o1)N(C1CCCCC1)C1CCCCC1 nan
CHEMBL1396471 37580 1 None 2 2 Human 7.0 pEC50 = 7.0 Functional
PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]
ChEMBL 389 6 0 6 4.9 O=C(CSc1nnc(-c2ccco2)o1)N(C1CCCCC1)C1CCCCC1 nan
44412883 84072 0 None -77 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 404 7 1 4 6.2 Cc1cc(CCCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL208224 84072 0 None -77 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 404 7 1 4 6.2 Cc1cc(CCCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
11689680 86415 0 None -3890 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL211505 86415 0 None -3890 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
70686051 82048 0 None 1 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 466 4 2 4 5.2 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccc(C(=O)O)c21 10.1021/ml200252b
CHEMBL2037123 82048 0 None 1 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 466 4 2 4 5.2 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccc(C(=O)O)c21 10.1021/ml200252b
44625752 94368 0 None -2754 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 554 10 2 4 7.0 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(Br)c1 10.1021/ml300396r
CHEMBL2336066 94368 0 None -2754 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 554 10 2 4 7.0 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(Br)c1 10.1021/ml300396r
11689680 86415 0 None -3890 3 Human 6.0 pEC50 = 6.0 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL211505 86415 0 None -3890 3 Human 6.0 pEC50 = 6.0 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
57393585 77696 0 None -2454 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 503 9 1 7 6.5 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3C(C)C)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951315 77696 0 None -2454 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 503 9 1 7 6.5 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3C(C)C)cc2)n1 10.1016/j.bmcl.2011.12.019
57395264 78435 0 None -12882 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935583 78435 0 None -12882 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963633 78435 0 None -12882 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
53234382 155167 0 None -457 2 Human 5.0 pEC50 = 5.0 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 431 8 2 6 4.3 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CNCCC(=O)O)ccc2-3)cc1C#N nan
CHEMBL3937499 155167 0 None -457 2 Human 5.0 pEC50 = 5.0 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 431 8 2 6 4.3 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CNCCC(=O)O)ccc2-3)cc1C#N nan
24850258 64765 0 None 2 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.3 O=C(O)C1CN(Cc2ccc(-n3cc4cc(Cc5ccccc5)ccc4n3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672553 64765 0 None 2 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.3 O=C(O)C1CN(Cc2ccc(-n3cc4cc(Cc5ccccc5)ccc4n3)c(F)c2)C1 10.1021/ml100228m
118716140 121651 0 None -147 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 448 10 4 7 2.7 COc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341918 121651 0 None -147 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 448 10 4 7 2.7 COc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
76325531 112534 0 None -1584 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 11 3 8 2.5 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
CHEMBL3126602 112534 0 None -1584 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 11 3 8 2.5 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
76332955 112848 0 None -2 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 461 11 5 6 3.2 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)c[nH]1 10.1039/C3MD00079F
CHEMBL3133597 112848 0 None -2 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 461 11 5 6 3.2 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)c[nH]1 10.1039/C3MD00079F
76336566 112847 0 None -56 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 474 11 4 7 3.7 NC(CO)(CCc1ccc(Oc2ccc(-c3coc(C4CC4)n3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133596 112847 0 None -56 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 474 11 4 7 3.7 NC(CO)(CCc1ccc(Oc2ccc(-c3coc(C4CC4)n3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
57396084 77473 0 None -2238 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 476 7 3 6 4.3 N[C@@H](CC(=O)O)C(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950569 77473 0 None -2238 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 476 7 3 6 4.3 N[C@@H](CC(=O)O)C(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
11315069 15694 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 6 1 5 3.9 CC(C)/N=C1\S/C(=C\c2ccc(OCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097801 15694 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 6 1 5 3.9 CC(C)/N=C1\S/C(=C\c2ccc(OCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46237178 15696 0 None 3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 423 8 0 5 4.9 CC(C)/N=C1\S/C(=C\c2ccc(OCCCN(C)C)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097803 15696 0 None 3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 423 8 0 5 4.9 CC(C)/N=C1\S/C(=C\c2ccc(OCCCN(C)C)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46236270 15782 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 370 3 1 4 4.7 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CC2)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098449 15782 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 370 3 1 4 4.7 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CC2)N1c1ccccc1 10.1021/jm100181s
76325748 112868 0 None -33 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 475 11 4 5 3.9 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccc(F)cc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133704 112868 0 None -33 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 475 11 4 5 3.9 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccc(F)cc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
66636757 112317 0 None -1288 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 445 10 3 8 2.9 CCCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
CHEMBL3121971 112317 0 None -1288 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 445 10 3 8 2.9 CCCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
25182900 159786 0 None -60 2 Human 5.9 pEC50 = 5.9 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 401 6 1 5 4.8 O=C(Nc1ccnc2ccccc12)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL3975495 159786 0 None -60 2 Human 5.9 pEC50 = 5.9 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 401 6 1 5 4.8 O=C(Nc1ccnc2ccccc12)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
44565738 196532 0 None -19 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 445 11 4 5 3.8 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL515917 196532 0 None -19 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 445 11 4 5 3.8 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
46236398 15332 0 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 380 7 1 4 5.3 CCCCCCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1094502 15332 0 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 380 7 1 4 5.3 CCCCCCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
2924 8421 43 None -10 7 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm901776q
44398069 8421 43 None -10 7 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm901776q
9908268 8421 43 None -10 7 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm901776q
CHEMBL114606 8421 43 None -10 7 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm901776q
44565596 196325 0 None -104 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 422 11 4 5 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL514302 196325 0 None -104 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 422 11 4 5 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
24956673 15291 0 None -2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 372 3 1 4 4.9 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094192 15291 0 None -2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 372 3 1 4 4.9 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
42622931 146455 0 None -199 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 516 13 3 9 3.3 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3797940 146455 0 None -199 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 516 13 3 9 3.3 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
66829308 146871 0 None -169 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 14 3 9 3.7 CCCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3800591 146871 0 None -169 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 14 3 9 3.7 CCCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
11540052 187346 0 None -33 4 Human 6.9 pEC50 = 6.9 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
CHEMBL475405 187346 0 None -33 4 Human 6.9 pEC50 = 6.9 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
11624780 84717 0 None -354 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 365 7 1 5 4.3 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(CC(C)C)cn2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL209566 84717 0 None -354 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 365 7 1 5 4.3 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(CC(C)C)cn2)n1 10.1016/j.bmcl.2006.04.084
11360553 65223 0 None -26 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 365 9 1 3 4.3 O=C(O)CCN1CC=C(c2ccc(OCCCc3ccccc3)cc2)CC1 10.1016/j.bmcl.2011.01.029
CHEMBL1683049 65223 0 None -26 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 365 9 1 3 4.3 O=C(O)CCN1CC=C(c2ccc(OCCCc3ccccc3)cc2)CC1 10.1016/j.bmcl.2011.01.029
53324339 64773 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 468 6 1 4 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)cc5F)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672561 64773 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 468 6 1 4 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)cc5F)ccc4s3)c(F)c2)C1 10.1021/ml100228m
127046096 146383 0 None -12 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3ccc(C)c(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797452 146383 0 None -12 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3ccc(C)c(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
56949137 157371 0 None -8 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 368 5 0 3 5.9 Fc1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c(F)c1 nan
CHEMBL3955131 157371 0 None -8 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 368 5 0 3 5.9 Fc1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c(F)c1 nan
57391457 77677 0 None -109 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1ccc(Oc2ccc(-c3nc(-c4csc(CN5CC(C(=O)O)C5)c4)no3)cc2)cc1 10.1016/j.bmcl.2011.12.019
CHEMBL1951155 77677 0 None -109 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1ccc(Oc2ccc(-c3nc(-c4csc(CN5CC(C(=O)O)C5)c4)no3)cc2)cc1 10.1016/j.bmcl.2011.12.019
118707197 119821 0 None -5248 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 463 13 3 5 4.1 CCc1cc(C(=O)CCCc2ccc(C)cc2)ccc1COC[C@@](C)(N)COP(=O)(O)O 10.1016/j.bmc.2014.05.035
CHEMBL3311352 119821 0 None -5248 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 463 13 3 5 4.1 CCc1cc(C(=O)CCCc2ccc(C)cc2)ccc1COC[C@@](C)(N)COP(=O)(O)O 10.1016/j.bmc.2014.05.035
46846901 146872 0 None -7585 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 430 7 1 7 4.1 CCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3800595 146872 0 None -7585 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 430 7 1 7 4.1 CCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
53318124 64163 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
CHEMBL1651850 64163 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
53318124 64163 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1651850 64163 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
53318124 64163 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651850 64163 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100306h
118716182 121679 0 None -81 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 502 10 4 8 2.6 NC(CO)(CCc1ccc(-c2cn(-c3ccc(OC(F)(F)F)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3342007 121679 0 None -81 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 502 10 4 8 2.6 NC(CO)(CCc1ccc(-c2cn(-c3ccc(OC(F)(F)F)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
11852955 112346 0 None -81 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 513 9 3 8 4.0 CCc1cc(-c2noc(-c3sc(C)c4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3122000 112346 0 None -81 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 513 9 3 8 4.0 CCc1cc(-c2noc(-c3sc(C)c4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
44412827 84516 0 None -102 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 432 9 1 4 6.9 Cc1cc(CCCCCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL209008 84516 0 None -102 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 432 9 1 4 6.9 Cc1cc(CCCCCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
46238366 15588 0 None -6 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 358 3 1 4 4.5 CC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1096788 15588 0 None -6 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 358 3 1 4 4.5 CC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
11224984 15489 23 None -44 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1095833 15489 23 None -44 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
44439850 152805 0 None -588 3 Human 6.9 pEC50 = 6.9 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 446 6 1 5 5.7 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL391870 152805 0 None -588 3 Human 6.9 pEC50 = 6.9 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 446 6 1 5 5.7 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
76318197 112541 0 None -53 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 3 9 2.4 CCc1cc(-c2noc(-c3cnc(N4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126609 112541 0 None -53 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 3 9 2.4 CCc1cc(-c2noc(-c3cnc(N4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
46237179 15600 0 None -11 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 430 7 1 5 4.9 CCC/N=C1\S/C(=C\c2ccc(OCCO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1096873 15600 0 None -11 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 430 7 1 5 4.9 CCC/N=C1\S/C(=C\c2ccc(OCCO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
46236400 15330 0 None 3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 396 6 1 6 3.7 CCOC(=O)CCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1094491 15330 0 None 3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 396 6 1 6 3.7 CCOC(=O)CCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
44199424 112549 0 None -251 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)cc(CC(C)C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126617 112549 0 None -251 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)cc(CC(C)C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
70690096 81761 0 None -1258 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 7 1 4 6.1 O=C(O)C1CN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
CHEMBL2032441 81761 0 None -1258 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 7 1 4 6.1 O=C(O)C1CN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
44219369 146732 0 None -346 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799748 146732 0 None -346 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
66636736 112316 0 None -269 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 459 11 3 8 3.3 CCCCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
CHEMBL3121970 112316 0 None -269 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 459 11 3 8 3.3 CCCCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
66655198 170439 0 None -79 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 449 7 1 4 5.2 O=C(O)CCCN1CCC2(CC1)COc1cc(OCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4204437 170439 0 None -79 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 449 7 1 4 5.2 O=C(O)CCCN1CCC2(CC1)COc1cc(OCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
70694326 81752 0 None -1000 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 5 1 4 6.9 O=C(O)CC1CCN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032432 81752 0 None -1000 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 5 1 4 6.9 O=C(O)CC1CCN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
44129373 123173 0 None -2511 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 418 6 2 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4CC(=O)O)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359849 123173 0 None -2511 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 418 6 2 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4CC(=O)O)no2)cc1C#N 10.1021/jm5010336
11852437 112322 0 None -316 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 444 9 2 5 5.0 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC(C)(C)CC2 10.1021/jm401456d
CHEMBL3121977 112322 0 None -316 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 444 9 2 5 5.0 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC(C)(C)CC2 10.1021/jm401456d
46236662 15545 0 None 1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1 10.1021/jm100181s
CHEMBL1096478 15545 0 None 1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1 10.1021/jm100181s
73333750 112845 0 None -31 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 448 10 4 7 3.2 Cc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133594 112845 0 None -31 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 448 10 4 7 3.2 Cc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
46236271 15784 0 None 1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 384 3 1 4 5.1 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCC2)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098450 15784 0 None 1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 384 3 1 4 5.1 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCC2)N1c1ccccc1 10.1021/jm100181s
24957028 15700 0 None -3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 406 3 1 4 5.6 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1cccc(Cl)c1 10.1021/jm100181s
CHEMBL1097808 15700 0 None -3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 406 3 1 4 5.6 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1cccc(Cl)c1 10.1021/jm100181s
45255648 155692 0 None -19 2 Human 6.9 pEC50 = 6.9 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 454 10 3 9 2.2 CCOc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1OCC nan
CHEMBL3941765 155692 0 None -19 2 Human 6.9 pEC50 = 6.9 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 454 10 3 9 2.2 CCOc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1OCC nan
46205774 14689 0 None -8 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 491 11 4 5 4.3 NC(CO)(CCc1ccc(-c2ccc(OCc3ccccc3)cc2)cc1Cl)COP(=O)(O)O 10.1021/jm901776q
CHEMBL1090223 14689 0 None -8 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 491 11 4 5 4.3 NC(CO)(CCc1ccc(-c2ccc(OCc3ccccc3)cc2)cc1Cl)COP(=O)(O)O 10.1021/jm901776q
76336568 112787 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 407 11 4 4 2.8 CCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3132869 112787 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 407 11 4 4 2.8 CCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
46846912 146581 0 None -128 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 478 7 1 7 5.2 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4-c4ccccc4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3798784 146581 0 None -128 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 478 7 1 7 5.2 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4-c4ccccc4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
70688177 82056 0 None -33 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 495 6 2 5 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cnc(CCC(=O)O)cc21 10.1021/ml200252b
CHEMBL2037131 82056 0 None -33 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 495 6 2 5 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cnc(CCC(=O)O)cc21 10.1021/ml200252b
58537228 146723 0 None -2951 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 8 1 7 4.5 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3799693 146723 0 None -2951 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 8 1 7 4.5 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
57570486 94371 0 None -3235 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 11 2 4 7.1 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(C2CC2)c1 10.1021/ml300396r
CHEMBL2336069 94371 0 None -3235 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 11 2 4 7.1 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(C2CC2)c1 10.1021/ml300396r
56949017 151566 0 None 2 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 480 7 0 5 7.1 Clc1ncn(Cc2cccc(-c3noc(CCC4(c5ccccc5)CCCCC4)n3)c2)c1Cl nan
CHEMBL3909228 151566 0 None 2 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 480 7 0 5 7.1 Clc1ncn(Cc2cccc(-c3noc(CCC4(c5ccccc5)CCCCC4)n3)c2)c1Cl nan
53235407 156273 0 None -1000 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 404 6 1 5 4.4 CCCc1ccc(-c2noc3c2COc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1 nan
CHEMBL3946363 156273 0 None -1000 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 404 6 1 5 4.4 CCCc1ccc(-c2noc3c2COc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1 nan
57395297 77686 0 None -426 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 9 1 7 5.7 CCCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951305 77686 0 None -426 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 9 1 7 5.7 CCCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)cc2)n1 10.1016/j.bmcl.2011.12.019
46881538 14098 0 None -66 2 Human 5.9 pEC50 = 5.9 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 529 12 3 7 3.7 Cc1cc(S(=O)(=O)NCCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1086158 14098 0 None -66 2 Human 5.9 pEC50 = 5.9 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 529 12 3 7 3.7 Cc1cc(S(=O)(=O)NCCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
44599024 64175 0 None -10 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 473 6 1 5 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CCC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651862 64175 0 None -10 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 473 6 1 5 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CCC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
76321895 112539 0 None -13489 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 12 3 8 3.4 CCc1cc(-c2noc(-c3ccnc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126607 112539 0 None -13489 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 12 3 8 3.4 CCc1cc(-c2noc(-c3ccnc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
46224715 206037 0 None -123 4 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 371 3 1 5 2.5 Cc1nn(C(=O)/C=C/c2cccc(S(N)(=O)=O)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
CHEMBL590135 206037 0 None -123 4 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 371 3 1 5 2.5 Cc1nn(C(=O)/C=C/c2cccc(S(N)(=O)=O)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
11553524 111176 0 None -741 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 418 7 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(Cl)c1OCCO 10.1021/jm4014373
CHEMBL3102989 111176 0 None -741 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 418 7 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(Cl)c1OCCO 10.1021/jm4014373
46236931 15790 0 None 7 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 0 3 5.3 CC(C)/N=C1\S/C(=C\c2ccc(Br)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098484 15790 0 None 7 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 0 3 5.3 CC(C)/N=C1\S/C(=C\c2ccc(Br)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46236929 15748 0 None -6 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 5 0 5 4.6 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1OC 10.1021/jm100181s
CHEMBL1098202 15748 0 None -6 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 5 0 5 4.6 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1OC 10.1021/jm100181s
118716177 121674 0 None -12 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 432 9 4 7 2.0 Cc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342002 121674 0 None -12 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 432 9 4 7 2.0 Cc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
24956675 15408 0 None -4 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1095152 15408 0 None -4 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
44217839 112550 0 None -107 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(CC(C)C)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126618 112550 0 None -107 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(CC(C)C)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
118716186 121683 0 None -5 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 443 9 4 8 1.5 N#Cc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342011 121683 0 None -5 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 443 9 4 8 1.5 N#Cc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
118716155 121668 0 None -3 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 500 10 4 6 3.7 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(C(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341933 121668 0 None -3 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 500 10 4 6 3.7 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(C(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
44591265 186760 0 None -23 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 425 13 4 5 4.1 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2008.11.072
CHEMBL474689 186760 0 None -23 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 425 13 4 5 4.1 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2008.11.072
46238363 15586 0 None -2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 373 3 1 5 4.0 CN(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1096786 15586 0 None -2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 373 3 1 5 4.0 CN(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
127046549 146838 0 None -199 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cnc(OC4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800402 146838 0 None -199 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cnc(OC4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11852143 112351 0 None -549 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 8 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OC[C@@H](O)CO 10.1021/jm401456d
CHEMBL3122005 112351 0 None -549 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 8 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OC[C@@H](O)CO 10.1021/jm401456d
67266022 146842 0 None -70 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 516 13 4 9 3.2 CCc1cc(-c2noc(-c3cc(C)c(CNCC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800430 146842 0 None -70 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 516 13 4 9 3.2 CCc1cc(-c2noc(-c3cc(C)c(CNCC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
44217997 146362 0 None -933 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 498 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(OC)cc(CC(C)C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797365 146362 0 None -933 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 498 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(OC)cc(CC(C)C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
127046568 146365 0 None -128 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(OC4CCCC4)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797376 146365 0 None -128 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(OC4CCCC4)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
57391821 78434 0 None -707 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC(C)CCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935581 78434 0 None -707 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC(C)CCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963632 78434 0 None -707 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC(C)CCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
57437353 112340 0 None -234 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 515 12 3 6 4.4 CCc1cc(CCC(=O)c2sc(CC)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121995 112340 0 None -234 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 515 12 3 6 4.4 CCc1cc(CCC(=O)c2sc(CC)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
46237176 15635 0 None 6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 7 2 6 3.3 CC(C)/N=C1\S/C(=C\c2ccc(OC(CO)CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097183 15635 0 None 6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 7 2 6 3.3 CC(C)/N=C1\S/C(=C\c2ccc(OC(CO)CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46236523 15734 0 None -3 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 420 3 1 4 5.9 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1Cl 10.1021/jm100181s
CHEMBL1098143 15734 0 None -3 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 420 3 1 4 5.9 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1Cl 10.1021/jm100181s
57397897 77470 0 None -724 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 447 8 2 5 4.8 O=C(O)CNCCc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950566 77470 0 None -724 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 447 8 2 5 4.8 O=C(O)CNCCc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
16737345 64126 0 None -1 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 390 5 1 4 4.6 O=C(O)C1CN(Cc2ccc(-c3cc4cc(N5CCCCC5)ccc4o3)cc2)C1 10.1021/ml100227q
CHEMBL1651708 64126 0 None -1 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 390 5 1 4 4.6 O=C(O)C1CN(Cc2ccc(-c3cc4cc(N5CCCCC5)ccc4o3)cc2)C1 10.1021/ml100227q
66829311 146587 0 None -288 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 13 3 9 3.6 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798837 146587 0 None -288 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 13 3 9 3.6 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
67170110 150542 0 None -7079 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 499 4 1 6 5.4 O=C(O)C1CN(c2cc3c(cc2F)-c2noc(-c4onc(-c5ccccc5)c4C(F)(F)F)c2CC3)C1 nan
CHEMBL3900885 150542 0 None -7079 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 499 4 1 6 5.4 O=C(O)C1CN(c2cc3c(cc2F)-c2noc(-c4onc(-c5ccccc5)c4C(F)(F)F)c2CC3)C1 nan
76332741 112519 0 None -147 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 10 3 8 3.9 CCc1cc(-c2noc(-c3cc(C)nc(C4CCCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126586 112519 0 None -147 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 10 3 8 3.9 CCc1cc(-c2noc(-c3cc(C)nc(C4CCCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76321770 112212 0 None -6 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 8 1 6 6.4 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](C)CO 10.1021/jm401456d
CHEMBL3120183 112212 0 None -6 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 8 1 6 6.4 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](C)CO 10.1021/jm401456d
76336212 112310 0 None -9 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 8 3 8 3.8 Cc1cc(-c2noc(-c3sc(C)c4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121964 112310 0 None -9 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 8 3 8 3.8 Cc1cc(-c2noc(-c3sc(C)c4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
66829279 146372 0 None -117 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 12 3 9 2.9 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CC)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797412 146372 0 None -117 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 12 3 9 2.9 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CC)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
11603726 83605 0 None -6760 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 400 7 1 5 5.2 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL206940 83605 0 None -6760 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 400 7 1 5 5.2 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
57391920 76661 0 None -21 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1021/ml200252b
CHEMBL1938937 76661 0 None -21 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1021/ml200252b
57391920 76661 0 None -21 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938937 76661 0 None -21 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57570498 94387 0 None -5011 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 476 10 2 4 6.3 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
CHEMBL2336086 94387 0 None -5011 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 476 10 2 4 6.3 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
127048143 146625 0 None -354 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 525 14 3 9 3.1 CCCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1016/j.ejmech.2016.03.048
CHEMBL3799148 146625 0 None -354 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 525 14 3 9 3.1 CCCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1016/j.ejmech.2016.03.048
127046566 146775 0 None -338 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(C4CCCC4)cc(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799976 146775 0 None -338 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(C4CCCC4)cc(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
53235479 157341 0 None -1737 2 Human 5.8 pEC50 = 5.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 475 6 1 6 4.8 CC(C)Cc1onc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)c1C(F)(F)F nan
CHEMBL3954922 157341 0 None -1737 2 Human 5.8 pEC50 = 5.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 475 6 1 6 4.8 CC(C)Cc1onc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)c1C(F)(F)F nan
44422590 92304 0 None -12 2 Human 4.8 pEC50 = 4.8 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1ccc(NC(=O)[C@@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL227530 92304 0 None -12 2 Human 4.8 pEC50 = 4.8 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1ccc(NC(=O)[C@@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
57397066 77687 0 None -199 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.9 CC(C)c1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951306 77687 0 None -199 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.9 CC(C)c1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)cc2)n1 10.1016/j.bmcl.2011.12.019
11978048 77692 0 None -3801 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 491 9 1 8 5.3 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3OC)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951311 77692 0 None -3801 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 491 9 1 8 5.3 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3OC)cc2)n1 10.1016/j.bmcl.2011.12.019
46881875 14102 0 None -7 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 371 13 3 3 4.3 CCCCCCCOc1ccc(CC[C@](C)(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1086170 14102 0 None -7 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 371 13 3 3 4.3 CCCCCCCOc1ccc(CC[C@](C)(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
25031771 112512 0 None -5011 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.4 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
CHEMBL3126434 112512 0 None -5011 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.4 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
44218002 112543 0 None -776 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)c(CC(C)C)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126611 112543 0 None -776 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)c(CC(C)C)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
118716157 121670 0 None -23 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 412 12 4 6 2.8 CCCCCc1nc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)co1 10.1016/j.ejmech.2014.07.081
CHEMBL3341935 121670 0 None -23 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 412 12 4 6 2.8 CCCCCc1nc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)co1 10.1016/j.ejmech.2014.07.081
57396172 77447 0 None -512 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 433 7 2 5 4.8 O=C(O)CNCc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950481 77447 0 None -512 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 433 7 2 5 4.8 O=C(O)CNCc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
66655362 170398 0 None -79 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 423 8 1 4 4.6 CCc1cccc(CC)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
CHEMBL4203755 170398 0 None -79 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 423 8 1 4 4.6 CCc1cccc(CC)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
68082485 174299 0 None 1 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 395 8 1 4 3.9 O=C(O)CCN1CCC2(CC1)COc1cc(OCCCc3ccccc3)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4207162 174299 0 None 1 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 395 8 1 4 3.9 O=C(O)CCN1CCC2(CC1)COc1cc(OCCCc3ccccc3)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4300006 174299 0 None 1 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 395 8 1 4 3.9 O=C(O)CCN1CCC2(CC1)COc1cc(OCCCc3ccccc3)ccc12 10.1016/j.bmcl.2017.12.018
70695743 79961 0 None -39810 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 516 9 1 6 6.1 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2cccc3c2ccn3CCC(=O)O)s1 10.1016/j.bmcl.2012.02.016
CHEMBL2011746 79961 0 None -39810 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 516 9 1 6 6.1 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2cccc3c2ccn3CCC(=O)O)s1 10.1016/j.bmcl.2012.02.016
24824717 127635 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 496 6 1 7 6.1 O=C(O)c1cnn(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)c1 10.1021/jm5010336
CHEMBL3360358 127635 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 496 6 1 7 6.1 O=C(O)c1cnn(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)c1 10.1021/jm5010336
CHEMBL3558705 127635 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 496 6 1 7 6.1 O=C(O)c1cnn(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)c1 10.1021/jm5010336
54758399 72732 0 None -794 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 448 7 2 8 2.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(C(CO)CO)CC4)no2)cc1C#N 10.1021/jm200609t
CHEMBL1836172 72732 0 None -794 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 448 7 2 8 2.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(C(CO)CO)CC4)no2)cc1C#N 10.1021/jm200609t
44124898 123197 0 None -398 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 369 4 1 5 4.5 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3360365 123197 0 None -398 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 369 4 1 5 4.5 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4)no2)cc1Cl 10.1021/jm5010336
44129142 123199 0 None -125 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 385 4 1 6 4.3 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNCCO4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3360367 123199 0 None -125 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 385 4 1 6 4.3 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNCCO4)no2)cc1Cl 10.1021/jm5010336
11222939 74349 9 None -4 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.02.006
44438254 74349 9 None -4 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.02.006
CHEMBL190006 74349 9 None -4 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.02.006
44591249 187415 0 None -7 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 402 13 4 5 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2008.11.072
CHEMBL475495 187415 0 None -7 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 402 13 4 5 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2008.11.072
44412882 84063 0 None -316 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 390 6 1 4 5.8 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL208168 84063 0 None -316 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 390 6 1 4 5.8 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
11626664 84703 0 None -1584 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 455 7 1 6 5.1 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C(F)(F)F)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL209484 84703 0 None -1584 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 455 7 1 6 5.1 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C(F)(F)F)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
16038017 146196 0 None -14454 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 431 7 1 6 4.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OCC(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL379380 146196 0 None -14454 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 431 7 1 6 4.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OCC(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
10174255 91992 0 None -158 4 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1016/j.bmcl.2011.12.019
CHEMBL225575 91992 0 None -158 4 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1016/j.bmcl.2011.12.019
70681815 82052 0 None -8 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 480 5 2 4 5.1 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccc(CC(=O)O)cc21 10.1021/ml200252b
CHEMBL2037127 82052 0 None -8 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 480 5 2 4 5.1 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccc(CC(=O)O)cc21 10.1021/ml200252b
46835922 146233 13 None -4466 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3794064 146233 13 None -4466 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
57570459 94386 0 None -2630 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 462 10 2 4 5.9 C/C(=N\OCc1ccc(C2CCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
CHEMBL2336085 94386 0 None -2630 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 462 10 2 4 5.9 C/C(=N\OCc1ccc(C2CCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
127046183 146854 0 None -56 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 518 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)nc(-c4ccccc4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800496 146854 0 None -56 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 518 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)nc(-c4ccccc4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
56949019 152773 0 None -79 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 392 7 0 5 5.6 COc1ccc(OC)c(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
CHEMBL3918461 152773 0 None -79 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 392 7 0 5 5.6 COc1ccc(OC)c(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
69144915 111213 0 None -107 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 370 7 1 4 4.5 Cc1sc(C(=O)CCc2ccc(OCCO)cc2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
CHEMBL3103661 111213 0 None -107 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 370 7 1 4 4.5 Cc1sc(C(=O)CCc2ccc(OCCO)cc2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
46236274 15331 0 None -2 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1C(C)C 10.1021/jm100181s
CHEMBL1094501 15331 0 None -2 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1C(C)C 10.1021/jm100181s
67172159 149657 0 None -1174 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 497 6 2 6 5.5 CC(N)(CCc1ccc2c(c1)CCc1c-2noc1-c1noc(-c2ccccc2)c1C(F)(F)F)C(=O)O nan
CHEMBL3893505 149657 0 None -1174 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 497 6 2 6 5.5 CC(N)(CCc1ccc2c(c1)CCc1c-2noc1-c1noc(-c2ccccc2)c1C(F)(F)F)C(=O)O nan
46236930 15749 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 365 4 0 4 4.6 CC(C)/N=C1\S/C(=C\c2ccc(N(C)C)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098203 15749 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 365 4 0 4 4.6 CC(C)/N=C1\S/C(=C\c2ccc(N(C)C)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
10174255 91992 0 None -158 4 Human 7.8 pEC50 = 7.8 Functional
Activity at human S1P3 receptor expressed in CHO cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1021/jm0492507
CHEMBL225575 91992 0 None -158 4 Human 7.8 pEC50 = 7.8 Functional
Activity at human S1P3 receptor expressed in CHO cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1021/jm0492507
127046550 146641 0 None -11 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cnc(OC)c(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799227 146641 0 None -11 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cnc(OC)c(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
127048099 146359 0 None -602 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 518 13 4 10 1.9 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CCO)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797357 146359 0 None -602 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 518 13 4 10 1.9 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CCO)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
56948899 155292 0 None 1 2 Human 5.8 pEC50 = 5.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 392 7 0 5 5.6 COc1cc(OC)cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
CHEMBL3938390 155292 0 None 1 2 Human 5.8 pEC50 = 5.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 392 7 0 5 5.6 COc1cc(OC)cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
24851764 112559 0 None -295 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccc(CC(C)C)nc3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126627 112559 0 None -295 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccc(CC(C)C)nc3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76322127 112869 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 491 11 4 5 4.5 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccc(Cl)cc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133705 112869 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 491 11 4 5 4.5 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccc(Cl)cc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
76321769 112311 0 None -26 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 11 3 8 4.0 CCc1c(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)sc(C)c1CC(C)C 10.1021/jm401456d
CHEMBL3121965 112311 0 None -26 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 11 3 8 4.0 CCc1c(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)sc(C)c1CC(C)C 10.1021/jm401456d
76318058 112330 0 None -194 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 10 3 8 3.6 CCc1cc(-c2noc(-c3sc(CC)c4c3CCCC4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121985 112330 0 None -194 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 10 3 8 3.6 CCc1cc(-c2noc(-c3sc(CC)c4c3CCCC4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
16737679 64136 0 None -70 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1651717 64136 0 None -70 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100228m
76329327 112788 0 None -10 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 485 12 4 5 4.4 CCc1ccc(Cc2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1039/C3MD00079F
CHEMBL3132870 112788 0 None -10 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 485 12 4 5 4.4 CCc1ccc(Cc2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1039/C3MD00079F
46237180 15636 1 None -14 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OCC(O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1097184 15636 1 None -14 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OCC(O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
11852234 112336 0 None -407 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 513 10 2 6 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CN1CC(C(=O)O)C1 10.1021/jm401456d
CHEMBL3121991 112336 0 None -407 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 513 10 2 6 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CN1CC(C(=O)O)C1 10.1021/jm401456d
44218903 112542 0 None -63 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 509 11 3 9 2.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1N1CCCC1 10.1021/jm4014696
CHEMBL3126610 112542 0 None -63 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 509 11 3 9 2.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1N1CCCC1 10.1021/jm4014696
76318199 112561 0 None -389 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 11 3 8 2.5 CCCc1ccc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cn1 10.1021/jm4014696
CHEMBL3126629 112561 0 None -389 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 11 3 8 2.5 CCCc1ccc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cn1 10.1021/jm4014696
76311230 112849 0 None -26 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 441 12 4 5 3.7 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2F)cc1 10.1039/C3MD00079F
CHEMBL3133598 112849 0 None -26 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 441 12 4 5 3.7 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2F)cc1 10.1039/C3MD00079F
46236399 15333 0 None -1 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 378 3 1 4 5.1 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1C1CCCCC1 10.1021/jm100181s
CHEMBL1094503 15333 0 None -1 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 378 3 1 4 5.1 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1C1CCCCC1 10.1021/jm100181s
25192001 14831 0 None -2 4 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1091103 14831 0 None -2 4 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
118707193 119817 0 None -58 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 449 12 3 5 3.9 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(C)c2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311348 119817 0 None -58 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 449 12 3 5 3.9 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(C)c2)cc1 10.1016/j.bmc.2014.05.035
127046400 146388 0 None -162 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(C(CC)CC)cc(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797486 146388 0 None -162 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(C(CC)CC)cc(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
53322738 64778 0 None -22 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 446 6 1 4 5.5 Cc1ccc(Cc2ccc3sc(-c4ccc(CN5CC(C(=O)O)C5)cc4F)nc3c2)cc1 10.1021/ml100228m
CHEMBL1672566 64778 0 None -22 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 446 6 1 4 5.5 Cc1ccc(Cc2ccc3sc(-c4ccc(CN5CC(C(=O)O)C5)cc4F)nc3c2)cc1 10.1021/ml100228m
46846921 146578 0 None -549 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 442 7 1 7 4.5 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4C4CC4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3798775 146578 0 None -549 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 442 7 1 7 4.5 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4C4CC4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
58907649 93344 0 None -27 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 336 12 3 4 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315814 93344 0 None -27 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 336 12 3 4 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
11697277 111179 0 None -380 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 412 8 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCO 10.1021/jm4014373
CHEMBL3102992 111179 0 None -380 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 412 8 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCO 10.1021/jm4014373
46236666 15561 0 None 5 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 5 1 4 5.0 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1CCc1ccccc1 10.1021/jm100181s
CHEMBL1096541 15561 0 None 5 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 5 1 4 5.0 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1CCc1ccccc1 10.1021/jm100181s
76322117 112860 0 None 1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 449 13 4 4 4.1 CC(C)c1ccc(CCCCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133608 112860 0 None 1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 449 13 4 4 4.1 CC(C)c1ccc(CCCCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
11496072 152802 0 None -1513 3 Human 6.7 pEC50 = 6.7 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 448 7 1 5 6.1 Cc1cc(C(C)CC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL391869 152802 0 None -1513 3 Human 6.7 pEC50 = 6.7 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 448 7 1 5 6.1 Cc1cc(C(C)CC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
59202022 112318 0 None -436 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 431 9 3 8 2.5 CCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
CHEMBL3121972 112318 0 None -436 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 431 9 3 8 2.5 CCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
24956674 15629 0 None -2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 372 4 1 4 4.9 CCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097103 15629 0 None -2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 372 4 1 4 4.9 CCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
72793810 111468 0 None -28 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2nc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)no2)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
CHEMBL3105248 111468 0 None -28 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2nc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)no2)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
44406749 81811 0 None -1 3 Human 7.7 pEC50 = 7.7 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 565 18 4 10 4.7 C[C@@](N)(CCc1ccc(OCCCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
CHEMBL203475 81811 0 None -1 3 Human 7.7 pEC50 = 7.7 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 565 18 4 10 4.7 C[C@@](N)(CCc1ccc(OCCCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
134319702 173344 0 None -190 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human EDG3-Ga15-bla expressed in HEK293T cells after 45 mins by [35S]GTPgammaS binding assayAgonist activity at human EDG3-Ga15-bla expressed in HEK293T cells after 45 mins by [35S]GTPgammaS binding assay
ChEMBL 496 11 3 7 4.2 CCCCOCCOc1nc2c(s1)-c1ccc([C@H]3CC[C@](N)(COP(=O)(O)O)C3)cc1CC2 10.1039/C6MD00539J
CHEMBL4279752 173344 0 None -190 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human EDG3-Ga15-bla expressed in HEK293T cells after 45 mins by [35S]GTPgammaS binding assayAgonist activity at human EDG3-Ga15-bla expressed in HEK293T cells after 45 mins by [35S]GTPgammaS binding assay
ChEMBL 496 11 3 7 4.2 CCCCOCCOc1nc2c(s1)-c1ccc([C@H]3CC[C@](N)(COP(=O)(O)O)C3)cc1CC2 10.1039/C6MD00539J
127046741 146780 0 None -190 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(C)nc(OC4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800019 146780 0 None -190 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(C)nc(OC4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
23121374 65220 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 353 11 2 3 4.2 C/C(=C\c1ccc(OCCCc2ccccc2)cc1)CNCCC(=O)O 10.1016/j.bmcl.2011.01.029
CHEMBL1683046 65220 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 353 11 2 3 4.2 C/C(=C\c1ccc(OCCCc2ccccc2)cc1)CNCCC(=O)O 10.1016/j.bmcl.2011.01.029
46846904 146569 0 None -3548 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 466 7 1 7 4.7 CC(F)(F)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3798735 146569 0 None -3548 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 466 7 1 7 4.7 CC(F)(F)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
57570463 94367 0 None -3162 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 510 10 2 4 6.9 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(Cl)c1 10.1021/ml300396r
CHEMBL2336065 94367 0 None -3162 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 510 10 2 4 6.9 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(Cl)c1 10.1021/ml300396r
16737504 64122 0 None -7 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 363 6 1 3 4.8 CC(C)Cc1ccc2oc(-c3ccc(CN4CC(C(=O)O)C4)cc3)cc2c1 10.1021/ml100227q
CHEMBL1651704 64122 0 None -7 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 363 6 1 3 4.8 CC(C)Cc1ccc2oc(-c3ccc(CN4CC(C(=O)O)C4)cc3)cc2c1 10.1021/ml100227q
118716183 121680 0 None -36 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 446 10 4 7 2.2 CCc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342008 121680 0 None -36 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 446 10 4 7 2.2 CCc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
53326641 64772 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)cc5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672560 64772 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)cc5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
118716138 121649 0 None -20 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 412 12 4 7 1.9 CCCCCn1cc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)nn1 10.1016/j.ejmech.2014.07.081
CHEMBL3341916 121649 0 None -20 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 412 12 4 7 1.9 CCCCCn1cc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)nn1 10.1016/j.ejmech.2014.07.081
70681687 81750 0 None -6309 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 454 8 2 4 5.8 O=C(O)CCNCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.04.095
CHEMBL2032430 81750 0 None -6309 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 454 8 2 4 5.8 O=C(O)CCNCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.04.095
25182782 14399 0 None -691 2 Human 5.7 pEC50 = 5.7 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 431 7 2 6 3.2 CCCN(c1cc(C(=O)Nc2ccc(S(N)(=O)=O)cc2C)ncn1)C1CCCCC1 nan
CHEMBL1088178 14399 0 None -691 2 Human 5.7 pEC50 = 5.7 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 431 7 2 6 3.2 CCCN(c1cc(C(=O)Nc2ccc(S(N)(=O)=O)cc2C)ncn1)C1CCCCC1 nan
145947403 174447 0 None -125 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 443 8 1 4 5.1 CCCc1cccc(Cl)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
CHEMBL4205878 174447 0 None -125 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 443 8 1 4 5.1 CCCc1cccc(Cl)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
CHEMBL4301965 174447 0 None -125 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 443 8 1 4 5.1 CCCc1cccc(Cl)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
44129144 123163 0 None -15 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 457 7 1 7 4.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CN(CCC(=O)O)CCO4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359839 123163 0 None -15 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 457 7 1 7 4.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CN(CCC(=O)O)CCO4)no2)cc1Cl 10.1021/jm5010336
44128909 123169 0 None -501 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 432 6 1 7 3.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CC(=O)O)CC4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359845 123169 0 None -501 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 432 6 1 7 3.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CC(=O)O)CC4)no2)cc1C#N 10.1021/jm5010336
44125470 123209 0 None -3 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 441 8 1 6 5.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CN(CCCC(=O)O)C4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3360377 123209 0 None -3 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 441 8 1 6 5.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CN(CCCC(=O)O)C4)no2)cc1Cl 10.1021/jm5010336
70692257 81753 0 None -1995 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 5 1 4 6.4 O=C(O)CN1CCC(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032433 81753 0 None -1995 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 5 1 4 6.4 O=C(O)CN1CCC(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
70692258 81755 0 None -5011 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 481 5 1 5 5.4 O=C(O)CN1CCN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032435 81755 0 None -5011 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 481 5 1 5 5.4 O=C(O)CN1CCN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
70696411 81758 0 None -3981 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 508 7 1 4 6.9 O=C(O)C1CCCN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
CHEMBL2032438 81758 0 None -3981 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 508 7 1 4 6.9 O=C(O)C1CCCN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
70681689 81759 0 None -199 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 438 4 1 4 5.7 O=C(O)C1CN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
CHEMBL2032439 81759 0 None -199 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 438 4 1 4 5.7 O=C(O)C1CN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
44125704 123178 0 None -316 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 472 8 2 8 4.5 CC(C)Oc1ncc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359854 123178 0 None -316 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 472 8 2 8 4.5 CC(C)Oc1ncc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
118716180 121677 0 None -47 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 452 9 4 7 2.3 NC(CO)(CCc1ccc(-c2cn(-c3ccc(Cl)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3342005 121677 0 None -47 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 452 9 4 7 2.3 NC(CO)(CCc1ccc(-c2cn(-c3ccc(Cl)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
11452022 10368 39 None -19 6 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmc.2014.05.035
6996 10368 39 None -19 6 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmc.2014.05.035
CHEMBL366208 10368 39 None -19 6 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmc.2014.05.035
10883396 10421 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2012.11.053
5283560 10421 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2012.11.053
911 10421 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2012.11.053
CHEMBL225155 10421 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2012.11.053
76325528 112522 0 None -7 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 11 3 8 3.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCCC2)n1 10.1021/jm4014696
CHEMBL3126589 112522 0 None -7 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 11 3 8 3.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCCC2)n1 10.1021/jm4014696
10883396 10421 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
5283560 10421 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
911 10421 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
CHEMBL225155 10421 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
11222939 74349 9 None -4 4 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
44438254 74349 9 None -4 4 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL190006 74349 9 None -4 4 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
66829334 146683 0 None -39 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 14 3 9 3.6 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1CC 10.1016/j.ejmech.2016.03.048
CHEMBL3799441 146683 0 None -39 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 14 3 9 3.6 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1CC 10.1016/j.ejmech.2016.03.048
118707012 119773 0 None -28 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 435 12 3 5 3.5 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311106 119773 0 None -28 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 435 12 3 5 3.5 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmc.2014.05.035
46236403 15409 0 None -1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1 10.1021/jm100181s
CHEMBL1095153 15409 0 None -1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1 10.1021/jm100181s
57394951 77679 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1ccccc1Oc1ccc(-c2nc(-c3csc(CN4CC(C(=O)O)C4)c3)no2)cc1 10.1016/j.bmcl.2011.12.019
CHEMBL1951157 77679 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1ccccc1Oc1ccc(-c2nc(-c3csc(CN4CC(C(=O)O)C4)c3)no2)cc1 10.1016/j.bmcl.2011.12.019
44219368 146501 0 None -251 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 482 11 3 8 2.5 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798218 146501 0 None -251 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 482 11 3 8 2.5 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
11853580 111172 0 None -181 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 11 2 5 5.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNCC(=O)O 10.1021/jm4014373
CHEMBL3102985 111172 0 None -181 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 11 2 5 5.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNCC(=O)O 10.1021/jm4014373
76332956 112850 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 441 12 4 5 3.7 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)c(F)c2)cc1 10.1039/C3MD00079F
CHEMBL3133599 112850 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 441 12 4 5 3.7 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)c(F)c2)cc1 10.1039/C3MD00079F
57400585 76657 0 None -48 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 471 5 1 6 4.2 CC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938933 76657 0 None -48 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 471 5 1 6 4.2 CC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
57402358 76652 0 None -19 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 461 7 1 5 5.6 CCC(c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1)c1ccccn1 10.1016/j.bmcl.2011.10.069
CHEMBL1938927 76652 0 None -19 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 461 7 1 5 5.6 CCC(c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1)c1ccccn1 10.1016/j.bmcl.2011.10.069
57402280 78267 0 None -31622 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.7 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCC(C)Cc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935580 78267 0 None -31622 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.7 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCC(C)Cc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1962533 78267 0 None -31622 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.7 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCC(C)Cc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
76311232 112857 0 None 1 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 421 12 4 4 3.2 CCCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133605 112857 0 None 1 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 421 12 4 4 3.2 CCCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
127046325 146403 0 None -208 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.5 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(CC)CC 10.1016/j.ejmech.2016.03.048
CHEMBL3797596 146403 0 None -208 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.5 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(CC)CC 10.1016/j.ejmech.2016.03.048
127047083 146770 0 None -346 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)c(C4CCCC4)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799953 146770 0 None -346 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)c(C4CCCC4)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
76322118 112861 0 None -2 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 409 12 4 4 3.7 CCCCCCc1ccc2cc(CCC(N)(CO)COP(=O)(O)O)ccc2c1 10.1039/C3MD00079F
CHEMBL3133609 112861 0 None -2 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 409 12 4 4 3.7 CCCCCCc1ccc2cc(CCC(N)(CO)COP(=O)(O)O)ccc2c1 10.1039/C3MD00079F
127046456 146432 0 None -138 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 4 8 3.2 CCc1cc(-c2noc(-c3cc(C)cc(CNCC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797802 146432 0 None -138 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 4 8 3.2 CCc1cc(-c2noc(-c3cc(C)cc(CNCC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
118716144 121656 0 None -28 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 502 10 4 7 3.6 NC(CO)(CCc1ccc(-c2coc(-c3ccc(OC(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341922 121656 0 None -28 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 502 10 4 7 3.6 NC(CO)(CCc1ccc(-c2coc(-c3ccc(OC(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
46236805 15562 0 None 8 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 428 7 1 4 5.7 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1CCCCc1ccccc1 10.1021/jm100181s
CHEMBL1096542 15562 0 None 8 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 428 7 1 4 5.7 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1CCCCc1ccccc1 10.1021/jm100181s
46236934 15827 0 None 2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 368 4 1 5 4.3 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1O 10.1021/jm100181s
CHEMBL1098772 15827 0 None 2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 368 4 1 5 4.3 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1O 10.1021/jm100181s
76322128 112872 0 None -6 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 473 11 4 6 3.9 COc1cccc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)c1 10.1039/C3MD00079F
CHEMBL3133708 112872 0 None -6 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 473 11 4 6 3.9 COc1cccc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)c1 10.1039/C3MD00079F
127047020 146798 0 None -72 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 496 11 3 9 2.8 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800133 146798 0 None -72 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 496 11 3 9 2.8 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
118707196 119820 0 None -54 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 469 12 3 5 4.2 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(Cl)c2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311351 119820 0 None -54 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 469 12 3 5 4.2 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(Cl)c2)cc1 10.1016/j.bmc.2014.05.035
59982944 94366 0 None -7244 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 494 10 2 4 6.4 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(F)c1 10.1021/ml300396r
CHEMBL2336064 94366 0 None -7244 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 494 10 2 4 6.4 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(F)c1 10.1021/ml300396r
11633613 111209 0 None -346 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 442 9 2 5 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(CO)CO 10.1021/jm4014373
CHEMBL3103657 111209 0 None -346 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 442 9 2 5 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(CO)CO 10.1021/jm4014373
56949269 151207 0 None -21 2 Human 5.7 pEC50 = 5.7 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 333 5 0 4 5.0 c1ccc(C2(CCc3nc(-c4cccnc4)no3)CCCCC2)cc1 nan
CHEMBL3906369 151207 0 None -21 2 Human 5.7 pEC50 = 5.7 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 333 5 0 4 5.0 c1ccc(C2(CCc3nc(-c4cccnc4)no3)CCCCC2)cc1 nan
56948778 153767 0 None -4 2 Human 5.7 pEC50 = 5.7 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 346 5 0 3 5.9 Cc1cccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
CHEMBL3926389 153767 0 None -4 2 Human 5.7 pEC50 = 5.7 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 346 5 0 3 5.9 Cc1cccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
57400476 78433 0 None -36307 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 5.0 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCC(C)c3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935579 78433 0 None -36307 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 5.0 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCC(C)c3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963631 78433 0 None -36307 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 5.0 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCC(C)c3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
76329326 112867 0 None -1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 471 11 4 5 4.1 Cc1ccc(Cc2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133703 112867 0 None -1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 471 11 4 5 4.1 Cc1ccc(Cc2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1039/C3MD00079F
46236664 15299 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 373 3 1 5 4.3 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1cccnc1 10.1021/jm100181s
CHEMBL1094247 15299 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 373 3 1 5 4.3 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1cccnc1 10.1021/jm100181s
44422604 92223 0 None -10 5 Human 7.6 pEC50 = 7.6 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 432 15 4 4 4.4 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)CC(F)OP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL226612 92223 0 None -10 5 Human 7.6 pEC50 = 7.6 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 432 15 4 4 4.4 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)CC(F)OP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
11575913 84897 0 None -5 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 444 7 1 5 5.3 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Br)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL210316 84897 0 None -5 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 444 7 1 5 5.3 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Br)c2)n1 10.1016/j.bmcl.2006.04.084
127046179 146585 0 None -41 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 544 13 3 9 3.9 CCc1cc(-c2noc(-c3sc(CN(C)CC(C)C)c(C)c3C)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798807 146585 0 None -41 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 544 13 3 9 3.9 CCc1cc(-c2noc(-c3sc(CN(C)CC(C)C)c(C)c3C)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
46880801 13038 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 314 7 2 5 3.1 CCCN(CCC)c1cc(C(=O)Nc2ccc(O)cc2)ncn1 nan
CHEMBL1081646 13038 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 314 7 2 5 3.1 CCCN(CCC)c1cc(C(=O)Nc2ccc(O)cc2)ncn1 nan
46880801 13038 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 314 7 2 5 3.1 CCCN(CCC)c1cc(C(=O)Nc2ccc(O)cc2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1081646 13038 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 314 7 2 5 3.1 CCCN(CCC)c1cc(C(=O)Nc2ccc(O)cc2)ncn1 10.1016/j.bmcl.2010.01.102
25182774 12899 0 None -11 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 364 4 2 5 3.7 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(C)C2CCCCC2)ncn1 nan
CHEMBL1080881 12899 0 None -11 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 364 4 2 5 3.7 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(C)C2CCCCC2)ncn1 nan
25182928 152747 0 None -81 2 Human 6.6 pEC50 = 6.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 463 9 2 6 3.8 O=C(Nc1ccc(CN2CC(C(=O)O)C2)cc1)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL3918272 152747 0 None -81 2 Human 6.6 pEC50 = 6.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 463 9 2 6 3.8 O=C(Nc1ccc(CN2CC(C(=O)O)C2)cc1)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
46881623 13535 0 None -389 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 477 9 2 6 4.1 Cc1cc(CN2CC(C(=O)O)C2)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1083828 13535 0 None -389 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 477 9 2 6 4.1 Cc1cc(CN2CC(C(=O)O)C2)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
23729211 112314 0 None -154 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 10 3 8 3.4 Cc1cc(-c2noc(-c3cc(CC(C)C)c(C)s3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121968 112314 0 None -154 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 10 3 8 3.4 Cc1cc(-c2noc(-c3cc(CC(C)C)c(C)s3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
118716146 121658 0 None -10 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 10 4 6 3.9 CC(C)c1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341924 121658 0 None -10 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 10 4 6 3.9 CC(C)c1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
76310852 112332 0 None -21 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 525 10 3 8 4.0 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC3(CC3)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121987 112332 0 None -21 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 525 10 3 8 4.0 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC3(CC3)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
76310992 112517 0 None -239 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 480 10 3 8 3.1 CCc1cc(-c2noc(-c3cc(C)nc(C4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126584 112517 0 None -239 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 480 10 3 8 3.1 CCc1cc(-c2noc(-c3cc(C)nc(C4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76321896 112556 0 None -120 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 11 3 8 3.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1C1CCCC1 10.1021/jm4014696
CHEMBL3126624 112556 0 None -120 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 11 3 8 3.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1C1CCCC1 10.1021/jm4014696
46237175 15634 0 None -1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 7 2 6 3.3 CC(C)/N=C1\S/C(=C\c2ccc(OCC(O)CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097182 15634 0 None -1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 7 2 6 3.3 CC(C)/N=C1\S/C(=C\c2ccc(OCC(O)CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46881912 13538 0 None -5 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 425 13 2 5 2.8 CCCCCCCOc1ccc(CC[C@](C)(N)CCN2CC(=O)NS2(=O)=O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1083841 13538 0 None -5 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 425 13 2 5 2.8 CCCCCCCOc1ccc(CC[C@](C)(N)CCN2CC(=O)NS2(=O)=O)cc1 10.1016/j.bmcl.2010.01.118
57437389 112342 0 None -186 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 555 11 3 6 4.8 CCc1cc(CCC(=O)c2sc(C(F)(F)F)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121997 112342 0 None -186 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 555 11 3 6 4.8 CCc1cc(CCC(=O)c2sc(C(F)(F)F)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
5309153 44272 10 None 24 4 Human 6.6 pEC50 = 6.6 Functional
PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]
ChEMBL 318 5 0 3 4.7 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 nan
CHEMBL1455786 44272 10 None 24 4 Human 6.6 pEC50 = 6.6 Functional
PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]
ChEMBL 318 5 0 3 4.7 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 nan
53322737 64776 0 None -93 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 446 6 1 4 5.5 Cc1ccccc1Cc1ccc2sc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)nc2c1 10.1021/ml100228m
CHEMBL1672564 64776 0 None -93 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 446 6 1 4 5.5 Cc1ccccc1Cc1ccc2sc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)nc2c1 10.1021/ml100228m
118716141 121652 0 None -15 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 436 9 4 6 2.9 NC(CO)(CCc1ccc(-c2coc(-c3ccc(F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341919 121652 0 None -15 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 436 9 4 6 2.9 NC(CO)(CCc1ccc(-c2coc(-c3ccc(F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
46236522 15701 0 None -7 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 420 3 1 4 5.9 Cc1c(Cl)cccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1097809 15701 0 None -7 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 420 3 1 4 5.9 Cc1c(Cl)cccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
66636847 112315 0 None -407 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 459 10 3 8 3.1 Cc1cc(-c2noc(-c3ccc(CC(C)C)s3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121969 112315 0 None -407 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 459 10 3 8 3.1 Cc1cc(-c2noc(-c3ccc(CC(C)C)s3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
46880964 14370 0 None -416 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 457 8 2 6 3.5 CNS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)c(C)c1 nan
CHEMBL1087909 14370 0 None -416 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 457 8 2 6 3.5 CNS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)c(C)c1 nan
76328931 112323 0 None -63 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 472 11 2 5 5.8 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC(CC)(CC)CC2 10.1021/jm401456d
CHEMBL3121978 112323 0 None -63 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 472 11 2 5 5.8 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC(CC)(CC)CC2 10.1021/jm401456d
76336214 112341 0 None -19 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 529 13 3 6 4.8 CCCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c2)c2c1CC(C)(C)CC2 10.1021/jm401456d
CHEMBL3121996 112341 0 None -19 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 529 13 3 6 4.8 CCCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c2)c2c1CC(C)(C)CC2 10.1021/jm401456d
76325529 112523 0 None -12 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 522 11 3 8 4.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCCCC2)n1 10.1021/jm4014696
CHEMBL3126590 112523 0 None -12 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 522 11 3 8 4.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCCCC2)n1 10.1021/jm4014696
76314625 112554 0 None -251 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cnc(C4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126622 112554 0 None -251 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cnc(C4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
25192001 14831 0 None -2 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1091103 14831 0 None -2 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
57391921 76662 0 None -61 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1nc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938938 76662 0 None -61 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1nc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57395370 76663 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ncccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938939 76663 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ncccc21 10.1016/j.bmcl.2011.10.085
57402391 76664 0 None -104 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938940 76664 0 None -104 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
57395371 76665 0 None -87 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccncc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938941 76665 0 None -87 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccncc21 10.1016/j.bmcl.2011.10.085
57395372 76666 0 None -13 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccnc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938942 76666 0 None -13 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccnc21 10.1016/j.bmcl.2011.10.085
57393649 76667 0 None -60 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)n2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938943 76667 0 None -60 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)n2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57395373 76668 0 None -2 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2cc(C(F)(F)F)c(-c3ccccc3)cn2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938944 76668 0 None -2 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2cc(C(F)(F)F)c(-c3ccccc3)cn2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57395374 76669 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2cnc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938945 76669 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2cnc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57402392 76670 0 None -41 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938946 76670 0 None -41 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57400586 76671 0 None -8 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3cccnc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938947 76671 0 None -8 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3cccnc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57400587 76672 0 None -5 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccncc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938948 76672 0 None -5 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccncc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
56834955 76673 0 None -125 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 424 3 1 5 4.3 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)n2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938949 76673 0 None -125 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 424 3 1 5 4.3 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)n2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
57400588 76674 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 424 3 1 5 4.3 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)c2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938950 76674 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 424 3 1 5 4.3 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)c2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
57398897 76675 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 425 3 1 6 3.7 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)n2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938951 76675 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 425 3 1 6 3.7 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)n2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
57570467 94365 0 None -147 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 466 10 2 5 5.9 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)o1 10.1021/ml300396r
CHEMBL2336063 94365 0 None -147 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 466 10 2 5 5.9 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)o1 10.1021/ml300396r
16737513 64127 0 None -11 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 379 8 1 4 4.8 CCCCOc1ccc2cc(-c3ccc(CN4CC(C(=O)O)C4)cc3)oc2c1 10.1021/ml100227q
CHEMBL1651709 64127 0 None -11 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 379 8 1 4 4.8 CCCCOc1ccc2cc(-c3ccc(CN4CC(C(=O)O)C4)cc3)oc2c1 10.1021/ml100227q
44125589 123175 0 None -100 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 457 7 2 7 4.6 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNC(CCC(=O)O)CO4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359851 123175 0 None -100 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 457 7 2 7 4.6 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNC(CCC(=O)O)CO4)no2)cc1Cl 10.1021/jm5010336
70694325 81748 0 None -7943 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 454 8 2 4 5.8 O=C(O)CNCCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.04.095
CHEMBL2032428 81748 0 None -7943 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 454 8 2 4 5.8 O=C(O)CNCCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.04.095
53323421 64173 0 None -75 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 461 6 1 5 5.3 CC(C)(c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
CHEMBL1651860 64173 0 None -75 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 461 6 1 5 5.3 CC(C)(c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
54576721 82820 0 None -3162 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 474 9 1 6 5.1 CCc1c(CCN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(CC(C)C)c(C#N)c2)n1 10.1021/jm2016107
CHEMBL2057286 82820 0 None -3162 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 474 9 1 6 5.1 CCc1c(CCN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(CC(C)C)c(C#N)c2)n1 10.1021/jm2016107
57522812 83222 0 None -10000 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 505 8 1 6 5.8 CCc1c(CN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
CHEMBL2059686 83222 0 None -10000 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 505 8 1 6 5.8 CCc1c(CN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
54576288 83223 0 None -25118 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 547 9 1 6 6.6 CCc1c(CCN2CCC(C(=O)O)CC2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
CHEMBL2059687 83223 0 None -25118 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 547 9 1 6 6.6 CCc1c(CCN2CCC(C(=O)O)CC2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
107970 8420 83 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
2407 8420 83 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
4167 8420 83 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
CHEMBL314854 8420 83 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
DB08868 8420 83 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
70689433 79950 0 None -10 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 556 11 2 7 4.4 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2cccc(S(=O)(=O)NCCC(=O)O)c2)s1 10.1016/j.bmcl.2012.02.016
CHEMBL2011735 79950 0 None -10 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 556 11 2 7 4.4 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2cccc(S(=O)(=O)NCCC(=O)O)c2)s1 10.1016/j.bmcl.2012.02.016
49842175 72731 0 None -19952 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 489 8 2 8 3.2 Cc1c(-c2noc(-c3ccc(OC(C)C)c(C#N)c3)n2)ccc2c1CCN(CC(=O)N[C@@H](C)CO)C2 10.1021/jm200609t
CHEMBL1836171 72731 0 None -19952 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 489 8 2 8 3.2 Cc1c(-c2noc(-c3ccc(OC(C)C)c(C#N)c3)n2)ccc2c1CCN(CC(=O)N[C@@H](C)CO)C2 10.1021/jm200609t
44129145 123165 0 None -398 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 462 8 1 8 4.1 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CN(CCCC(=O)O)CCO4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359841 123165 0 None -398 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 462 8 1 8 4.1 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CN(CCCC(=O)O)CCO4)no2)cc1C#N 10.1021/jm5010336
42636536 123177 0 None -2511 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 471 8 2 7 5.1 CC(C)Oc1ccc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359853 123177 0 None -2511 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 471 8 2 7 5.1 CC(C)Oc1ccc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
76329073 112528 0 None -288 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C4CCCC4)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126596 112528 0 None -288 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C4CCCC4)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
46237047 15666 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 356 3 0 3 5.2 CC(C)/N=C1\S/C(=C\c2ccccc2Cl)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097527 15666 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 356 3 0 3 5.2 CC(C)/N=C1\S/C(=C\c2ccccc2Cl)C(=O)N1c1ccccc1 10.1021/jm100181s
25182909 12803 0 None -21 2 Human 6.6 pEC50 = 6.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 501 10 3 7 2.9 Cc1cc(S(=O)(=O)NCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1080384 12803 0 None -21 2 Human 6.6 pEC50 = 6.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 501 10 3 7 2.9 Cc1cc(S(=O)(=O)NCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
69143673 111219 0 None -446 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 384 7 1 4 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)ccc1OCCO 10.1021/jm4014373
CHEMBL3103667 111219 0 None -446 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 384 7 1 4 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)ccc1OCCO 10.1021/jm4014373
76318055 112306 0 None -5 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 8 1 6 6.3 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OCCC(=O)O 10.1021/jm401456d
CHEMBL3121960 112306 0 None -5 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 8 1 6 6.3 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OCCC(=O)O 10.1021/jm401456d
46846902 146542 0 None -501 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 6 1 7 4.9 CC(C)(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3798531 146542 0 None -501 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 6 1 7 4.9 CC(C)(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
44625753 94363 0 None -1862 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 477 10 2 5 5.7 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cn1 10.1021/ml300396r
CHEMBL2336061 94363 0 None -1862 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 477 10 2 5 5.7 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cn1 10.1021/ml300396r
44439851 152425 0 None -5248 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 403 6 1 6 4.6 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL391581 152425 0 None -5248 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 403 6 1 6 4.6 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
76310994 112553 0 None -2951 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.7 CCc1cc(-c2noc(-c3cnc(C(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126621 112553 0 None -2951 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.7 CCc1cc(-c2noc(-c3cnc(C(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
24956676 15294 0 None -2 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 5 1 4 5.3 CCCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094213 15294 0 None -2 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 5 1 4 5.3 CCCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
44439851 152425 0 None -5248 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 403 6 1 6 4.6 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL391581 152425 0 None -5248 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 403 6 1 6 4.6 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
57395369 76660 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 5 1 6 4.5 CC1(C)SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938936 76660 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 5 1 6 4.5 CC1(C)SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
11452022 10368 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.085
6996 10368 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.085
CHEMBL366208 10368 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.085
68547259 146754 0 None -89 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 498 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(CC(C)C)nc(OC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799872 146754 0 None -89 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 498 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(CC(C)C)nc(OC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11452022 10368 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assayAgonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.0c00631
6996 10368 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assayAgonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.0c00631
CHEMBL366208 10368 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assayAgonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.0c00631
11452022 10368 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
6996 10368 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
CHEMBL366208 10368 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
44422573 92331 0 None -10 4 Human 6.6 pEC50 = 6.6 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1ccc(NC(=O)[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL227851 92331 0 None -10 4 Human 6.6 pEC50 = 6.6 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1ccc(NC(=O)[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
16737679 64136 0 None -70 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100227q
CHEMBL1651717 64136 0 None -70 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100227q
53324301 64769 0 None -1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.3 O=C(O)C1CN(Cc2ccc(-n3cc4ccc(Cc5ccccc5)cc4n3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672557 64769 0 None -1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.3 O=C(O)C1CN(Cc2ccc(-n3cc4ccc(Cc5ccccc5)cc4n3)c(F)c2)C1 10.1021/ml100228m
24825339 98541 0 None -6309 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 392 7 1 7 3.8 Cc1nc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL241052 98541 0 None -6309 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 392 7 1 7 3.8 Cc1nc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
11567535 111214 0 None -602 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 400 8 1 5 4.5 COc1cc(OCCO)ccc1CCC(=O)c1sc(C)c2c1C[C@@H]1[C@H]2C1(C)C 10.1021/jm4014373
CHEMBL3103662 111214 0 None -602 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 400 8 1 5 4.5 COc1cc(OCCO)ccc1CCC(=O)c1sc(C)c2c1C[C@@H]1[C@H]2C1(C)C 10.1021/jm4014373
44565715 187222 0 None -3 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 498 12 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475253 187222 0 None -3 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 498 12 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
11222939 74349 9 None -4 4 Human 7.5 pEC50 = 7.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1021/jm050242f
44438254 74349 9 None -4 4 Human 7.5 pEC50 = 7.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1021/jm050242f
CHEMBL190006 74349 9 None -4 4 Human 7.5 pEC50 = 7.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1021/jm050242f
11853338 111498 0 None -263 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 8 0 4 5.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCN(C)C 10.1021/jm4014373
CHEMBL3105491 111498 0 None -263 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 8 0 4 5.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCN(C)C 10.1021/jm4014373
44565739 185739 0 None -33 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 459 12 4 5 4.2 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL470511 185739 0 None -33 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 459 12 4 5 4.2 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
69263869 111486 0 None -660 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 436 6 1 5 6.0 CCc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1CCC(=O)O 10.1021/jm4014373
CHEMBL3105479 111486 0 None -660 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 436 6 1 5 6.0 CCc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1CCC(=O)O 10.1021/jm4014373
53318125 64166 0 None -20 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)cnc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651853 64166 0 None -20 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)cnc4s3)c(F)c2)C1 10.1021/ml100306h
68762699 112555 0 None -288 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1CC(C)C 10.1021/jm4014696
CHEMBL3126623 112555 0 None -288 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1CC(C)C 10.1021/jm4014696
57395262 78271 0 None -1071 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3F)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935578 78271 0 None -1071 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3F)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1962545 78271 0 None -1071 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3F)ccc21 10.1016/j.bmcl.2011.11.048
76318200 112562 0 None -741 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccc(C(C)C)nc3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126630 112562 0 None -741 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccc(C(C)C)nc3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
127046095 146566 0 None -9 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3798722 146566 0 None -9 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1C 10.1016/j.ejmech.2016.03.048
57402284 78268 0 None -26915 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 437 9 1 3 5.2 CC[C@H](COc1ccc2c(c1)CCC(CN1CC(C(=O)O)C1)=C2C)Cc1ccc(F)cc1 10.1016/j.bmcl.2011.11.048
CHEMBL1935585 78268 0 None -26915 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 437 9 1 3 5.2 CC[C@H](COc1ccc2c(c1)CCC(CN1CC(C(=O)O)C1)=C2C)Cc1ccc(F)cc1 10.1016/j.bmcl.2011.11.048
CHEMBL1962534 78268 0 None -26915 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 437 9 1 3 5.2 CC[C@H](COc1ccc2c(c1)CCC(CN1CC(C(=O)O)C1)=C2C)Cc1ccc(F)cc1 10.1016/j.bmcl.2011.11.048
118716148 121660 0 None -19 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 443 9 4 7 2.6 N#Cc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341926 121660 0 None -19 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 443 9 4 7 2.6 N#Cc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
11452022 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at SIP3 receptorAgonist activity at SIP3 receptor
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2012.04.095
6996 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at SIP3 receptorAgonist activity at SIP3 receptor
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2012.04.095
CHEMBL366208 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at SIP3 receptorAgonist activity at SIP3 receptor
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2012.04.095
10883396 10421 45 None 1 15 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
5283560 10421 45 None 1 15 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
911 10421 45 None 1 15 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
CHEMBL225155 10421 45 None 1 15 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
11452022 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm050242f
6996 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm050242f
CHEMBL366208 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm050242f
11452022 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2012.02.022
6996 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2012.02.022
CHEMBL366208 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2012.02.022
11452022 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100301k
6996 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100301k
CHEMBL366208 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100301k
44217654 146873 0 None -1 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 552 15 3 8 4.2 CCCc1cc(CN(C)CC(C)C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
CHEMBL3800604 146873 0 None -1 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 552 15 3 8 4.2 CCCc1cc(CN(C)CC(C)C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
2924 8421 43 None -10 7 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor by GTPgammaS binding assayAgonist activity at human S1P3 receptor by GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.5b00448
44398069 8421 43 None -10 7 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor by GTPgammaS binding assayAgonist activity at human S1P3 receptor by GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.5b00448
9908268 8421 43 None -10 7 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor by GTPgammaS binding assayAgonist activity at human S1P3 receptor by GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.5b00448
CHEMBL114606 8421 43 None -10 7 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor by GTPgammaS binding assayAgonist activity at human S1P3 receptor by GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.5b00448
76314621 112520 0 None -18 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 510 13 3 8 4.0 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C(CC)CC)n1 10.1021/jm4014696
CHEMBL3126587 112520 0 None -18 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 510 13 3 8 4.0 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C(CC)CC)n1 10.1021/jm4014696
2924 8421 43 None -10 7 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting methodAgonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.0c01109
44398069 8421 43 None -10 7 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting methodAgonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.0c01109
9908268 8421 43 None -10 7 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting methodAgonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.0c01109
CHEMBL114606 8421 43 None -10 7 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting methodAgonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.0c01109
76322116 112859 0 None 54 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 421 12 4 4 3.2 CCc1ccc(CCCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133607 112859 0 None 54 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 421 12 4 4 3.2 CCc1ccc(CCCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
10883396 10421 45 None 1 15 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation countingAgonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/ml400194r
5283560 10421 45 None 1 15 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation countingAgonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/ml400194r
911 10421 45 None 1 15 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation countingAgonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/ml400194r
CHEMBL225155 10421 45 None 1 15 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation countingAgonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/ml400194r
44218604 112540 0 None -100 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 13 3 9 2.9 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1N(CC)CC 10.1021/jm4014696
CHEMBL3126608 112540 0 None -100 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 13 3 9 2.9 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1N(CC)CC 10.1021/jm4014696
45377662 90892 0 None -1000 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 468 9 1 6 4.3 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207778 90892 0 None -1000 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 468 9 1 6 4.3 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
58390859 90904 0 None -338 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 484 9 1 6 4.8 CCCCN(C(=O)c1ccccc1Cl)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207791 90904 0 None -338 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 484 9 1 6 4.8 CCCCN(C(=O)c1ccccc1Cl)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
46866185 14104 0 None -15 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 321 12 2 3 4.2 CCCCCCCOc1ccc(CC[C@](C)(N)CC(=O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1086172 14104 0 None -15 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 321 12 2 3 4.2 CCCCCCCOc1ccc(CC[C@](C)(N)CC(=O)O)cc1 10.1016/j.bmcl.2010.01.118
57394952 77680 0 None -144 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1cc(-c2nc(-c3csc(CN4CC(C(=O)O)C4)c3)no2)ccc1Oc1ccccc1 10.1016/j.bmcl.2011.12.019
CHEMBL1951158 77680 0 None -144 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1cc(-c2nc(-c3csc(CN4CC(C(=O)O)C4)c3)no2)ccc1Oc1ccccc1 10.1016/j.bmcl.2011.12.019
23121172 70209 0 None -301 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 367 12 2 3 4.6 C/C(=C\c1ccc(OCCCCc2ccccc2)cc1)CNCCC(=O)O 10.1016/j.bmcl.2011.05.029
CHEMBL1797506 70209 0 None -301 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 367 12 2 3 4.6 C/C(=C\c1ccc(OCCCCc2ccccc2)cc1)CNCCC(=O)O 10.1016/j.bmcl.2011.05.029
57570487 94384 0 None -199 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 460 10 2 5 5.5 C/C(=N\OCc1ccc(-c2ccco2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
CHEMBL2336083 94384 0 None -199 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 460 10 2 5 5.5 C/C(=N\OCc1ccc(-c2ccco2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
118716178 121675 0 None -23 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 448 10 4 8 1.7 COc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342003 121675 0 None -23 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 448 10 4 8 1.7 COc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
76322119 112864 0 None -4 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 423 12 4 5 3.6 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133612 112864 0 None -4 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 423 12 4 5 3.6 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
46236272 15370 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 398 3 1 4 5.5 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCCC2)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094834 15370 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 398 3 1 4 5.5 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCCC2)N1c1ccccc1 10.1021/jm100181s
46236517 15787 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1cccc(C)c1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1098467 15787 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1cccc(C)c1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
25072410 112526 0 None -162 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 3 9 2.4 CCc1cc(-c2noc(-c3cc(C)nc(N4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126593 112526 0 None -162 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 3 9 2.4 CCc1cc(-c2noc(-c3cc(C)nc(N4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76329076 112544 0 None -707 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3ccc(CC(C)C)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126612 112544 0 None -707 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3ccc(CC(C)C)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11678855 141221 0 None -31 3 Human 7.5 pEC50 = 7.5 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 607 21 4 10 5.9 C[C@@](N)(CCc1ccc(OCCCCCCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
CHEMBL371758 141221 0 None -31 3 Human 7.5 pEC50 = 7.5 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 607 21 4 10 5.9 C[C@@](N)(CCc1ccc(OCCCCCCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
46236273 15292 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 3 1 4 5.9 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCCCC2)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094193 15292 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 3 1 4 5.9 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCCCC2)N1c1ccccc1 10.1021/jm100181s
25032056 112513 0 None -776 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.8 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
CHEMBL3126435 112513 0 None -776 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.8 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
46195467 156136 0 None -17 2 Human 6.5 pEC50 = 6.5 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 482 12 3 9 3.0 CCCOc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1OCCC nan
CHEMBL3945262 156136 0 None -17 2 Human 6.5 pEC50 = 6.5 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 482 12 3 9 3.0 CCCOc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1OCCC nan
46881876 12373 0 None -12 3 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 335 13 2 3 4.6 CCCCCCCOc1ccc(CC[C@](C)(N)CCC(=O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1077288 12373 0 None -12 3 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 335 13 2 3 4.6 CCCCCCCOc1ccc(CC[C@](C)(N)CCC(=O)O)cc1 10.1016/j.bmcl.2010.01.118
127046992 146814 0 None -61 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 508 11 3 8 3.0 CCc1cc(-c2noc(-c3ccc(CN4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800230 146814 0 None -61 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 508 11 3 8 3.0 CCc1cc(-c2noc(-c3ccc(CN4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
44547414 75118 0 None -2398 6 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at recombinant human S1P3 receptor expressed in HEK293 cells after 2 hrs by beta-arrestin assayAgonist activity at recombinant human S1P3 receptor expressed in HEK293 cells after 2 hrs by beta-arrestin assay
ChEMBL 499 5 1 5 5.2 O=C(O)CCC(=O)N1CCc2cc(-c3noc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)ccc21 10.1016/j.bmcl.2011.05.110
CHEMBL1916559 75118 0 None -2398 6 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at recombinant human S1P3 receptor expressed in HEK293 cells after 2 hrs by beta-arrestin assayAgonist activity at recombinant human S1P3 receptor expressed in HEK293 cells after 2 hrs by beta-arrestin assay
ChEMBL 499 5 1 5 5.2 O=C(O)CCC(=O)N1CCc2cc(-c3noc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)ccc21 10.1016/j.bmcl.2011.05.110
11852848 112344 0 None -186 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 9 3 8 3.7 CCc1cc(-c2noc(-c3scc4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121999 112344 0 None -186 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 9 3 8 3.7 CCc1cc(-c2noc(-c3scc4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
54576289 83224 0 None -12589 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 519 9 1 6 5.8 CCc1c(CCN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
CHEMBL2059688 83224 0 None -12589 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 519 9 1 6 5.8 CCc1c(CCN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
57505996 123196 1 None -7943 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 360 4 1 6 3.7 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCNC4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3360364 123196 1 None -7943 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 360 4 1 6 3.7 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCNC4)no2)cc1C#N 10.1021/jm5010336
46236806 15501 0 None 3 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 322 3 0 3 4.6 CC(C)/N=C1\S/C(=C\c2ccccc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1095987 15501 0 None 3 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 322 3 0 3 4.6 CC(C)/N=C1\S/C(=C\c2ccccc2)C(=O)N1c1ccccc1 10.1021/jm100181s
68763522 112565 0 None -316 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cnc(CC(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126633 112565 0 None -316 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cnc(CC(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
24784418 112558 0 None -446 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 11 3 8 3.4 CCc1cc(-c2noc(-c3ccc(CC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126626 112558 0 None -446 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 11 3 8 3.4 CCc1cc(-c2noc(-c3ccc(CC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11315809 78432 0 None -3801 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935576 78432 0 None -3801 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963630 78432 0 None -3801 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
57570476 94372 0 None -1995 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 502 8 1 4 6.5 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CN2CC(C(=O)O)C2)c(C)c1 10.1021/ml300396r
CHEMBL2336070 94372 0 None -1995 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 502 8 1 4 6.5 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CN2CC(C(=O)O)C2)c(C)c1 10.1021/ml300396r
44217170 146526 0 None -446 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 482 11 3 8 2.5 CCc1cc(-c2noc(-c3ccc(CN(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798420 146526 0 None -446 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 482 11 3 8 2.5 CCc1cc(-c2noc(-c3ccc(CN(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
25182776 154456 0 None -17 2 Human 4.5 pEC50 = 4.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 365 4 2 5 3.0 CN(c1cc(C(=O)Nc2ccc3c(c2)CC(=O)N3)ncn1)C1CCCCC1 nan
CHEMBL3931810 154456 0 None -17 2 Human 4.5 pEC50 = 4.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 365 4 2 5 3.0 CN(c1cc(C(=O)Nc2ccc3c(c2)CC(=O)N3)ncn1)C1CCCCC1 nan
25182901 12801 0 None -537 2 Human 5.5 pEC50 = 5.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 404 6 2 5 4.5 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1080382 12801 0 None -537 2 Human 5.5 pEC50 = 5.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 404 6 2 5 4.5 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
25182901 12801 0 None -537 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 404 6 2 5 4.5 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1080382 12801 0 None -537 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 404 6 2 5 4.5 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
68555865 112514 0 None -331 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)nc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126436 112514 0 None -331 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)nc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
59446971 160845 0 None -173 2 Human 5.5 pEC50 = 5.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 501 11 2 7 3.5 COCCNS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)c(C)c1 nan
CHEMBL3984678 160845 0 None -173 2 Human 5.5 pEC50 = 5.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 501 11 2 7 3.5 COCCNS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)c(C)c1 nan
11313781 65219 0 None -47 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 339 11 2 3 3.8 O=C(O)CCNC/C=C/c1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
11313781 65219 0 None -47 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 339 11 2 3 3.8 O=C(O)CCNC/C=C/c1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.05.029
CHEMBL1683045 65219 0 None -47 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 339 11 2 3 3.8 O=C(O)CCNC/C=C/c1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
CHEMBL1683045 65219 0 None -47 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 339 11 2 3 3.8 O=C(O)CCNC/C=C/c1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.05.029
11371585 70207 0 None -77 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 351 9 1 3 3.7 O=C(O)C1CN(C/C=C/c2ccc(OCCCc3ccccc3)cc2)C1 10.1016/j.bmcl.2011.05.029
CHEMBL1797504 70207 0 None -77 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 351 9 1 3 3.7 O=C(O)C1CN(C/C=C/c2ccc(OCCCc3ccccc3)cc2)C1 10.1016/j.bmcl.2011.05.029
46236520 15672 0 None -2 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 4 1 4 5.5 CCc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1097537 15672 0 None -2 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 4 1 4 5.5 CCc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
46236810 15746 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 368 4 1 5 4.3 COc1cc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
CHEMBL1098200 15746 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 368 4 1 5 4.3 COc1cc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
44412994 85095 0 None -3388 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 499 7 1 6 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C(F)(F)F)C(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL210942 85095 0 None -3388 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 499 7 1 6 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C(F)(F)F)C(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
118707198 119822 0 None -154 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 463 12 3 5 4.2 Cc1ccc(CCCC(=O)c2cc(C)c(COC[C@@](C)(N)COP(=O)(O)O)c(C)c2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311353 119822 0 None -154 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 463 12 3 5 4.2 Cc1ccc(CCCC(=O)c2cc(C)c(COC[C@@](C)(N)COP(=O)(O)O)c(C)c2)cc1 10.1016/j.bmc.2014.05.035
11854090 111465 0 None -776 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 455 9 2 5 4.3 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(=O)NCCO 10.1021/jm4014373
CHEMBL3105245 111465 0 None -776 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 455 9 2 5 4.3 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(=O)NCCO 10.1021/jm4014373
16737507 64135 0 None -8 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)cc2F)C1 10.1021/ml100227q
CHEMBL1651716 64135 0 None -8 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)cc2F)C1 10.1021/ml100227q
46224767 206077 0 None -48 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 293 2 0 4 3.2 Cc1nn(C(=O)/C=C/c2ccncc2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
CHEMBL590383 206077 0 None -48 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 293 2 0 4 3.2 Cc1nn(C(=O)/C=C/c2ccncc2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
53324746 64167 0 None -15 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1651854 64167 0 None -15 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100228m
51346934 64770 32 None -83 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5F)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672558 64770 32 None -83 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5F)ccc4s3)c(F)c2)C1 10.1021/ml100228m
53324746 64167 0 None -15 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651854 64167 0 None -15 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100306h
72793790 111487 0 None -100 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 527 13 3 6 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNC(CC(=O)O)C(=O)O 10.1021/jm4014373
CHEMBL3105480 111487 0 None -100 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 527 13 3 6 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNC(CC(=O)O)C(=O)O 10.1021/jm4014373
76318445 112853 0 None -12 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 496 11 4 7 4.1 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)c(Cl)c3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133601 112853 0 None -12 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 496 11 4 7 4.1 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)c(Cl)c3)cc2)co1 10.1039/C3MD00079F
46236932 15825 0 None 5 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1cccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)c1 10.1021/jm100181s
CHEMBL1098770 15825 0 None 5 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1cccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)c1 10.1021/jm100181s
2924 8421 43 None -10 7 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2014.07.081
44398069 8421 43 None -10 7 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2014.07.081
9908268 8421 43 None -10 7 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2014.07.081
CHEMBL114606 8421 43 None -10 7 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2014.07.081
11676168 77725 12 None -316 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 422 11 3 5 3.3 Cc1ccc(CCCC(=O)c2ccc(CC[C@@](C)(N)COP(=O)(O)O)n2C)cc1 10.1016/j.ejmech.2012.02.022
CHEMBL1951588 77725 12 None -316 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 422 11 3 5 3.3 Cc1ccc(CCCC(=O)c2ccc(CC[C@@](C)(N)COP(=O)(O)O)n2C)cc1 10.1016/j.ejmech.2012.02.022
11676168 77725 12 None -316 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 422 11 3 5 3.3 Cc1ccc(CCCC(=O)c2ccc(CC[C@@](C)(N)COP(=O)(O)O)n2C)cc1 10.1021/ml100301k
CHEMBL1951588 77725 12 None -316 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 422 11 3 5 3.3 Cc1ccc(CCCC(=O)c2ccc(CC[C@@](C)(N)COP(=O)(O)O)n2C)cc1 10.1021/ml100301k
46236518 15670 0 None -4 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1C 10.1021/jm100181s
CHEMBL1097535 15670 0 None -4 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1C 10.1021/jm100181s
44219528 146475 0 None -66 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1ccc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3798068 146475 0 None -66 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1ccc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
25074253 112525 15 None -575 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(N(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3126592 112525 15 None -575 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(N(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
67172039 155769 0 None -3235 2 Human 5.5 pEC50 = 5.5 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 484 6 1 4 5.8 CC(C)Cc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F nan
CHEMBL3942289 155769 0 None -3235 2 Human 5.5 pEC50 = 5.5 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 484 6 1 4 5.8 CC(C)Cc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F nan
25074253 112525 15 None -575 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(N(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126592 112525 15 None -575 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(N(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
53322715 64763 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 416 6 1 4 4.7 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672550 64763 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 416 6 1 4 4.7 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100228m
118716143 121655 0 None -32 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 486 9 4 6 3.8 NC(CO)(CCc1ccc(-c2coc(-c3ccc(C(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341921 121655 0 None -32 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 486 9 4 6 3.8 NC(CO)(CCc1ccc(-c2coc(-c3ccc(C(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
127045963 146611 0 None -26 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 13 3 9 3.6 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c(C)c1C 10.1016/j.ejmech.2016.03.048
CHEMBL3799029 146611 0 None -26 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 13 3 9 3.6 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c(C)c1C 10.1016/j.ejmech.2016.03.048
76318196 112538 0 None -446 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 12 3 8 3.1 CCc1cc(-c2noc(-c3ccnc(CCC(C)C)c3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126606 112538 0 None -446 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 12 3 8 3.1 CCc1cc(-c2noc(-c3ccnc(CCC(C)C)c3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014696
127046551 146474 0 None -1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cnc(C)c(OC4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3798060 146474 0 None -1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cnc(C)c(OC4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
25192005 14508 0 None -3 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1089004 14508 0 None -3 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
44219370 146507 0 None -93 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCCN(C)Cc1cc(C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
CHEMBL3798240 146507 0 None -93 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCCN(C)Cc1cc(C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
73774584 112870 0 None -7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 443 10 4 5 3.9 NC(CO)(CCc1ccc(Oc2ccc(-c3ccccc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133706 112870 0 None -7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 443 10 4 5 3.9 NC(CO)(CCc1ccc(Oc2ccc(-c3ccccc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
76318057 112321 0 None -190 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 416 9 2 5 4.4 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CCCC2 10.1021/jm401456d
CHEMBL3121976 112321 0 None -190 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 416 9 2 5 4.4 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CCCC2 10.1021/jm401456d
53320107 64780 0 None -79 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 466 6 1 4 5.9 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5cccc(Cl)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672568 64780 0 None -79 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 466 6 1 4 5.9 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5cccc(Cl)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
46195468 159296 0 None -5 2 Human 7.4 pEC50 = 7.4 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 454 10 3 9 2.2 CCOc1ccc(-c2nc(-c3ccc4c(c3)CN(CC(N)(CO)CO)C4)no2)cc1OCC nan
CHEMBL3971409 159296 0 None -5 2 Human 7.4 pEC50 = 7.4 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 454 10 3 9 2.2 CCOc1ccc(-c2nc(-c3ccc4c(c3)CN(CC(N)(CO)CO)C4)no2)cc1OCC nan
56835182 76658 0 None -30 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 6 1 6 4.5 CCC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938934 76658 0 None -30 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 6 1 6 4.5 CCC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
57404009 78438 0 None -977 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3cccc(F)c3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935577 78438 0 None -977 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3cccc(F)c3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963645 78438 0 None -977 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3cccc(F)c3)ccc21 10.1016/j.bmcl.2011.11.048
76318446 112865 0 None -4 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 457 11 4 5 3.8 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccccc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133613 112865 0 None -4 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 457 11 4 5 3.8 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccccc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
76321773 112343 0 None -3019 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 517 12 3 7 3.8 CCc1cc(CCC(=O)c2sc(OC)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121998 112343 0 None -3019 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 517 12 3 7 3.8 CCc1cc(CCC(=O)c2sc(OC)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
11852952 112334 0 None -776 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 10 3 6 3.9 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121989 112334 0 None -776 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 10 3 6 3.9 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
76336361 112535 1 None -12882 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccnc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126603 112535 1 None -12882 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccnc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
66655211 174514 0 None -316 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 451 6 1 4 5.5 O=C(O)CCN1CCC2(CC1)COc1cc(SCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4205124 174514 0 None -316 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 451 6 1 4 5.5 O=C(O)CCN1CCC2(CC1)COc1cc(SCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4302786 174514 0 None -316 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 451 6 1 4 5.5 O=C(O)CCN1CCC2(CC1)COc1cc(SCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
118723864 123166 0 None -630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 432 7 1 7 3.9 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCC(=O)O)C4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359842 123166 0 None -630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 432 7 1 7 3.9 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCC(=O)O)C4)no2)cc1C#N 10.1021/jm5010336
46205775 15001 0 None -3 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 475 11 4 5 3.8 NC(CO)(CCc1ccc(-c2ccc(OCc3ccccc3)cc2F)cc1)COP(=O)(O)O 10.1021/jm901776q
CHEMBL1092272 15001 0 None -3 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 475 11 4 5 3.8 NC(CO)(CCc1ccc(-c2ccc(OCc3ccccc3)cc2F)cc1)COP(=O)(O)O 10.1021/jm901776q
46206105 15007 0 None -1 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 477 10 4 5 4.4 NC(CO)(CCc1ccc(-c2ccc(Sc3ccccc3)cc2F)cc1)COP(=O)(O)O 10.1021/jm901776q
CHEMBL1092286 15007 0 None -1 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 477 10 4 5 4.4 NC(CO)(CCc1ccc(-c2ccc(Sc3ccccc3)cc2F)cc1)COP(=O)(O)O 10.1021/jm901776q
11852237 111467 0 None -37 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
CHEMBL3105247 111467 0 None -37 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
70681384 80936 0 None -363 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor by [S35]GTPgammaS binding assayAgonist activity at human S1P3 receptor by [S35]GTPgammaS binding assay
ChEMBL 484 10 1 6 6.4 CCCc1cc(-c2cnc(-c3sc(CN4CC(C(=O)O)C4)cc3CC)s2)ccc1OC(C)C 10.1016/j.bmcl.2012.03.067
CHEMBL2022905 80936 0 None -363 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor by [S35]GTPgammaS binding assayAgonist activity at human S1P3 receptor by [S35]GTPgammaS binding assay
ChEMBL 484 10 1 6 6.4 CCCc1cc(-c2cnc(-c3sc(CN4CC(C(=O)O)C4)cc3CC)s2)ccc1OC(C)C 10.1016/j.bmcl.2012.03.067
11662328 98540 0 None -1318 3 Human 6.4 pEC50 = 6.4 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 448 7 1 5 5.8 Cc1cc(CC(C)C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL241050 98540 0 None -1318 3 Human 6.4 pEC50 = 6.4 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 448 7 1 5 5.8 Cc1cc(CC(C)C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
57570503 94364 0 None -1819 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 482 10 2 5 6.3 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)s1 10.1021/ml300396r
CHEMBL2336062 94364 0 None -1819 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 482 10 2 5 6.3 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)s1 10.1021/ml300396r
67414717 111210 0 None -288 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 397 7 1 4 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCN 10.1021/jm4014373
CHEMBL3103658 111210 0 None -288 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 397 7 1 4 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCN 10.1021/jm4014373
11501873 146925 0 None -2137 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 384 7 1 5 4.7 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(F)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL380253 146925 0 None -2137 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 384 7 1 5 4.7 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(F)c2)n1 10.1016/j.bmcl.2006.04.084
46846820 146830 0 None -4168 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3800349 146830 0 None -4168 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
25182899 12895 0 None -33 3 Human 6.4 pEC50 = 6.4 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 350 7 2 5 3.2 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1 nan
CHEMBL1080865 12895 0 None -33 3 Human 6.4 pEC50 = 6.4 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 350 7 2 5 3.2 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1 nan
25182899 12895 0 None -33 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 350 7 2 5 3.2 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1080865 12895 0 None -33 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 350 7 2 5 3.2 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1 10.1016/j.bmcl.2010.01.102
118716145 121657 0 None -16 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341923 121657 0 None -16 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
44565622 186119 0 None -5 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 428 11 4 5 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCC2CCCCC2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473562 186119 0 None -5 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 428 11 4 5 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCC2CCCCC2)cc1 10.1016/j.bmcl.2009.02.073
9969355 65215 0 None -26 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 369 14 2 3 4.5 O=C(O)CCNCCCc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
CHEMBL1683041 65215 0 None -26 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 369 14 2 3 4.5 O=C(O)CCNCCCc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
67416434 111499 0 None -630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 8 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCN 10.1021/jm4014373
CHEMBL3105492 111499 0 None -630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 8 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCN 10.1021/jm4014373
46236521 15699 0 None -7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 406 3 1 4 5.6 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1Cl 10.1021/jm100181s
CHEMBL1097807 15699 0 None -7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 406 3 1 4 5.6 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1Cl 10.1021/jm100181s
44199411 146616 0 None -165 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1cc(C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
CHEMBL3799086 146616 0 None -165 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1cc(C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
11597340 111175 0 None -3890 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 438 7 1 4 5.8 Cc1sc(C(=O)CCc2cc(Cl)c(OCCO)c(Cl)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
CHEMBL3102988 111175 0 None -3890 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 438 7 1 4 5.8 Cc1sc(C(=O)CCc2cc(Cl)c(OCCO)c(Cl)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
46236660 15735 0 None -3 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1098144 15735 0 None -3 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
76325530 112529 0 None -331 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)cc(N(CC)CC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126597 112529 0 None -331 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)cc(N(CC)CC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76336364 112552 0 None -4265 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 10 3 8 2.9 CCc1cc(-c2noc(-c3cnc(C(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126620 112552 0 None -4265 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 10 3 8 2.9 CCc1cc(-c2noc(-c3cnc(C(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
44422601 92356 0 None -11 5 Human 7.4 pEC50 = 7.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 398 14 4 3 4.2 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL228139 92356 0 None -11 5 Human 7.4 pEC50 = 7.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 398 14 4 3 4.2 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
11854607 111491 0 None -346 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 10 3 6 3.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3105484 111491 0 None -346 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 10 3 6 3.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
56949140 154038 0 None -83 2 Human 6.4 pEC50 = 6.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 367 5 0 4 5.6 Clc1cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)ccn1 nan
CHEMBL3928616 154038 0 None -83 2 Human 6.4 pEC50 = 6.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 367 5 0 4 5.6 Clc1cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)ccn1 nan
68280743 154699 0 None -11 2 Human 6.4 pEC50 = 6.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 348 5 1 5 4.5 Nc1cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)ccn1 nan
CHEMBL3933624 154699 0 None -11 2 Human 6.4 pEC50 = 6.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 348 5 1 5 4.5 Nc1cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)ccn1 nan
25110406 8079 53 None -2238 4 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 409 9 2 7 3.8 OCCNC1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)OCC)OCC nan
2928 8079 53 None -2238 4 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 409 9 2 7 3.8 OCCNC1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)OCC)OCC nan
CHEMBL3922179 8079 53 None -2238 4 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 409 9 2 7 3.8 OCCNC1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)OCC)OCC nan
57570461 94388 0 None -1659 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 477 10 2 5 5.7 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)nc1 10.1021/ml300396r
CHEMBL2336087 94388 0 None -1659 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 477 10 2 5 5.7 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)nc1 10.1021/ml300396r
44218451 146395 0 None -1230 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 522 12 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN1CCCC1 10.1016/j.ejmech.2016.03.048
CHEMBL3797541 146395 0 None -1230 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 522 12 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN1CCCC1 10.1016/j.ejmech.2016.03.048
127047780 146484 0 None -14 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3798148 146484 0 None -14 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1C 10.1016/j.ejmech.2016.03.048
11854607 111491 0 None -346 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 10 3 6 3.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014373
CHEMBL3105484 111491 0 None -346 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 10 3 6 3.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014373
2924 8421 43 None -10 7 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1039/C3MD00079F
44398069 8421 43 None -10 7 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1039/C3MD00079F
9908268 8421 43 None -10 7 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1039/C3MD00079F
CHEMBL114606 8421 43 None -10 7 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1039/C3MD00079F
127045962 146793 0 None -676 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 11 3 9 2.9 CCc1cc(-c2noc(-c3sc(CN(C)C)c(C)c3C)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800102 146793 0 None -676 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 11 3 9 2.9 CCc1cc(-c2noc(-c3sc(CN(C)C)c(C)c3C)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
52914984 154336 0 None -5011 2 Human 5.4 pEC50 = 5.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 nan
CHEMBL3930827 154336 0 None -5011 2 Human 5.4 pEC50 = 5.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 nan
11852953 112339 0 None -3630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 11 3 6 4.1 CCc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121994 112339 0 None -3630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 11 3 6 4.1 CCc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
11852049 112349 0 None -234 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 400 7 1 4 5.4 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCO 10.1021/jm401456d
CHEMBL3122003 112349 0 None -234 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 400 7 1 4 5.4 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCO 10.1021/jm401456d
11852142 112350 0 None -63 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 414 8 1 4 5.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCCO 10.1021/jm401456d
CHEMBL3122004 112350 0 None -63 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 414 8 1 4 5.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCCO 10.1021/jm401456d
66829275 146410 0 None -147 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 12 3 9 2.8 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)sc1CN(C)C 10.1016/j.ejmech.2016.03.048
CHEMBL3797647 146410 0 None -147 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 12 3 9 2.8 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)sc1CN(C)C 10.1016/j.ejmech.2016.03.048
11588811 10784 45 None -8 4 Human 6.4 pEC50 = 6.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
136212600 10784 45 None -8 4 Human 6.4 pEC50 = 6.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
3324 10784 45 None -8 4 Human 6.4 pEC50 = 6.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
CHEMBL228102 10784 45 None -8 4 Human 6.4 pEC50 = 6.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
57391849 77693 0 None -1479 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.6 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3C)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951312 77693 0 None -1479 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.6 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3C)cc2)n1 10.1016/j.bmcl.2011.12.019
58344526 156907 4 None -28183 5 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCCO)no2)cc1C#N nan
CHEMBL3951270 156907 4 None -28183 5 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCCO)no2)cc1C#N nan
58390949 90890 0 None -81 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 442 10 2 6 4.0 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CNCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207776 90890 0 None -81 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 442 10 2 6 4.0 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CNCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.09.110
46236519 15671 0 None -2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c(C)c1 10.1021/jm100181s
CHEMBL1097536 15671 0 None -2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c(C)c1 10.1021/jm100181s
25031140 112420 0 None -229 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.7 CCc1cc(-c2noc(-c3cc(C)nc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3124957 112420 0 None -229 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.7 CCc1cc(-c2noc(-c3cc(C)nc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11646599 84441 0 None -2290 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 380 7 1 5 4.8 Cc1cc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)ccc1OC(C)C 10.1016/j.bmcl.2006.04.084
CHEMBL208898 84441 0 None -2290 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 380 7 1 5 4.8 Cc1cc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)ccc1OC(C)C 10.1016/j.bmcl.2006.04.084
44412867 86517 0 None -1148 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 420 7 1 5 5.1 CCOc1ccc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)cc1C(F)(F)F 10.1016/j.bmcl.2006.04.084
CHEMBL211689 86517 0 None -1148 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 420 7 1 5 5.1 CCOc1ccc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)cc1C(F)(F)F 10.1016/j.bmcl.2006.04.084
57396699 77674 0 None -537 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 433 7 1 7 4.8 O=C(O)C1CN(Cc2cc(-c3noc(-c4ccc(Oc5ccccc5)cc4)n3)cs2)C1 10.1016/j.bmcl.2011.12.019
CHEMBL1951152 77674 0 None -537 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 433 7 1 7 4.8 O=C(O)C1CN(Cc2cc(-c3noc(-c4ccc(Oc5ccccc5)cc4)n3)cs2)C1 10.1016/j.bmcl.2011.12.019
127046866 146618 0 None -676 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 488 12 3 9 2.6 CCc1cc(-c2noc(-c3ccc(CN(C)CC)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799109 146618 0 None -676 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 488 12 3 9 2.6 CCc1cc(-c2noc(-c3ccc(CN(C)CC)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
69144360 111220 0 None -478 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 404 7 1 4 5.2 Cc1sc(C(=O)CCc2ccc(OCCO)c(Cl)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
CHEMBL3103668 111220 0 None -478 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 404 7 1 4 5.2 Cc1sc(C(=O)CCc2ccc(OCCO)c(Cl)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
67171242 155401 0 None -141 2 Human 5.3 pEC50 = 5.3 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 523 5 1 6 6.1 O=C(O)[C@H]1CCCN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 nan
CHEMBL3939314 155401 0 None -141 2 Human 5.3 pEC50 = 5.3 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 523 5 1 6 6.1 O=C(O)[C@H]1CCCN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 nan
44600645 64178 0 None -123 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 458 6 1 4 5.7 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)cc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651865 64178 0 None -123 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 458 6 1 4 5.7 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)cc4s3)c(F)c2)C1 10.1021/ml100306h
118716185 121682 0 None -245 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 11 4 7 2.6 CCCc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342010 121682 0 None -245 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 11 4 7 2.6 CCCc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
68553624 112518 0 None -234 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126585 112518 0 None -234 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11540052 187346 0 None -33 4 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475405 187346 0 None -33 4 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
11611053 84718 0 None -524 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 401 7 1 5 4.9 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(C(F)(F)C(C)C)cn2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL209567 84718 0 None -524 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 401 7 1 5 4.9 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(C(F)(F)C(C)C)cn2)n1 10.1016/j.bmcl.2006.04.084
44412936 145544 0 None -6606 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 405 8 1 6 4.8 CC[C@H](C)Oc1ccc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)cc1C#N 10.1016/j.bmcl.2006.04.084
CHEMBL378054 145544 0 None -6606 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 405 8 1 6 4.8 CC[C@H](C)Oc1ccc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)cc1C#N 10.1016/j.bmcl.2006.04.084
25182773 14398 0 None -26915 3 Human 4.3 pEC50 = 4.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 443 7 2 6 3.2 Cc1cc(S(N)(=O)=O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1088177 14398 0 None -26915 3 Human 4.3 pEC50 = 4.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 443 7 2 6 3.2 Cc1cc(S(N)(=O)=O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
53322061 64170 0 None -2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)nc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651857 64170 0 None -2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)nc4s3)c(F)c2)C1 10.1021/ml100306h
44218131 146764 0 None -371 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(C)C 10.1016/j.ejmech.2016.03.048
CHEMBL3799916 146764 0 None -371 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(C)C 10.1016/j.ejmech.2016.03.048
16736754 64139 0 None -16 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 395 7 1 4 4.5 O=C(O)C1CN(Cc2ccc(-c3cc4cc(OCC5CC5)ccc4o3)c(F)c2)C1 10.1021/ml100227q
CHEMBL1651720 64139 0 None -16 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 395 7 1 4 4.5 O=C(O)C1CN(Cc2ccc(-c3cc4cc(OCC5CC5)ccc4o3)c(F)c2)C1 10.1021/ml100227q
58390878 90893 0 None -380 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 482 9 1 6 4.7 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CCC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207779 90893 0 None -380 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 482 9 1 6 4.7 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CCC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
53320363 64779 0 None -117 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 466 6 1 4 5.9 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5Cl)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672567 64779 0 None -117 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 466 6 1 4 5.9 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5Cl)ccc4s3)c(F)c2)C1 10.1021/ml100228m
11690483 111208 0 None -346 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 428 8 2 5 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OC[C@H](O)CO 10.1021/jm4014373
CHEMBL3103656 111208 0 None -346 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 428 8 2 5 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OC[C@H](O)CO 10.1021/jm4014373
118716184 121681 0 None -17 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 10 4 7 2.8 CC(C)c1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342009 121681 0 None -17 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 10 4 7 2.8 CC(C)c1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
76314622 112521 0 None -50 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 11 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCC2)n1 10.1021/jm4014696
CHEMBL3126588 112521 0 None -50 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 11 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCC2)n1 10.1021/jm4014696
11452022 10368 39 None -19 6 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm200609t
6996 10368 39 None -19 6 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm200609t
CHEMBL366208 10368 39 None -19 6 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm200609t
44406009 79484 0 None 10 4 Human 8.3 pEC50 = 8.3 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 515 18 5 10 3.4 N[C@@H](COP(=O)(O)O)[C@H](O)/C=C/CCCCCCCCCCNc1ccc([N+](=O)[O-])c2nonc12 10.1016/j.bmcl.2005.09.038
CHEMBL199754 79484 0 None 10 4 Human 8.3 pEC50 = 8.3 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 515 18 5 10 3.4 N[C@@H](COP(=O)(O)O)[C@H](O)/C=C/CCCCCCCCCCNc1ccc([N+](=O)[O-])c2nonc12 10.1016/j.bmcl.2005.09.038
46881847 13830 0 None -6 4 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(CC[C@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1084929 13830 0 None -6 4 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(CC[C@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
76336211 112307 0 None -4 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 11 2 7 5.9 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OCCNCCC(=O)O 10.1021/jm401456d
CHEMBL3121961 112307 0 None -4 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 11 2 7 5.9 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OCCNCCC(=O)O 10.1021/jm401456d
46236809 15503 0 None -1 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 3 1 4 4.6 Cc1cc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
CHEMBL1095995 15503 0 None -1 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 3 1 4 4.6 Cc1cc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
127046743 146602 0 None -45 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 524 12 3 9 3.4 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(OC2CCCC2)n1 10.1016/j.ejmech.2016.03.020
CHEMBL3798969 146602 0 None -45 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 524 12 3 9 3.4 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(OC2CCCC2)n1 10.1016/j.ejmech.2016.03.020
44412971 145712 0 None -16595 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 445 7 1 6 4.9 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL378436 145712 0 None -16595 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 445 7 1 6 4.9 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
57398802 78266 0 None -1659 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 391 8 1 3 4.4 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935575 78266 0 None -1659 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 391 8 1 3 4.4 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1962532 78266 0 None -1659 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 391 8 1 3 4.4 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
44599207 10381 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
5326 10381 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
9289 10381 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
CHEMBL2336071 10381 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
DB12371 10381 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
57404344 79951 0 None -398 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 556 11 2 7 4.4 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2ccc(S(=O)(=O)NCCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.02.016
CHEMBL2011736 79951 0 None -398 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 556 11 2 7 4.4 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2ccc(S(=O)(=O)NCCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.02.016
70681688 81756 0 None -3162 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 494 6 1 4 6.5 O=C(O)C1CCN(CCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032436 81756 0 None -3162 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 494 6 1 4 6.5 O=C(O)C1CCN(CCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
70685939 81757 0 None -630 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 508 7 1 4 6.9 O=C(O)C1CCN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032437 81757 0 None -630 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 508 7 1 4 6.9 O=C(O)C1CCN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
44129298 123172 0 None -251 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 427 6 2 6 4.5 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4CC(=O)O)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359848 123172 0 None -251 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 427 6 2 6 4.5 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4CC(=O)O)no2)cc1Cl 10.1021/jm5010336
72793788 111500 0 None -741 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 9 1 4 5.8 CNCCCOc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
CHEMBL3105493 111500 0 None -741 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 9 1 4 5.8 CNCCCOc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
76329311 112863 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 415 12 4 5 3.1 CCCCCCC1CCc2cc(CCC(N)(CO)COP(=O)(O)O)ccc2O1 10.1039/C3MD00079F
CHEMBL3133611 112863 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 415 12 4 5 3.1 CCCCCCC1CCc2cc(CCC(N)(CO)COP(=O)(O)O)ccc2O1 10.1039/C3MD00079F
11697911 20991 0 None -97 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 441 12 4 5 3.4 CCCCOc1ccc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)c(F)c1 10.1021/jm901776q
CHEMBL1089557 20991 0 None -97 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 441 12 4 5 3.4 CCCCOc1ccc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)c(F)c1 10.1021/jm901776q
CHEMBL1199009 20991 0 None -97 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 441 12 4 5 3.4 CCCCOc1ccc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)c(F)c1 10.1021/jm901776q
127045708 146858 0 None -3981 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 7 1 7 4.7 CC(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3800513 146858 0 None -3981 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 7 1 7 4.7 CC(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
46236661 15348 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1 10.1021/jm100181s
CHEMBL1094699 15348 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1 10.1021/jm100181s
24851766 112566 0 None -269 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cnc(CC(C)C)c(C)c3)n2)cc(C)c1OC[C@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126634 112566 0 None -269 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cnc(CC(C)C)c(C)c3)n2)cc(C)c1OC[C@H](O)CNC(=O)CO 10.1021/jm4014696
44218479 146779 0 None -436 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(OC)cc(C(CC)CC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800001 146779 0 None -436 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(OC)cc(C(CC)CC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11495124 111215 0 None -812 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 404 7 1 4 5.2 Cc1sc(C(=O)CCc2ccc(OCCO)cc2Cl)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
CHEMBL3103663 111215 0 None -812 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 404 7 1 4 5.2 Cc1sc(C(=O)CCc2ccc(OCCO)cc2Cl)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
59593534 111493 0 None -295 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 410 7 1 3 5.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1CCC(=O)O 10.1021/jm4014373
CHEMBL3105486 111493 0 None -295 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 410 7 1 3 5.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1CCC(=O)O 10.1021/jm4014373
25182754 159001 0 None -4 2 Human 5.3 pEC50 = 5.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 347 4 2 5 4.0 O=C(Nc1ccnc2ccccc12)c1cc(NC2CCCCC2)ncn1 nan
CHEMBL3968786 159001 0 None -4 2 Human 5.3 pEC50 = 5.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 347 4 2 5 4.0 O=C(Nc1ccnc2ccccc12)c1cc(NC2CCCCC2)ncn1 nan
76310993 112530 0 None -97 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(N(CC)CC)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126598 112530 0 None -97 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(N(CC)CC)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
46236663 15298 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 432 5 1 6 4.9 COc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c(OC)c1 10.1021/jm100181s
CHEMBL1094246 15298 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 432 5 1 6 4.9 COc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c(OC)c1 10.1021/jm100181s
67351486 112308 0 None -1949 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 475 12 3 6 3.8 Cc1cc(CCC(=O)c2sc(C)c(CC(C)C)c2C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121962 112308 0 None -1949 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 475 12 3 6 3.8 Cc1cc(CCC(=O)c2sc(C)c(CC(C)C)c2C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
76336213 112338 0 None -1096 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 11 3 6 3.8 CCc1cc(CCC(=O)c2scc3c2CCC(C)(C)C3)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121993 112338 0 None -1096 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 11 3 6 3.8 CCc1cc(CCC(=O)c2scc3c2CCC(C)(C)C3)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
25110382 152887 0 None -33113 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 366 6 1 6 4.2 CCOc1ccc(-c2nc(-c3cccc4c3CCC4O)no2)cc1OCC nan
CHEMBL3919445 152887 0 None -33113 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 366 6 1 6 4.2 CCOc1ccc(-c2nc(-c3cccc4c3CCC4O)no2)cc1OCC nan
23729229 112313 0 None -346 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 10 3 8 3.4 Cc1cc(-c2noc(-c3scc(CC(C)C)c3C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121967 112313 0 None -346 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 10 3 8 3.4 Cc1cc(-c2noc(-c3scc(CC(C)C)c3C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
46237177 15695 0 None 2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 6 1 5 3.9 CC(C)/N=C1\S/C(=C\c2cccc(OCCO)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097802 15695 0 None 2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 6 1 5 3.9 CC(C)/N=C1\S/C(=C\c2cccc(OCCO)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
46237051 15693 0 None 1 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 380 6 1 4 4.5 CC(C)/N=C1\S/C(=C\c2ccc(CCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097800 15693 0 None 1 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 380 6 1 4 4.5 CC(C)/N=C1\S/C(=C\c2ccc(CCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
44565716 186522 0 None -25 4 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 493 10 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL474418 186522 0 None -25 4 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 493 10 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
44565717 196309 0 None -7 4 Human 7.3 pEC50 = 7.3 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2010.02.098
CHEMBL514170 196309 0 None -7 4 Human 7.3 pEC50 = 7.3 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2010.02.098
53317713 64767 0 None -5 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 416 6 1 4 4.7 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4o3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672555 64767 0 None -5 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 416 6 1 4 4.7 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4o3)c(F)c2)C1 10.1021/ml100228m
53326037 64169 0 None -1 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4cnc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651856 64169 0 None -1 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4cnc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100306h
127046742 146705 0 None -50 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 12 3 9 3.0 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(OC2CCC2)n1 10.1016/j.ejmech.2016.03.020
CHEMBL3799580 146705 0 None -50 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 12 3 9 3.0 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(OC2CCC2)n1 10.1016/j.ejmech.2016.03.020
56949141 154915 0 None -48 2 Human 6.3 pEC50 = 6.3 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 348 5 1 5 4.5 Nc1ncccc1-c1noc(CCC2(c3ccccc3)CCCCC2)n1 nan
CHEMBL3935426 154915 0 None -48 2 Human 6.3 pEC50 = 6.3 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 348 5 1 5 4.5 Nc1ncccc1-c1noc(CCC2(c3ccccc3)CCCCC2)n1 nan
127046323 146792 0 None -79 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 11 3 8 2.8 CCc1cc(-c2noc(-c3cc(C)c(CN(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800093 146792 0 None -79 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 11 3 8 2.8 CCc1cc(-c2noc(-c3cc(C)c(CN(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
11854857 111490 0 None -616 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 10 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNC(=O)CO 10.1021/jm4014373
CHEMBL3105483 111490 0 None -616 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 10 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNC(=O)CO 10.1021/jm4014373
57394329 77471 0 None -295 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 461 7 2 5 5.4 O=C(O)CCC(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950567 77471 0 None -295 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 461 7 2 5 5.4 O=C(O)CCC(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
66931911 146378 0 None -56 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCc1cc(-c2noc(-c3ccc(CN(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797436 146378 0 None -56 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCc1cc(-c2noc(-c3ccc(CN(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
127048142 146610 0 None -173 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 525 13 3 9 2.9 CCc1cc(-c2noc(-c3cc(C)nc(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799026 146610 0 None -173 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 525 13 3 9 2.9 CCc1cc(-c2noc(-c3cc(C)nc(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
70681813 82047 0 None -69 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 451 4 2 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccc(CN)c21 10.1021/ml200252b
CHEMBL2037122 82047 0 None -69 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 451 4 2 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccc(CN)c21 10.1021/ml200252b
46881537 14097 0 None -169 2 Human 5.3 pEC50 = 5.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 475 12 3 7 2.4 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc(S(=O)(=O)NCCC(=O)O)cc2C)ncn1 nan
CHEMBL1086157 14097 0 None -169 2 Human 5.3 pEC50 = 5.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 475 12 3 7 2.4 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc(S(=O)(=O)NCCC(=O)O)cc2C)ncn1 nan
11854356 111466 0 None -169 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 475 9 1 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCNS(C)(=O)=O 10.1021/jm4014373
CHEMBL3105246 111466 0 None -169 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 475 9 1 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCNS(C)(=O)=O 10.1021/jm4014373
118716142 121654 0 None -61 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 452 9 4 6 3.4 NC(CO)(CCc1ccc(-c2coc(-c3ccc(Cl)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341920 121654 0 None -61 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 452 9 4 6 3.4 NC(CO)(CCc1ccc(-c2coc(-c3ccc(Cl)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
11852233 112335 0 None -467 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 12 3 6 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNCCC(=O)O 10.1021/jm401456d
CHEMBL3121990 112335 0 None -467 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 12 3 6 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNCCC(=O)O 10.1021/jm401456d
44217169 146645 0 None -44 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3ccc(CN(C)CC(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799260 146645 0 None -44 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3ccc(CN(C)CC(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
76321897 112560 0 None -64 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccc(CC(C)C)nc3)n2)cc(C)c1OC[C@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126628 112560 0 None -64 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccc(CC(C)C)nc3)n2)cc(C)c1OC[C@H](O)CNC(=O)CO 10.1021/jm4014696
46237046 15665 0 None 1 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 336 3 0 3 4.9 Cc1ccccc1/C=C1\S/C(=N\C(C)C)N(c2ccccc2)C1=O 10.1021/jm100181s
CHEMBL1097526 15665 0 None 1 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 336 3 0 3 4.9 Cc1ccccc1/C=C1\S/C(=N\C(C)C)N(c2ccccc2)C1=O 10.1021/jm100181s
46237050 15706 0 None 1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 366 5 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(CCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097843 15706 0 None 1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 366 5 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(CCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46236268 15780 0 None 1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 5.3 CCC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098447 15780 0 None 1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 5.3 CCC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
59202018 112309 0 None -75 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 447 12 3 6 3.2 Cc1cc(CCC(=O)c2ccc(CC(C)C)s2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121963 112309 0 None -75 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 447 12 3 6 3.2 Cc1cc(CCC(=O)c2ccc(CC(C)C)s2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
57570497 94369 0 None -2951 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 490 10 2 4 6.6 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(C)c1 10.1021/ml300396r
CHEMBL2336067 94369 0 None -2951 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 490 10 2 4 6.6 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(C)c1 10.1021/ml300396r
44625666 94385 0 None -331 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 476 10 2 5 5.9 C/C(=N\OCc1ccc(-c2cccs2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
CHEMBL2336084 94385 0 None -331 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 476 10 2 5 5.9 C/C(=N\OCc1ccc(-c2cccs2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
56948781 152429 0 None -17 2 Human 5.2 pEC50 = 5.2 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 368 5 0 3 5.9 Fc1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1F nan
CHEMBL3915834 152429 0 None -17 2 Human 5.2 pEC50 = 5.2 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 368 5 0 3 5.9 Fc1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1F nan
76336363 112548 0 None -630 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3ccc(N(CC)CC)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126616 112548 0 None -630 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3ccc(N(CC)CC)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11853834 111488 0 None -398 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 11 3 6 4.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNCC(=O)O 10.1021/jm4014373
CHEMBL3105481 111488 0 None -398 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 11 3 6 4.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNCC(=O)O 10.1021/jm4014373
57508868 112326 0 None -380 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 9 2 5 4.6 CCc1sc(C(=O)CCc2cc(C)c(OCC(O)CO)c(C)c2)c2c1CC(C)CC2 10.1021/jm401456d
CHEMBL3121981 112326 0 None -380 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 9 2 5 4.6 CCc1sc(C(=O)CCc2cc(C)c(OCC(O)CO)c(C)c2)c2c1CC(C)CC2 10.1021/jm401456d
10904818 7091 0 None -2 4 Human 8.2 pEC50 = 8.2 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 10.1016/j.bmcl.2005.09.038
2937 7091 0 None -2 4 Human 8.2 pEC50 = 8.2 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 10.1016/j.bmcl.2005.09.038
CHEMBL382739 7091 0 None -2 4 Human 8.2 pEC50 = 8.2 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 10.1016/j.bmcl.2005.09.038
118707195 119819 0 None -21 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 453 12 3 5 3.7 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(F)c2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311350 119819 0 None -21 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 453 12 3 5 3.7 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(F)c2)cc1 10.1016/j.bmc.2014.05.035
57400521 77700 0 None -794 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.6 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)c(C)c2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951319 77700 0 None -794 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.6 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)c(C)c2)n1 10.1016/j.bmcl.2011.12.019
53318790 64768 0 None -8 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.2 O=C(O)C1CN(Cc2ccc(-c3cn4ccc(Cc5ccccc5)cc4n3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672556 64768 0 None -8 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.2 O=C(O)C1CN(Cc2ccc(-c3cn4ccc(Cc5ccccc5)cc4n3)c(F)c2)C1 10.1021/ml100228m
118716181 121678 0 None -28 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 486 9 4 7 2.7 NC(CO)(CCc1ccc(-c2cn(-c3ccc(C(F)(F)F)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3342006 121678 0 None -28 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 486 9 4 7 2.7 NC(CO)(CCc1ccc(-c2cn(-c3ccc(C(F)(F)F)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
44199450 112557 1 None -295 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cnc(N(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126625 112557 1 None -295 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cnc(N(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76318198 112547 0 None -3090 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)c(N(CC)CC)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126615 112547 0 None -3090 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)c(N(CC)CC)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
25154344 13312 0 None -20 3 Human 7.2 pEC50 = 7.2 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 515 11 3 7 3.3 Cc1cc(S(=O)(=O)NCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1082869 13312 0 None -20 3 Human 7.2 pEC50 = 7.2 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 515 11 3 7 3.3 Cc1cc(S(=O)(=O)NCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
25154344 13312 0 None -20 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 515 11 3 7 3.3 Cc1cc(S(=O)(=O)NCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1082869 13312 0 None -20 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 515 11 3 7 3.3 Cc1cc(S(=O)(=O)NCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
76325392 112325 0 None -154 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 470 9 2 5 5.5 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC1(CCCC1)CC2 10.1021/jm401456d
CHEMBL3121980 112325 0 None -154 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 470 9 2 5 5.5 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC1(CCCC1)CC2 10.1021/jm401456d
11682696 86720 0 None -562 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 396 8 1 6 4.5 COc1cc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)ccc1OC(C)C 10.1016/j.bmcl.2006.04.084
CHEMBL212580 86720 0 None -562 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 396 8 1 6 4.5 COc1cc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)ccc1OC(C)C 10.1016/j.bmcl.2006.04.084
46846915 146791 0 None -15848 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 450 7 1 7 4.1 CC(C)Cc1onc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)c1C(F)(F)F 10.1021/acs.jmedchem.6b00089
CHEMBL3800091 146791 0 None -15848 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 450 7 1 7 4.1 CC(C)Cc1onc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)c1C(F)(F)F 10.1021/acs.jmedchem.6b00089
11568129 111180 0 None -776 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 428 8 2 5 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
CHEMBL3102993 111180 0 None -776 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 428 8 2 5 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
56835182 76658 0 None -30 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 6 1 6 4.5 CCC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938934 76658 0 None -30 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 6 1 6 4.5 CCC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
44565597 186066 0 None -6 4 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 436 12 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473156 186066 0 None -6 4 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 436 12 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
56948659 160849 0 None -30 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cell membranes after 45 mins by [35S] GTPgammaS binding based scintillation counting analysisAgonist activity at human S1P3 receptor expressed in CHO cell membranes after 45 mins by [35S] GTPgammaS binding based scintillation counting analysis
ChEMBL 332 5 0 3 5.6 c1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL3984700 160849 0 None -30 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cell membranes after 45 mins by [35S] GTPgammaS binding based scintillation counting analysisAgonist activity at human S1P3 receptor expressed in CHO cell membranes after 45 mins by [35S] GTPgammaS binding based scintillation counting analysis
ChEMBL 332 5 0 3 5.6 c1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1 10.1021/acs.jmedchem.6b01575
56948659 160849 0 None -30 2 Human 6.2 pEC50 = 6.2 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 332 5 0 3 5.6 c1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1 nan
CHEMBL3984700 160849 0 None -30 2 Human 6.2 pEC50 = 6.2 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 332 5 0 3 5.6 c1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1 nan
127046130 146693 0 None -144 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 402 6 1 7 3.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)on4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3799501 146693 0 None -144 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 402 6 1 7 3.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)on4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
54756908 72739 0 None -794 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 434 7 2 8 2.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(C(CO)CO)C4)no2)cc1C#N 10.1021/jm200609t
CHEMBL1836214 72739 0 None -794 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 434 7 2 8 2.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(C(CO)CO)C4)no2)cc1C#N 10.1021/jm200609t
44129140 123200 0 None -251 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 376 4 1 7 3.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNCCO4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3360368 123200 0 None -251 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 376 4 1 7 3.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNCCO4)no2)cc1C#N 10.1021/jm5010336
46881877 13877 0 None -9 4 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 359 13 2 5 3.8 CCCCCCCOc1ccc(CC[C@](C)(N)CCc2nnn[nH]2)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1085191 13877 0 None -9 4 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 359 13 2 5 3.8 CCCCCCCOc1ccc(CC[C@](C)(N)CCc2nnn[nH]2)cc1 10.1016/j.bmcl.2010.01.118
72793811 111469 0 None -93 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2nnc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)o2)cc(C)c1OCC(O)CO 10.1021/jm4014373
CHEMBL3105249 111469 0 None -93 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2nnc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)o2)cc(C)c1OCC(O)CO 10.1021/jm4014373
72793822 111485 0 None -15 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 8 3 8 3.5 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3105478 111485 0 None -15 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 8 3 8 3.5 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
66829256 146790 0 None -741 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 488 11 3 9 2.6 CCc1cc(-c2noc(-c3cc(C)c(CN(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800086 146790 0 None -741 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 488 11 3 9 2.6 CCc1cc(-c2noc(-c3cc(C)c(CN(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
25182913 155078 0 None -34 2 Human 6.2 pEC50 = 6.2 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 378 6 2 5 4.0 CC(C)CN(c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1)C1CCCC1 nan
CHEMBL3936796 155078 0 None -34 2 Human 6.2 pEC50 = 6.2 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 378 6 2 5 4.0 CC(C)CN(c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1)C1CCCC1 nan
46237048 15667 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1ccccc1/C=C1\S/C(=N\C(C)C)N(c2ccccc2)C1=O 10.1021/jm100181s
CHEMBL1097528 15667 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1ccccc1/C=C1\S/C(=N\C(C)C)N(c2ccccc2)C1=O 10.1021/jm100181s
11405953 70202 0 None -44 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 367 13 2 3 4.6 O=C(O)CCNC/C=C/c1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.05.029
CHEMBL1797499 70202 0 None -44 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 367 13 2 3 4.6 O=C(O)CCNC/C=C/c1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.05.029
76336569 112858 0 None -9 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 435 13 4 4 3.5 CCCCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133606 112858 0 None -9 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 435 13 4 4 3.5 CCCCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
46236665 15300 0 None -1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 4.9 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1Cc1ccccc1 10.1021/jm100181s
CHEMBL1094248 15300 0 None -1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 4.9 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1Cc1ccccc1 10.1021/jm100181s
53320088 64766 0 None -52 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4ccc(Cc5ccccc5)cc4o3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672554 64766 0 None -52 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4ccc(Cc5ccccc5)cc4o3)c(F)c2)C1 10.1021/ml100228m
46237052 15570 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 396 7 1 5 4.3 CC(C)/N=C1\S/C(=C\c2ccc(OCCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1096676 15570 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 396 7 1 5 4.3 CC(C)/N=C1\S/C(=C\c2ccc(OCCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46846899 146724 0 None -2511 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 9 1 7 4.9 CCCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3799701 146724 0 None -2511 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 9 1 7 4.9 CCCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
53322735 64771 0 None -33 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5cccc(F)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672559 64771 0 None -33 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5cccc(F)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
49872066 146588 0 None -95 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 524 11 3 9 3.6 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3798839 146588 0 None -95 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 524 11 3 9 3.6 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
72793822 111485 0 None -15 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 8 3 8 3.5 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014373
CHEMBL3105478 111485 0 None -15 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 8 3 8 3.5 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014373
45377797 90891 0 None -288 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 456 11 2 6 4.4 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CNCCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207777 90891 0 None -288 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 456 11 2 6 4.4 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CNCCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.09.110
76329075 112536 0 None -380 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 12 3 8 2.9 CCCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
CHEMBL3126604 112536 0 None -380 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 12 3 8 2.9 CCCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
127046548 146381 0 None -234 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cnc(C4CCCC4)c(OC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797447 146381 0 None -234 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cnc(C4CCCC4)c(OC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
49872065 146408 0 None -117 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797626 146408 0 None -117 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
44599687 77466 0 None -194 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 447 8 2 5 5.9 O=C(O)CCCNc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950562 77466 0 None -194 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 447 8 2 5 5.9 O=C(O)CCCNc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
23121435 70204 0 None -301 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 387 12 2 3 4.8 O=C(O)CCNC/C=C/c1ccc(OCCCCc2ccccc2)cc1Cl 10.1016/j.bmcl.2011.05.029
CHEMBL1797501 70204 0 None -301 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 387 12 2 3 4.8 O=C(O)CCNC/C=C/c1ccc(OCCCCc2ccccc2)cc1Cl 10.1016/j.bmcl.2011.05.029
11397995 94370 0 None -10232 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 504 11 2 4 6.8 CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CNCCC(=O)O 10.1021/ml300396r
CHEMBL2336068 94370 0 None -10232 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 504 11 2 4 6.8 CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CNCCC(=O)O 10.1021/ml300396r
46846900 146373 0 None -1288 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 8 1 7 4.8 CC(C)Cc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3797415 146373 0 None -1288 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 8 1 7 4.8 CC(C)Cc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
76325522 112511 0 None -7413 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 480 10 3 8 3.2 CCc1cc(-c2noc(-c3ccnc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126433 112511 0 None -7413 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 480 10 3 8 3.2 CCc1cc(-c2noc(-c3ccnc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
16657820 112312 0 None -147 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 10 3 8 3.7 Cc1cc(-c2noc(-c3sc(C)c(CC(C)C)c3C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121966 112312 0 None -147 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 10 3 8 3.7 Cc1cc(-c2noc(-c3sc(C)c(CC(C)C)c3C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
57390144 76656 0 None -2 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 457 5 1 6 3.8 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C(=O)N5CCSC5)cc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
CHEMBL1938932 76656 0 None -2 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 457 5 1 6 3.8 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C(=O)N5CCSC5)cc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
11853832 111171 0 None -1548 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 471 11 3 6 4.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNCCO 10.1021/jm4014373
CHEMBL3102984 111171 0 None -1548 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 471 11 3 6 4.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNCCO 10.1021/jm4014373
76325532 112537 0 None -3801 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccnc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126605 112537 0 None -3801 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccnc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
25182920 151006 0 None -16 2 Human 6.1 pEC50 = 6.1 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 465 11 2 7 3.9 COC(=O)CCNCc1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 nan
CHEMBL3904549 151006 0 None -16 2 Human 6.1 pEC50 = 6.1 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 465 11 2 7 3.9 COC(=O)CCNCc1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 nan
11853337 111496 0 None -301 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 8 1 4 5.4 CNCCOc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
CHEMBL3105489 111496 0 None -301 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 8 1 4 5.4 CNCCOc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
23121338 70210 0 None -134 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 379 11 2 3 4.5 O=C(O)CCNCC1=Cc2ccc(OCCCCc3ccccc3)cc2CC1 10.1016/j.bmcl.2011.05.029
CHEMBL1797507 70210 0 None -134 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 379 11 2 3 4.5 O=C(O)CCNCC1=Cc2ccc(OCCCCc3ccccc3)cc2CC1 10.1016/j.bmcl.2011.05.029
44125588 123174 0 None -158 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 429 5 2 7 3.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNC(C(=O)O)CO4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359850 123174 0 None -158 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 429 5 2 7 3.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNC(C(=O)O)CO4)no2)cc1Cl 10.1021/jm5010336
70694328 81760 0 None -1995 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 466 6 1 4 5.7 O=C(O)C1CN(CCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
CHEMBL2032440 81760 0 None -1995 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 466 6 1 4 5.7 O=C(O)C1CN(CCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
44128987 123171 0 None -1000 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 460 8 1 7 4.3 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCCC(=O)O)CC4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359847 123171 0 None -1000 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 460 8 1 7 4.3 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCCC(=O)O)CC4)no2)cc1C#N 10.1021/jm5010336
44128745 123195 0 None -3981 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 374 4 1 6 3.8 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNCC4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3360363 123195 0 None -3981 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 374 4 1 6 3.8 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNCC4)no2)cc1C#N 10.1021/jm5010336
44125469 123208 0 None -25 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 427 7 1 6 4.6 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CN(CCC(=O)O)C4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3360376 123208 0 None -25 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 427 7 1 6 4.6 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CN(CCC(=O)O)C4)no2)cc1Cl 10.1021/jm5010336
44217502 146756 0 None -7 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 538 14 3 8 3.8 CCc1cc(CN(C)CC(C)C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
CHEMBL3799888 146756 0 None -7 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 538 14 3 8 3.8 CCc1cc(CN(C)CC(C)C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
76314474 112347 0 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 527 10 3 8 4.3 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3122001 112347 0 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 527 10 3 8 4.3 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
45376041 90899 0 None -36 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 482 9 1 6 4.6 CC(C)CCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207785 90899 0 None -36 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 482 9 1 6 4.6 CC(C)CCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
57398468 77670 0 None -123 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 491 6 1 7 5.7 O=C(O)C1CN(Cc2cc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cs2)C1 10.1016/j.bmcl.2011.12.019
CHEMBL1951147 77670 0 None -123 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 491 6 1 7 5.7 O=C(O)C1CN(Cc2cc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cs2)C1 10.1016/j.bmcl.2011.12.019
127046399 146421 0 None -1122 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)cc(C4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797747 146421 0 None -1122 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)cc(C4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
24957029 15599 0 None -2 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 5.2 CCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1096872 15599 0 None -2 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 5.2 CCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
127048102 146691 0 None -181 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 511 13 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(CN(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799493 146691 0 None -181 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 511 13 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(CN(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
76314473 112324 0 None -741 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 442 9 2 5 4.7 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC1(CC2)CC1 10.1021/jm401456d
CHEMBL3121979 112324 0 None -741 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 442 9 2 5 4.7 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC1(CC2)CC1 10.1021/jm401456d
56835064 78270 0 None -14791 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 439 8 1 3 5.3 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(Cl)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935587 78270 0 None -14791 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 439 8 1 3 5.3 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(Cl)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1962536 78270 0 None -14791 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 439 8 1 3 5.3 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(Cl)cc3)ccc21 10.1016/j.bmcl.2011.11.048
53235405 151872 0 None -6760 2 Human 5.1 pEC50 = 5.1 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 404 6 1 5 4.4 CCCc1ccc(-c2onc3c2COc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1 nan
CHEMBL3911661 151872 0 None -6760 2 Human 5.1 pEC50 = 5.1 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 404 6 1 5 4.4 CCCc1ccc(-c2onc3c2COc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1 nan
46236402 15369 0 None -14 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 336 4 1 4 3.9 C=CCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1094831 15369 0 None -14 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 336 4 1 4 3.9 C=CCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
118716153 121666 0 None -15 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 450 10 4 6 2.8 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341931 121666 0 None -15 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 450 10 4 6 2.8 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
46886019 15005 0 None -45 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 457 10 4 5 4.2 Cc1ccc(Oc2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1021/jm901776q
CHEMBL1092284 15005 0 None -45 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 457 10 4 5 4.2 Cc1ccc(Oc2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1021/jm901776q
76314472 112320 0 None -45 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 529 10 3 9 3.7 CCc1cc(-c2noc(-c3sc(OC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121975 112320 0 None -45 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 529 10 3 9 3.7 CCc1cc(-c2noc(-c3sc(OC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
57399546 77472 0 None -1380 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 476 7 3 6 4.3 N[C@H](CC(=O)O)C(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950568 77472 0 None -1380 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 476 7 3 6 4.3 N[C@H](CC(=O)O)C(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
44600643 64177 0 None -25 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 501 6 1 5 6.3 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CCCCC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651864 64177 0 None -25 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 501 6 1 5 6.3 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CCCCC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
11853579 111170 0 None -616 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 455 11 2 5 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNCCO 10.1021/jm4014373
CHEMBL3102983 111170 0 None -616 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 455 11 2 5 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNCCO 10.1021/jm4014373
118716147 121659 0 None -19 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 11 4 6 3.7 CCCc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341925 121659 0 None -19 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 11 4 6 3.7 CCCc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
59446831 152122 0 None -2 2 Human 7.1 pEC50 = 7.1 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 500 11 2 7 3.9 O=C(O)CCCS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 nan
CHEMBL3913491 152122 0 None -2 2 Human 7.1 pEC50 = 7.1 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 500 11 2 7 3.9 O=C(O)CCCS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 nan
46846913 146457 0 None -2818 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 424 9 1 7 4.1 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1CC(C)C 10.1021/acs.jmedchem.6b00089
CHEMBL3797951 146457 0 None -2818 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 424 9 1 7 4.1 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1CC(C)C 10.1021/acs.jmedchem.6b00089
67168742 151539 0 None -3235 2 Human 5.1 pEC50 = 5.1 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 520 5 2 7 5.0 N#CC1(NC(=O)C(O)c2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)CC1 nan
CHEMBL3909064 151539 0 None -3235 2 Human 5.1 pEC50 = 5.1 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 520 5 2 7 5.0 N#CC1(NC(=O)C(O)c2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)CC1 nan
11852636 112353 0 None -1380 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 399 7 1 4 5.3 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCN 10.1021/jm401456d
CHEMBL3122007 112353 0 None -1380 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 399 7 1 4 5.3 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCN 10.1021/jm401456d
46237049 15668 0 None 4 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097529 15668 0 None 4 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
76336362 112546 0 None -1071 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3ccc(C4CCCC4)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126614 112546 0 None -1071 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3ccc(C4CCCC4)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76314624 112551 0 None -4365 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)cc(C4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126619 112551 0 None -4365 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)cc(C4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76314623 112524 0 None -2187 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 11 4 9 2.3 CCNc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
CHEMBL3126591 112524 0 None -2187 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 11 4 9 2.3 CCNc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
118716150 121662 0 None -17 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 424 9 4 7 2.8 NC(CO)(CCc1ccc(-c2coc(-c3cccs3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341928 121662 0 None -17 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 424 9 4 7 2.8 NC(CO)(CCc1ccc(-c2coc(-c3cccs3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
72793791 111495 0 None -257 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 7 1 4 4.9 CNC(=O)COc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
CHEMBL3105488 111495 0 None -257 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 7 1 4 4.9 CNC(=O)COc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
127048141 146563 0 None -102 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 511 13 3 9 2.7 CCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1016/j.ejmech.2016.03.048
CHEMBL3798697 146563 0 None -102 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 511 13 3 9 2.7 CCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1016/j.ejmech.2016.03.048
11853836 111494 0 None -1445 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 7 1 4 4.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(N)=O 10.1021/jm4014373
CHEMBL3105487 111494 0 None -1445 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 7 1 4 4.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(N)=O 10.1021/jm4014373
53319458 64171 0 None -25 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 447 6 1 5 5.2 C[C@@H](c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
CHEMBL1651858 64171 0 None -25 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 447 6 1 5 5.2 C[C@@H](c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
11589375 111174 0 None -338 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 398 7 1 4 5.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCO 10.1021/jm4014373
CHEMBL3102987 111174 0 None -338 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 398 7 1 4 5.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCO 10.1021/jm4014373
46236404 15733 0 None -1 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1 10.1021/jm100181s
CHEMBL1098142 15733 0 None -1 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1 10.1021/jm100181s
46238365 15587 0 None -8 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 344 2 1 4 4.2 C/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1096787 15587 0 None -8 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 344 2 1 4 4.2 C/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
58344592 161345 0 None -69183 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 445 7 1 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCC(=O)N(C)C)no2)cc1C#N nan
CHEMBL3921214 161345 0 None -69183 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 445 7 1 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCC(=O)N(C)C)no2)cc1C#N nan
CHEMBL3991184 161345 0 None -69183 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 445 7 1 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCC(=O)N(C)C)no2)cc1C#N nan
44600476 64174 7 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
CHEMBL1651861 64174 7 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
44600476 64174 7 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.12.073
CHEMBL1651861 64174 7 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.12.073
44600476 64174 7 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651861 64174 7 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
52938426 10149 12 None -38904 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 N#Cc1cc(ccc1OC(C)C)c1onc(n1)c1cccc2c1CC[C@@H]2N nan
9889 10149 12 None -38904 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 N#Cc1cc(ccc1OC(C)C)c1onc(n1)c1cccc2c1CC[C@@H]2N nan
CHEMBL3899384 10149 12 None -38904 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 N#Cc1cc(ccc1OC(C)C)c1onc(n1)c1cccc2c1CC[C@@H]2N nan
58344778 161316 0 None -52480 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4N)no2)cc1C#N nan
CHEMBL3902160 161316 0 None -52480 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4N)no2)cc1C#N nan
CHEMBL3990889 161316 0 None -52480 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4N)no2)cc1C#N nan
118716152 121665 0 None -34 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 462 11 4 7 2.7 COc1ccc(Cc2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341930 121665 0 None -34 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 462 11 4 7 2.7 COc1ccc(Cc2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
44591264 186758 0 None -7 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)c(F)c1 10.1016/j.bmcl.2008.11.072
CHEMBL474688 186758 0 None -7 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)c(F)c1 10.1016/j.bmcl.2008.11.072
11977818 77676 0 None -891 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 433 7 1 7 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(Oc5ccccc5)cc4)n3)s2)C1 10.1016/j.bmcl.2011.12.019
CHEMBL1951154 77676 0 None -891 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 433 7 1 7 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(Oc5ccccc5)cc4)n3)s2)C1 10.1016/j.bmcl.2011.12.019
57397196 76659 0 None -18 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 499 6 1 6 4.8 CC(C)C1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938935 76659 0 None -18 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 499 6 1 6 4.8 CC(C)C1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
11484624 65216 0 None -3 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 341 12 2 3 3.7 O=C(O)CCNCCCc1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
CHEMBL1683042 65216 0 None -3 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 341 12 2 3 3.7 O=C(O)CCNCCCc1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
127047779 146478 0 None -30 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3ccc(C)c(CN(C)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798098 146478 0 None -30 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3ccc(C)c(CN(C)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
44217168 146595 0 None -64 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3ccc(CN(C)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798876 146595 0 None -64 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3ccc(CN(C)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
127047084 146562 0 None -645 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3ccc(C4CCCC4)c(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3798690 146562 0 None -645 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3ccc(C4CCCC4)c(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
58537193 146651 0 None -5370 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 416 6 1 7 3.9 Cc1c(-c2ccccc2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1021/acs.jmedchem.6b00089
CHEMBL3799276 146651 0 None -5370 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 416 6 1 7 3.9 Cc1c(-c2ccccc2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1021/acs.jmedchem.6b00089
46883880 14790 0 None -67 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1090758 14790 0 None -67 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
118716156 121669 0 None -6 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 474 11 4 6 3.8 CC(C)c1ccc(Cc2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341934 121669 0 None -6 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 474 11 4 6 3.8 CC(C)c1ccc(Cc2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
127046567 146781 0 None -933 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(C)cc(OC4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800028 146781 0 None -933 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(C)cc(OC4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11603726 83605 0 None -6760 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 400 7 1 5 5.2 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.064
CHEMBL206940 83605 0 None -6760 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 400 7 1 5 5.2 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.064
70686052 82053 0 None -234 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 494 6 2 4 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccc(CCC(=O)O)cc21 10.1021/ml200252b
CHEMBL2037128 82053 0 None -234 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 494 6 2 4 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccc(CCC(=O)O)cc21 10.1021/ml200252b
57402282 78436 0 None -25118 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935584 78436 0 None -25118 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963634 78436 0 None -25118 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
46236807 15832 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.3 CC(C)/N=C1\S/C(=C\c2ccc(O)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098811 15832 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.3 CC(C)/N=C1\S/C(=C\c2ccc(O)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
127046184 146658 0 None -478 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 484 11 3 9 2.6 CCc1cc(-c2noc(-c3cc(C)nc(OC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799305 146658 0 None -478 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 484 11 3 9 2.6 CCc1cc(-c2noc(-c3cc(C)nc(OC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11697013 85038 0 None -1318 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 401 7 1 6 4.6 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.064
CHEMBL210695 85038 0 None -1318 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 401 7 1 6 4.6 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.064
58390929 90905 0 None -870 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 498 9 1 6 5.1 CCCCN(C(=O)c1ccccc1Cl)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2C)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207792 90905 0 None -870 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 498 9 1 6 5.1 CCCCN(C(=O)c1ccccc1Cl)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2C)s1 10.1016/j.bmcl.2012.09.110
11697013 85038 0 None -1318 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 401 7 1 6 4.6 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL210695 85038 0 None -1318 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 401 7 1 6 4.6 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
46236269 15781 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 2 1 4 5.3 CC(C)(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098448 15781 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 2 1 4 5.3 CC(C)(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
49871977 146828 0 None -239 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(OC)nc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800336 146828 0 None -239 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(OC)nc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
46195606 156090 0 None -40 2 Human 7.0 pEC50 = 7.0 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 450 10 3 7 3.4 CCCc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1CCC nan
CHEMBL3944892 156090 0 None -40 2 Human 7.0 pEC50 = 7.0 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 450 10 3 7 3.4 CCCc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1CCC nan
53326886 64775 0 None -32 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 468 6 1 4 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)c(F)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672563 64775 0 None -32 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 468 6 1 4 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)c(F)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
46884020 15212 0 None -30 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1093686 15212 0 None -30 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
2924 8421 43 None -10 7 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader methodAgonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.1c01979
44398069 8421 43 None -10 7 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader methodAgonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.1c01979
9908268 8421 43 None -10 7 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader methodAgonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.1c01979
CHEMBL114606 8421 43 None -10 7 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader methodAgonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.1c01979
118716154 121667 0 None -54 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 466 10 4 6 3.3 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(Cl)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341932 121667 0 None -54 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 466 10 4 6 3.3 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(Cl)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
57402358 76652 0 None -19 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 461 7 1 5 5.6 CCC(c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1)c1ccccn1 10.1016/j.bmcl.2011.10.069
CHEMBL1938927 76652 0 None -19 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 461 7 1 5 5.6 CCC(c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1)c1ccccn1 10.1016/j.bmcl.2011.10.069
46236808 15379 0 None 2 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 356 3 1 4 4.4 CC(C)/N=C1\S/C(=C\c2ccc(O)c(F)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094885 15379 0 None 2 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 356 3 1 4 4.4 CC(C)/N=C1\S/C(=C\c2ccc(O)c(F)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
52938427 9758 55 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
5383 9758 55 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
8709 9758 55 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
CHEMBL3707247 9758 55 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
DB12612 9758 55 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
46224769 207621 0 None -501 4 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 331 2 1 3 4.3 Cc1nn(C(=O)/C=C/c2cccc3[nH]ccc23)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
CHEMBL601062 207621 0 None -501 4 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 331 2 1 3 4.3 Cc1nn(C(=O)/C=C/c2cccc3[nH]ccc23)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
76318195 112533 0 None -4786 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 10 3 8 2.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
CHEMBL3126601 112533 0 None -4786 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 10 3 8 2.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
53323420 64172 0 None -26 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 447 6 1 5 5.2 C[C@H](c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
CHEMBL1651859 64172 0 None -26 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 447 6 1 5 5.2 C[C@H](c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
44607576 54882 0 None -25 3 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 391 5 1 4 5.5 COc1cccc(OC)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
CHEMBL1550998 54882 0 None -25 3 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 391 5 1 4 5.5 COc1cccc(OC)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
5038554 52961 5 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 318 4 1 3 4.3 Cc1ccc(NC(=O)C(C)c2ccc([N+](=O)[O-])cc2)cc1Cl nan
CHEMBL1534431 52961 5 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 318 4 1 3 4.3 Cc1ccc(NC(=O)C(C)c2ccc([N+](=O)[O-])cc2)cc1Cl nan
16105531 176145 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 582 16 3 7 5.6 CCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
CHEMBL442040 176145 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 582 16 3 7 5.6 CCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
2727678 91292 36 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 287 11 2 3 4.0 CCCCCCCCCCCC1N[C@H](C(=O)O)CS1 10.1021/jm060834d
CHEMBL222029 91292 36 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 287 11 2 3 4.0 CCCCCCCCCCCC1N[C@H](C(=O)O)CS1 10.1021/jm060834d
3893874 40731 4 None 1 2 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 397 5 1 4 5.4 Cc1cc(C(=O)OC(C(=O)Nc2ccc(C)c(Cl)c2)c2ccccc2)c(C)o1 nan
CHEMBL1424117 40731 4 None 1 2 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 397 5 1 4 5.4 Cc1cc(C(=O)OC(C(=O)Nc2ccc(C)c(Cl)c2)c2ccccc2)c(C)o1 nan
3247435 52917 3 None 2 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 347 7 1 2 5.7 CCCC[C@@H]1C[C@H]1[C@@H](NC(=O)c1cccs1)c1ccc(Cl)cc1 nan
CHEMBL1533923 52917 3 None 2 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 347 7 1 2 5.7 CCCC[C@@H]1C[C@H]1[C@@H](NC(=O)c1cccs1)c1ccc(Cl)cc1 nan
44437393 21478 0 None -29 4 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 608 17 2 5 9.5 CCCCCCCCCCC#CC(O)c1ccccc1-c1ccc(Sc2ccc(OCCCC)cc2)c(S(=O)(=O)O)c1 10.1016/j.bmc.2007.02.048
CHEMBL1206181 21478 0 None -29 4 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 608 17 2 5 9.5 CCCCCCCCCCC#CC(O)c1ccccc1-c1ccc(Sc2ccc(OCCCC)cc2)c(S(=O)(=O)O)c1 10.1016/j.bmc.2007.02.048
CHEMBL239659 21478 0 None -29 4 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 608 17 2 5 9.5 CCCCCCCCCCC#CC(O)c1ccccc1-c1ccc(Sc2ccc(OCCCC)cc2)c(S(=O)(=O)O)c1 10.1016/j.bmc.2007.02.048
10086559 126047 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 307 8 2 3 4.0 CCCCCCCc1ccc(C2N[C@H](C(=O)O)CS2)cc1 10.1021/jm060834d
CHEMBL343684 126047 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 307 8 2 3 4.0 CCCCCCCc1ccc(C2N[C@H](C(=O)O)CS2)cc1 10.1021/jm060834d
16105532 90844 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 582 16 3 7 5.6 CCCCCCCCOc1ccc(/C(=N\NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
CHEMBL220756 90844 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 582 16 3 7 5.6 CCCCCCCCOc1ccc(/C(=N\NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
1810026 26801 20 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 365 4 1 1 5.2 O=C(Nc1ccc(Br)cc1)C(c1ccccc1)c1ccccc1 nan
CHEMBL1303503 26801 20 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 365 4 1 1 5.2 O=C(Nc1ccc(Br)cc1)C(c1ccccc1)c1ccccc1 nan
2727676 89949 4 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 273 10 2 3 3.6 CCCCCCCCCCC1N[C@H](C(=O)O)CS1 10.1021/jm060834d
CHEMBL218352 89949 4 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 273 10 2 3 3.6 CCCCCCCCCCC1N[C@H](C(=O)O)CS1 10.1021/jm060834d
44607582 42041 0 None -52 3 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 437 4 1 4 5.5 Cc1ccc(S(C)(=O)=O)c(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
CHEMBL1436066 42041 0 None -52 3 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 437 4 1 4 5.5 Cc1ccc(S(C)(=O)=O)c(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
2328694 60502 3 None -11 5 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 408 6 2 3 5.2 O=C(Nc1ccccc1)Nc1cc(OCC(F)(F)F)cc(OCC(F)(F)F)c1 nan
CHEMBL1603615 60502 3 None -11 5 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 408 6 2 3 5.2 O=C(Nc1ccccc1)Nc1cc(OCC(F)(F)F)cc(OCC(F)(F)F)c1 nan
4492589 37681 6 None -251 4 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 359 3 1 2 6.1 Cc1cccc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
CHEMBL1397874 37681 6 None -251 4 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 359 3 1 2 6.1 Cc1cccc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
2971621 50499 9 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 390 8 1 5 5.3 COc1ccc(C(CC(=O)c2ccc(C)cc2)Nc2ccc([N+](=O)[O-])cc2)cc1 nan
CHEMBL1510469 50499 9 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 390 8 1 5 5.3 COc1ccc(C(CC(=O)c2ccc(C)cc2)Nc2ccc([N+](=O)[O-])cc2)cc1 nan
3827421 40221 7 None -1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 329 4 1 1 5.8 O=C(Nc1ccc2ccccc2c1)C(c1ccccc1)C1CCCC1 nan
CHEMBL1419954 40221 7 None -1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 329 4 1 1 5.8 O=C(Nc1ccc2ccccc2c1)C(c1ccccc1)C1CCCC1 nan
11452022 10368 39 None -19 6 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assayAgonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.088
6996 10368 39 None -19 6 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assayAgonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.088
CHEMBL366208 10368 39 None -19 6 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assayAgonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.088
3730347 49715 7 None 2 2 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 293 4 1 1 4.9 Cc1ccc(NC(=O)C(c2ccccc2)C2CCCC2)cc1 nan
CHEMBL1503503 49715 7 None 2 2 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 293 4 1 1 4.9 Cc1ccc(NC(=O)C(c2ccccc2)C2CCCC2)cc1 nan
1363299 39717 10 None -100 5 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 359 3 1 2 6.1 Cc1cccc(C)c1NC(=O)c1ccc(-c2ccc(Cl)cc2Cl)o1 nan
CHEMBL1415555 39717 10 None -100 5 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 359 3 1 2 6.1 Cc1cccc(C)c1NC(=O)c1ccc(-c2ccc(Cl)cc2Cl)o1 nan
16105530 89966 0 None 2 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 694 24 3 7 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
CHEMBL218445 89966 0 None 2 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 694 24 3 7 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
6890484 79664 7 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 375 6 1 5 4.1 O=C(N/N=C/c1ccc(-c2ccc([N+](=O)[O-])cc2)o1)[C@H]1C[C@@H]1c1ccccc1 nan
CHEMBL2003667 79664 7 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 375 6 1 5 4.1 O=C(N/N=C/c1ccc(-c2ccc([N+](=O)[O-])cc2)o1)[C@H]1C[C@@H]1c1ccccc1 nan
2101118 46989 7 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 386 4 2 1 6.2 FC(F)(F)c1cccc(NC(S)=NC(c2ccccc2)c2ccccc2)c1 nan
CHEMBL1480424 46989 7 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 386 4 2 1 6.2 FC(F)(F)c1cccc(NC(S)=NC(c2ccccc2)c2ccccc2)c1 nan
6056442 85881 5 None 1 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 701 23 3 7 8.1 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)N2CCCCC2)cc1OC 10.1021/jm060834d
CHEMBL2113260 85881 5 None 1 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 701 23 3 7 8.1 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)N2CCCCC2)cc1OC 10.1021/jm060834d
16105541 89967 0 None 1 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 694 24 3 7 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N\NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
CHEMBL218446 89967 0 None 1 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 694 24 3 7 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N\NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
44419095 103441 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 743 27 4 7 10.2 CCCCCCCCCCCCCCCCCC(=O)Nc1ccc(C(=O)CC(=O)Cc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1 10.1021/jm060834d
CHEMBL263827 103441 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 743 27 4 7 10.2 CCCCCCCCCCCCCCCCCC(=O)Nc1ccc(C(=O)CC(=O)Cc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1 10.1021/jm060834d
564008 52021 13 None -1 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 333 4 0 5 4.5 O=[N+]([O-])c1ccc(C2=NN(c3ccccc3)C(c3ccco3)C2)cc1 nan
CHEMBL1526126 52021 13 None -1 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 333 4 0 5 4.5 O=[N+]([O-])c1ccc(C2=NN(c3ccccc3)C(c3ccco3)C2)cc1 nan
2353214 35841 6 None -3 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 387 6 1 2 5.7 O=C(Nc1ccc(OC(F)F)c(Cl)c1)C(c1ccccc1)c1ccccc1 nan
CHEMBL1380914 35841 6 None -3 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 387 6 1 2 5.7 O=C(Nc1ccc(OC(F)F)c(Cl)c1)C(c1ccccc1)c1ccccc1 nan
2727242 46739 5 None - 1 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 428 4 1 3 6.1 O=C(Nc1ccc(F)cc1F)c1c(C(F)(F)F)ccnc1Oc1ccc(Cl)cc1 nan
CHEMBL1478342 46739 5 None - 1 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 428 4 1 3 6.1 O=C(Nc1ccc(F)cc1F)c1c(C(F)(F)F)ccnc1Oc1ccc(Cl)cc1 nan
44419094 104031 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 715 27 4 7 10.2 CCCCCCCCCCCCCCCCCNc1ccc(C(=O)CC(=O)Cc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1 10.1021/jm060834d
CHEMBL268805 104031 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 715 27 4 7 10.2 CCCCCCCCCCCCCCCCCNc1ccc(C(=O)CC(=O)Cc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1 10.1021/jm060834d
6217704 39357 3 None -14 6 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 490 7 0 8 5.2 CCOC(=O)/C(=C\c1ccc(OC(F)F)cc1)C1=Nn2c(nnc2-c2ccc(Cl)cc2)SC1 nan
CHEMBL1412583 39357 3 None -14 6 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 490 7 0 8 5.2 CCOC(=O)/C(=C\c1ccc(OC(F)F)cc1)C1=Nn2c(nnc2-c2ccc(Cl)cc2)SC1 nan
44437418 21601 0 None -39 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 612 17 3 7 6.9 CCCCOc1ccc(Sc2ccc(-c3ccccc3C(O)C#CCOCCCCCCCO)cc2S(=O)(=O)O)cc1 10.1016/j.bmc.2007.02.048
CHEMBL1207343 21601 0 None -39 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 612 17 3 7 6.9 CCCCOc1ccc(Sc2ccc(-c3ccccc3C(O)C#CCOCCCCCCCO)cc2S(=O)(=O)O)cc1 10.1016/j.bmc.2007.02.048
CHEMBL397081 21601 0 None -39 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 612 17 3 7 6.9 CCCCOc1ccc(Sc2ccc(-c3ccccc3C(O)C#CCOCCCCCCCO)cc2S(=O)(=O)O)cc1 10.1016/j.bmc.2007.02.048
2233014 45739 9 None -3 5 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 429 7 1 6 4.9 COc1ccc(CC(=O)Nc2cccc(-c3nnc(-c4cccc(C)c4)o3)c2)cc1OC nan
CHEMBL1467999 45739 9 None -3 5 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 429 7 1 6 4.9 COc1ccc(CC(=O)Nc2cccc(-c3nnc(-c4cccc(C)c4)o3)c2)cc1OC nan
2810094 36356 3 None -1 3 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 365 4 1 3 4.9 Cc1cccc(Cn2nc(C(C)(C)C)cc2C(=O)Nc2ccc(F)cc2)c1 nan
CHEMBL1385499 36356 3 None -1 3 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 365 4 1 3 4.9 Cc1cccc(Cn2nc(C(C)(C)C)cc2C(=O)Nc2ccc(F)cc2)c1 nan
4841482 52854 5 None 2 2 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 397 5 1 3 5.3 Cc1ccc(NC(=O)C(OC(=O)c2ccc(F)cc2)c2ccccc2)cc1Cl nan
CHEMBL1533427 52854 5 None 2 2 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 397 5 1 3 5.3 Cc1ccc(NC(=O)C(OC(=O)c2ccc(F)cc2)c2ccccc2)cc1Cl nan
2794045 38343 9 None 1 2 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 279 4 1 1 4.6 O=C(Nc1ccccc1)C(c1ccccc1)C1CCCC1 nan
CHEMBL1404080 38343 9 None 1 2 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 279 4 1 1 4.6 O=C(Nc1ccccc1)C(c1ccccc1)C1CCCC1 nan
969623 208183 10 None 1 3 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 324 4 1 3 4.4 Cc1ccc(NC(=O)C2(c3ccc([N+](=O)[O-])cc3)CCCC2)cc1 nan
CHEMBL604664 208183 10 None 1 3 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 324 4 1 3 4.4 Cc1ccc(NC(=O)C2(c3ccc([N+](=O)[O-])cc3)CCCC2)cc1 nan
4168101 27639 4 None 1 2 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 405 5 1 3 5.5 O=C(OC(C(=O)Nc1cccc(C(F)(F)F)c1)c1ccccc1)C1CCCCC1 nan
CHEMBL1310437 27639 4 None 1 2 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 405 5 1 3 5.5 O=C(OC(C(=O)Nc1cccc(C(F)(F)F)c1)c1ccccc1)C1CCCCC1 nan
71450073 89364 0 None -234 4 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human S1P3R receptor expressed in CHO cell membranes by [35S]GTPgamma binding assayAntagonist activity at human S1P3R receptor expressed in CHO cell membranes by [35S]GTPgamma binding assay
ChEMBL 585 10 2 5 5.5 Cc1cc(S(=O)(=O)Nc2cccc(-c3cc(C)c(C(=O)N(C)[C@@H](CCN(C)C)C(=O)O)c(C)c3)c2)c(C)cc1Cl 10.1021/jm3009508
CHEMBL2178814 89364 0 None -234 4 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human S1P3R receptor expressed in CHO cell membranes by [35S]GTPgamma binding assayAntagonist activity at human S1P3R receptor expressed in CHO cell membranes by [35S]GTPgamma binding assay
ChEMBL 585 10 2 5 5.5 Cc1cc(S(=O)(=O)Nc2cccc(-c3cc(C)c(C(=O)N(C)[C@@H](CCN(C)C)C(=O)O)c(C)c3)c2)c(C)cc1Cl 10.1021/jm3009508
4460714 148738 10 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 442 18 2 4 6.5 CCCCCCCCCCCCCCCCOc1ccc(S(=O)(=O)O)cc1C(=O)O 10.1021/jm060834d
CHEMBL387252 148738 10 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 442 18 2 4 6.5 CCCCCCCCCCCCCCCCOc1ccc(S(=O)(=O)O)cc1C(=O)O 10.1021/jm060834d
3513763 29905 5 None -1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 413 5 1 3 5.8 Cc1ccc(NC(=O)C(OC(=O)c2ccccc2Cl)c2ccccc2)cc1Cl nan
CHEMBL1330917 29905 5 None -1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 413 5 1 3 5.8 Cc1ccc(NC(=O)C(OC(=O)c2ccccc2Cl)c2ccccc2)cc1Cl nan
9883039 38398 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 307 8 2 3 4.0 CCCCCCCc1cccc(C2N[C@H](C(=O)O)CS2)c1 10.1021/jm060834d
CHEMBL140460 38398 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 307 8 2 3 4.0 CCCCCCCc1cccc(C2N[C@H](C(=O)O)CS2)c1 10.1021/jm060834d
16105533 89968 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 664 23 3 6 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1 10.1021/jm060834d
CHEMBL218447 89968 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 664 23 3 6 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1 10.1021/jm060834d
44607575 59321 0 None -60 5 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 375 4 1 3 5.8 COc1cccc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
CHEMBL1592119 59321 0 None -60 5 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 375 4 1 3 5.8 COc1cccc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
17253208 8081 51 None 1819 2 Human 8.5 pA2 = 8.5 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 26494861
9494 8081 51 None 1819 2 Human 8.5 pA2 = 8.5 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 26494861
CHEMBL1970071 8081 51 None 1819 2 Human 8.5 pA2 = 8.5 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 26494861
49869062 10429 0 None 28 2 Human 9.3 pA2 = 9.3 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 513 10 4 5 5.8 CCC[C@@](COP(=O)(O)O)(CCc1ccc(cc1Cl)Sc1cc(ccc1O)C(F)(F)F)N 26494861
9493 10429 0 None 28 2 Human 9.3 pA2 = 9.3 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 513 10 4 5 5.8 CCC[C@@](COP(=O)(O)O)(CCc1ccc(cc1Cl)Sc1cc(ccc1O)C(F)(F)F)N 26494861
44599207 10381 43 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
5326 10381 43 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
9289 10381 43 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
CHEMBL2336071 10381 43 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
DB12371 10381 43 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
52938427 9758 55 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
5383 9758 55 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
8709 9758 55 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
CHEMBL3707247 9758 55 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
DB12612 9758 55 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
11363176 9923 47 None -12 4 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C None
5446 9923 47 None -12 4 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C None
9320 9923 47 None -12 4 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C None
CHEMBL1096146 9923 47 None -12 4 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C None
107970 8420 83 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
2407 8420 83 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
4167 8420 83 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
CHEMBL314854 8420 83 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
DB08868 8420 83 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
49848557 7884 0 None -3162 5 Human 5.1 pEC50 = 5.1 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 461 7 1 8 4.0 OC(=O)CCN1CCc2c(C1)c(C)n(n2)c1nnc(s1)c1ccc(c(c1)Cl)OC(C)C 26751273
9492 7884 0 None -3162 5 Human 5.1 pEC50 = 5.1 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 461 7 1 8 4.0 OC(=O)CCN1CCc2c(C1)c(C)n(n2)c1nnc(s1)c1ccc(c(c1)Cl)OC(C)C 26751273
CHEMBL3769933 7884 0 None -3162 5 Human 5.1 pEC50 = 5.1 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 461 7 1 8 4.0 OC(=O)CCN1CCc2c(C1)c(C)n(n2)c1nnc(s1)c1ccc(c(c1)Cl)OC(C)C 26751273
44599207 10381 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
5326 10381 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
9289 10381 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
CHEMBL2336071 10381 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
DB12371 10381 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
16755143 7290 0 None -123 4 Human 6.0 pEC50 = 6.0 Functional
In a GTPγS binding assay.In a GTPγS binding assay.
Guide to Pharmacology 442 4 1 5 5.6 C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2 25347187
9569 7290 0 None -123 4 Human 6.0 pEC50 = 6.0 Functional
In a GTPγS binding assay.In a GTPγS binding assay.
Guide to Pharmacology 442 4 1 5 5.6 C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2 25347187
CHEMBL4297350 7290 0 None -123 4 Human 6.0 pEC50 = 6.0 Functional
In a GTPγS binding assay.In a GTPγS binding assay.
Guide to Pharmacology 442 4 1 5 5.6 C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2 25347187
DB11819 7290 0 None -123 4 Human 6.0 pEC50 = 6.0 Functional
In a GTPγS binding assay.In a GTPγS binding assay.
Guide to Pharmacology 442 4 1 5 5.6 C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2 25347187
11259583 7312 17 None -1318 7 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17113298
11259583 7312 17 None -1318 7 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17114004
2925 7312 17 None -1318 7 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17113298
2925 7312 17 None -1318 7 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17114004
CHEMBL4579553 7312 17 None -1318 7 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17113298
CHEMBL4579553 7312 17 None -1318 7 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17114004
11452022 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 17114004
6996 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 17114004
CHEMBL366208 10368 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 17114004
10904818 7091 0 None -2 4 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 11967257
2937 7091 0 None -2 4 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 11967257
CHEMBL382739 7091 0 None -2 4 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 11967257
2924 8421 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
2924 8421 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
44398069 8421 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
44398069 8421 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
9908268 8421 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
9908268 8421 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
CHEMBL114606 8421 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
CHEMBL114606 8421 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
10883396 10421 45 None -2 15 Mouse 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 14732717
5283560 10421 45 None -2 15 Mouse 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 14732717
911 10421 45 None -2 15 Mouse 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 14732717
CHEMBL225155 10421 45 None -2 15 Mouse 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 14732717
10883396 10421 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11705398
10883396 10421 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11967257
10883396 10421 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17114004
5283560 10421 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11705398
5283560 10421 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11967257
5283560 10421 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17114004
911 10421 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11705398
911 10421 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11967257
911 10421 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17114004
CHEMBL225155 10421 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11705398
CHEMBL225155 10421 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11967257
CHEMBL225155 10421 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17114004
52938427 9758 55 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
5383 9758 55 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
8709 9758 55 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
CHEMBL3707247 9758 55 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
DB12612 9758 55 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
10282223 10782 4 None 5 3 Human 6.5 pEC50 None 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 601 24 3 4 8.4 CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccc1)COP(=O)(O)O 17113298
2909 10782 4 None 5 3 Human 6.5 pEC50 None 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 601 24 3 4 8.4 CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccc1)COP(=O)(O)O 17113298
CHEMBL327240 10782 4 None 5 3 Human 6.5 pEC50 None 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 601 24 3 4 8.4 CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccc1)COP(=O)(O)O 17113298
2924 8421 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
2924 8421 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
44398069 8421 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
44398069 8421 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
9908268 8421 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
9908268 8421 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
CHEMBL114606 8421 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
CHEMBL114606 8421 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
10430549 7834 39 None -20417 4 Human 4.9 pIC50 None 4.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 16190743
2929 7834 39 None -20417 4 Human 4.9 pIC50 None 4.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 16190743
CHEMBL194419 7834 39 None -20417 4 Human 4.9 pIC50 None 4.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 16190743




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

10883396 10421 45 None -1 4 Human 9.7 pEC50 = 9.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
5283560 10421 45 None -1 4 Human 9.7 pEC50 = 9.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
911 10421 45 None -1 4 Human 9.7 pEC50 = 9.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
CHEMBL225155 10421 45 None -1 4 Human 9.7 pEC50 = 9.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
10883396 10421 45 None -1 4 Human 9.0 pEC50 = 9.0 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
5283560 10421 45 None -1 4 Human 9.0 pEC50 = 9.0 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
911 10421 45 None -1 4 Human 9.0 pEC50 = 9.0 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
CHEMBL225155 10421 45 None -1 4 Human 9.0 pEC50 = 9.0 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
10883396 10421 45 None -1 4 Human 8.9 pEC50 = 8.9 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.07.030
5283560 10421 45 None -1 4 Human 8.9 pEC50 = 8.9 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.07.030
911 10421 45 None -1 4 Human 8.9 pEC50 = 8.9 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.07.030
CHEMBL225155 10421 45 None -1 4 Human 8.9 pEC50 = 8.9 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.07.030
49839234 124729 1 None - 0 Human 5.0 pEC50 = 5 Binding
Agonist activity at human S1P3 receptor by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor by beta-arrestin recruitment assay
ChEMBL 472 6 3 3 6.1 O=C(O)CC1NCCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21 10.1016/j.bmcl.2014.11.089
CHEMBL3403619 124729 1 None - 0 Human 5.0 pEC50 = 5 Binding
Agonist activity at human S1P3 receptor by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor by beta-arrestin recruitment assay
ChEMBL 472 6 3 3 6.1 O=C(O)CC1NCCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21 10.1016/j.bmcl.2014.11.089
25110488 78760 0 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 352 4 0 3 5.4 O=C(c1cc(-c2ccccc2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1973788 78760 0 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 352 4 0 3 5.4 O=C(c1cc(-c2ccccc2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
17253208 8081 51 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 10.1016/j.bmcl.2013.09.075
9494 8081 51 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 10.1016/j.bmcl.2013.09.075
CHEMBL1970071 8081 51 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 10.1016/j.bmcl.2013.09.075
127031187 145660 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
CHEMBL3781008 145660 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
CHEMBL3782062 145660 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
67169586 189117 0 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 486 6 1 5 5.4 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)c(C(F)(F)F)c1 10.1021/acs.jmedchem.6b01099
CHEMBL4784466 189117 0 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 486 6 1 5 5.4 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)c(C(F)(F)F)c1 10.1021/acs.jmedchem.6b01099
76325531 112534 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 454 11 3 8 2.5 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
CHEMBL3126602 112534 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 454 11 3 8 2.5 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
67168053 187626 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 497 5 1 7 5.1 O=C(O)C1CN(Cc2ccc3c(c2)OCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4757149 187626 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 497 5 1 7 5.1 O=C(O)C1CN(Cc2ccc3c(c2)OCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
67169634 187772 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 509 5 1 6 5.6 Cc1cc2c(cc1CN1CC(C(=O)O)C1)CCc1c-2noc1-c1noc(-c2ccccc2)c1C(F)(F)F 10.1021/acs.jmedchem.6b01099
CHEMBL4758827 187772 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 509 5 1 6 5.6 Cc1cc2c(cc1CN1CC(C(=O)O)C1)CCc1c-2noc1-c1noc(-c2ccccc2)c1C(F)(F)F 10.1021/acs.jmedchem.6b01099
67170332 187452 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2nc(-c4onc(-c5ccccc5)c4C(F)(F)F)sc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4755286 187452 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2nc(-c4onc(-c5ccccc5)c4C(F)(F)F)sc2-3)C1 10.1021/acs.jmedchem.6b01099
162673462 189970 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 509 5 1 6 5.7 O=C(O)C1CN(Cc2ccc3c(c2)CCCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4795734 189970 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 509 5 1 6 5.7 O=C(O)C1CN(Cc2ccc3c(c2)CCCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
2924 8421 43 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2020.127141
44398069 8421 43 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2020.127141
9908268 8421 43 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2020.127141
CHEMBL114606 8421 43 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2020.127141
53235408 187654 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 473 5 1 6 4.7 CC1(c2onc(-c3onc4c3CCc3cc(CN5CC(C(=O)O)C5)ccc3-4)c2C(F)(F)F)CC1 10.1021/acs.jmedchem.6b01099
CHEMBL4757437 187654 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 473 5 1 6 4.7 CC1(c2onc(-c3onc4c3CCc3cc(CN5CC(C(=O)O)C5)ccc3-4)c2C(F)(F)F)CC1 10.1021/acs.jmedchem.6b01099
67171369 188470 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 496 5 1 7 4.7 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2onc(-c3ccccn3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4776597 188470 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 496 5 1 7 4.7 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2onc(-c3ccccn3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
162660222 188008 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 553 6 2 7 5.6 O=C(O)[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4761456 188008 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 553 6 2 7 5.6 O=C(O)[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
76321895 112539 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 482 12 3 8 3.4 CCc1cc(-c2noc(-c3ccnc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3126607 112539 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 482 12 3 8 3.4 CCc1cc(-c2noc(-c3ccnc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
25110485 79538 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 332 5 0 3 5.0 CC(C)Cc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1999116 79538 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 332 5 0 3 5.0 CC(C)Cc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
67169708 189103 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2nsc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4784344 189103 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2nsc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
68182170 189810 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 448 8 1 6 4.4 CCOc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1OCC 10.1021/acs.jmedchem.6b01099
CHEMBL4793933 189810 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 448 8 1 6 4.4 CCOc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1OCC 10.1021/acs.jmedchem.6b01099
57391920 76661 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at S1P3 (unknown origin)Agonist activity at S1P3 (unknown origin)
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1021/acs.jmedchem.9b02092
CHEMBL1938937 76661 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at S1P3 (unknown origin)Agonist activity at S1P3 (unknown origin)
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1021/acs.jmedchem.9b02092
44342468 18890 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
In vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL1184089 18890 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
In vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL332050 18890 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
In vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
162662293 188225 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 513 5 1 6 5.4 O=C(O)C1CN(Cc2cc3c(cc2F)-c2noc(-c4noc(-c5ccccc5)c4C(F)(F)F)c2CC3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4764300 188225 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 513 5 1 6 5.4 O=C(O)C1CN(Cc2cc3c(cc2F)-c2noc(-c4noc(-c5ccccc5)c4C(F)(F)F)c2CC3)C1 10.1021/acs.jmedchem.6b01099
46835922 146233 13 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b01099
CHEMBL3794064 146233 13 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b01099
68192004 190192 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 7 5.1 O=C(O)C1CN(Cc2ccc3c(c2)OCCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4798447 190192 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 7 5.1 O=C(O)C1CN(Cc2ccc3c(c2)OCCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
46835922 146233 13 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1016/j.bmcl.2016.03.105
CHEMBL3794064 146233 13 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1016/j.bmcl.2016.03.105
44398012 19036 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 12 4 4 4.4 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1184707 19036 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 12 4 4 4.4 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL364950 19036 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 12 4 4 4.4 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
162660222 188008 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 553 6 2 7 5.6 O=C(O)[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4761456 188008 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 553 6 2 7 5.6 O=C(O)[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
25110492 78700 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 302 4 0 3 4.3 O=C(c1cc(C2CC2)on1)N(C1CCCCC1)C1CCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1972130 78700 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 302 4 0 3 4.3 O=C(c1cc(C2CC2)on1)N(C1CCCCC1)C1CCCC1 10.1016/j.bmcl.2013.09.075
162671724 189742 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 567 7 2 7 6.0 O=C(O)C[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4792990 189742 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 567 7 2 7 6.0 O=C(O)C[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
44398058 18538 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181660 18538 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL187712 18538 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
25110510 79442 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.5 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1995815 79442 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.5 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCC1 10.1016/j.bmcl.2013.09.075
162656217 187746 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 561 7 2 8 4.0 CS(=O)(=O)CCNC(=O)C(O)c1ccc2c(c1)CCc1c(-c3noc(-c4ccccc4)c3C(F)(F)F)noc1-2 10.1021/acs.jmedchem.6b01099
CHEMBL4758481 187746 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 561 7 2 8 4.0 CS(=O)(=O)CCNC(=O)C(O)c1ccc2c(c1)CCc1c(-c3noc(-c4ccccc4)c3C(F)(F)F)noc1-2 10.1021/acs.jmedchem.6b01099
52914984 154336 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL3930827 154336 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
46847147 146105 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 431 7 1 8 3.5 CCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
CHEMBL3792704 146105 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 431 7 1 8 3.5 CCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
127027154 145098 0 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 330 4 0 4 5.3 CC(C)Oc1ccc(-c2nnc(-c3ccccc3)s2)cc1Cl 10.1021/acs.jmedchem.5b01512
CHEMBL3771092 145098 0 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 330 4 0 4 5.3 CC(C)Oc1ccc(-c2nnc(-c3ccccc3)s2)cc1Cl 10.1021/acs.jmedchem.5b01512
2924 8421 43 None - 0 Human 8.7 pEC50 = 8.7 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2005.05.097
44398069 8421 43 None - 0 Human 8.7 pEC50 = 8.7 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2005.05.097
9908268 8421 43 None - 0 Human 8.7 pEC50 = 8.7 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2005.05.097
CHEMBL114606 8421 43 None - 0 Human 8.7 pEC50 = 8.7 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2005.05.097
25110496 78614 0 None - 0 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.2 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCC1C 10.1016/j.bmcl.2013.09.075
CHEMBL1969371 78614 0 None - 0 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.2 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCC1C 10.1016/j.bmcl.2013.09.075
77050638 147088 9 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to controlAgonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to control
ChEMBL 329 7 2 2 4.7 CCCCCC[C@@H]1CCc2cc([C@H]3CC[C@](N)(CO)C3)ccc2C1 10.1021/acs.jmedchem.6b01433
CHEMBL3806158 147088 9 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to controlAgonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to control
ChEMBL 329 7 2 2 4.7 CCCCCC[C@@H]1CCc2cc([C@H]3CC[C@](N)(CO)C3)ccc2C1 10.1021/acs.jmedchem.6b01433
67170391 187083 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 510 5 1 4 6.7 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2ccc(C3CCCCC3)c(C(F)(F)F)c2)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4750972 187083 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 510 5 1 4 6.7 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2ccc(C3CCCCC3)c(C(F)(F)F)c2)C1 10.1021/acs.jmedchem.6b01099
46847145 146161 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 8 1 8 3.9 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
CHEMBL3793185 146161 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 8 1 8 3.9 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
162657458 187817 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 535 4 2 7 4.2 O=C1NC(=O)C2(CN(Cc3ccc4c(c3)CCc3c(-c5noc(-c6ccccc6)c5C(F)(F)F)noc3-4)C2)N1 10.1021/acs.jmedchem.6b01099
CHEMBL4759408 187817 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 535 4 2 7 4.2 O=C1NC(=O)C2(CN(Cc3ccc4c(c3)CCc3c(-c5noc(-c6ccccc6)c5C(F)(F)F)noc3-4)C2)N1 10.1021/acs.jmedchem.6b01099
86299710 125654 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 482 12 3 8 3.1 CCc1cc(-c2noc(-c3ccnc(CCC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3422425 125654 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 482 12 3 8 3.1 CCc1cc(-c2noc(-c3ccnc(CCC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
53234380 159193 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 486 6 1 5 5.4 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F 10.1021/acs.jmedchem.6b01099
CHEMBL3970572 159193 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 486 6 1 5 5.4 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F 10.1021/acs.jmedchem.6b01099
44398172 18551 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 315 10 3 3 4.0 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)CO)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181739 18551 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 315 10 3 3 4.0 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)CO)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL190529 18551 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 315 10 3 3 4.0 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)CO)n2)cc1 10.1016/j.bmcl.2005.05.097
25110511 78823 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(c1cc(C2CC2)on1)N(C1CCCCCC1)C1CCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1976353 78823 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(c1cc(C2CC2)on1)N(C1CCCCCC1)C1CCCC1 10.1016/j.bmcl.2013.09.075
67172039 155769 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 484 6 1 4 5.8 CC(C)Cc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F 10.1021/acs.jmedchem.6b01099
CHEMBL3942289 155769 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 484 6 1 4 5.8 CC(C)Cc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F 10.1021/acs.jmedchem.6b01099
25110501 78950 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 332 4 0 4 3.8 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCOCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1979798 78950 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 332 4 0 4 3.8 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCOCC1 10.1016/j.bmcl.2013.09.075
46835914 146237 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 471 6 1 8 4.0 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccn5)c4C(F)(F)F)n3)cc2)C1 10.1016/j.bmcl.2016.03.105
CHEMBL3794145 146237 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 471 6 1 8 4.0 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccn5)c4C(F)(F)F)n3)cc2)C1 10.1016/j.bmcl.2016.03.105
107970 8420 83 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
2407 8420 83 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
4167 8420 83 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
CHEMBL314854 8420 83 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
DB08868 8420 83 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
67171285 190080 0 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 481 5 1 6 5.1 O=C(O)C1CN(Cc2ccc3c(c2)Cc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4797042 190080 0 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 481 5 1 6 5.1 O=C(O)C1CN(Cc2ccc3c(c2)Cc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
25110484 79114 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 382 5 0 4 5.5 COc1ccc(-c2cc(C(=O)N(C3CCCCC3)C3CCCCC3)no2)cc1 10.1016/j.bmcl.2013.09.075
CHEMBL1984536 79114 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 382 5 0 4 5.5 COc1ccc(-c2cc(C(=O)N(C3CCCCC3)C3CCCCC3)no2)cc1 10.1016/j.bmcl.2013.09.075
11682677 18554 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181748 18554 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL190865 18554 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
25110498 79700 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 330 4 0 3 4.9 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL2004782 79700 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 330 4 0 3 4.9 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
56955982 110523 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.4 O=C(c1cc(C2CCCC2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL3088204 110523 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.4 O=C(c1cc(C2CCCC2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
25110494 78796 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 330 5 0 3 4.9 O=C(c1cc(C2CC2)on1)N(CC1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1975200 78796 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 330 5 0 3 4.9 O=C(c1cc(C2CC2)on1)N(CC1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
25110500 78577 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 4 0 4 3.5 O=C(c1cc(C2CC2)on1)N(C1CCCCC1)C1CCOCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1967913 78577 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 4 0 4 3.5 O=C(c1cc(C2CC2)on1)N(C1CCCCC1)C1CCOCC1 10.1016/j.bmcl.2013.09.075
156016628 184470 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CC[C@](N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
CHEMBL4641924 184470 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CC[C@](N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
118717778 121950 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 525 7 2 8 3.3 N[C@@H](CO)COc1cc(Cl)c(-c2nnc(N3CCN(C(=O)c4cccc(Cl)c4)CC3)s2)cc1F 10.1016/j.bmcl.2014.09.003
CHEMBL3344420 121950 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 525 7 2 8 3.3 N[C@@H](CO)COc1cc(Cl)c(-c2nnc(N3CCN(C(=O)c4cccc(Cl)c4)CC3)s2)cc1F 10.1016/j.bmcl.2014.09.003
76336361 112535 1 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccnc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3126603 112535 1 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccnc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
118717777 121949 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 483 7 2 8 2.5 N[C@@H](CO)COc1cc(Cl)c(-c2nnc(N3CCN(C(=O)C4CCCC4)CC3)s2)cc1F 10.1016/j.bmcl.2014.09.003
CHEMBL3344419 121949 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 483 7 2 8 2.5 N[C@@H](CO)COc1cc(Cl)c(-c2nnc(N3CCN(C(=O)C4CCCC4)CC3)s2)cc1F 10.1016/j.bmcl.2014.09.003
5309153 44272 10 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 5 0 3 4.7 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1455786 44272 10 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 5 0 3 4.7 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
53235481 157921 0 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2onc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL3959509 157921 0 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2onc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
67170089 186826 0 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c(-c4onc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4747682 186826 0 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c(-c4onc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
118717764 121935 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 481 7 2 8 2.3 CC1(C)CC(C(=O)N2CCN(c3noc(-c4cc(F)c(OC[C@@H](N)CO)cc4Cl)n3)CC2)C1 10.1016/j.bmcl.2014.09.003
CHEMBL3344405 121935 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 481 7 2 8 2.3 CC1(C)CC(C(=O)N2CCN(c3noc(-c4cc(F)c(OC[C@@H](N)CO)cc4Cl)n3)CC2)C1 10.1016/j.bmcl.2014.09.003
44342175 92295 0 None -10 2 Human 6.4 pEC50 = 6.4 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL227371 92295 0 None -10 2 Human 6.4 pEC50 = 6.4 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL422074 92295 0 None -10 2 Human 6.4 pEC50 = 6.4 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
67167161 188975 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2snc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4782854 188975 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2snc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
118717771 121943 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 509 7 2 8 2.5 CC(C)(C(=O)N1CCN(c2noc(-c3cc(F)c(OC[C@@H](N)CO)cc3Cl)n2)CC1)C(F)(F)F 10.1016/j.bmcl.2014.09.003
CHEMBL3344413 121943 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 509 7 2 8 2.5 CC(C)(C(=O)N1CCN(c2noc(-c3cc(F)c(OC[C@@H](N)CO)cc3Cl)n2)CC1)C(F)(F)F 10.1016/j.bmcl.2014.09.003
76311231 112855 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
CHEMBL3133603 112855 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
CHEMBL3780292 112855 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
11452022 10368 39 None - 0 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.5b01512
6996 10368 39 None - 0 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.5b01512
CHEMBL366208 10368 39 None - 0 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.5b01512
44392705 73440 0 None - 0 Human 7.3 pEC50 = 7.3 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
9821227 73440 0 None - 0 Human 7.3 pEC50 = 7.3 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL185389 73440 0 None - 0 Human 7.3 pEC50 = 7.3 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL332472 73440 0 None - 0 Human 7.3 pEC50 = 7.3 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
127031187 145660 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
CHEMBL3781008 145660 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
CHEMBL3782062 145660 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
25110499 78472 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.3 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1965004 78472 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.3 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCCC1 10.1016/j.bmcl.2013.09.075
56955980 110522 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 358 4 0 3 5.8 O=C(c1cc(C2CCCCC2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL3088203 110522 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 358 4 0 3 5.8 O=C(c1cc(C2CCCCC2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
44342246 18184 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 396 18 4 5 3.2 CCCCCCCCCCCCCCONC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL115505 18184 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 396 18 4 5 3.2 CCCCCCCCCCCCCCONC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL1180159 18184 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 396 18 4 5 3.2 CCCCCCCCCCCCCCONC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
162656217 187746 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 561 7 2 8 4.0 CS(=O)(=O)CCNC(=O)C(O)c1ccc2c(c1)CCc1c(-c3noc(-c4ccccc4)c3C(F)(F)F)noc1-2 10.1021/acs.jmedchem.6b01099
CHEMBL4758481 187746 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 561 7 2 8 4.0 CS(=O)(=O)CCNC(=O)C(O)c1ccc2c(c1)CCc1c(-c3noc(-c4ccccc4)c3C(F)(F)F)noc1-2 10.1021/acs.jmedchem.6b01099
46847148 146156 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 8 1 8 3.9 CCCc1c(-c2ccccn2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1016/j.bmcl.2016.03.105
CHEMBL3793145 146156 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 8 1 8 3.9 CCCc1c(-c2ccccn2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1016/j.bmcl.2016.03.105
44398076 19672 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 13 5 5 3.2 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1188968 19672 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 13 5 5 3.2 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL537849 19672 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 13 5 5 3.2 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
25110212 110521 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 319 5 0 4 3.8 O=C(c1cc(C2CC2)on1)N(Cc1ccccc1)c1ccccn1 10.1016/j.bmcl.2013.09.075
CHEMBL3088201 110521 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 319 5 0 4 3.8 O=C(c1cc(C2CC2)on1)N(Cc1ccccc1)c1ccccn1 10.1016/j.bmcl.2013.09.075
3245758 34404 7 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 290 3 0 3 4.1 Cc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1369793 34404 7 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 290 3 0 3 4.1 Cc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
44398170 18544 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 411 12 4 4 4.2 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181688 18544 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 411 12 4 4 4.2 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL188826 18544 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 411 12 4 4 4.2 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
76329075 112536 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 468 12 3 8 2.9 CCCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
CHEMBL3126604 112536 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 468 12 3 8 2.9 CCCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
25110210 110465 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 5 0 3 4.4 O=C(c1cc(C2CC2)on1)N(Cc1ccccc1)c1ccccc1 10.1016/j.bmcl.2013.09.075
CHEMBL3087666 110465 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 5 0 3 4.4 O=C(c1cc(C2CC2)on1)N(Cc1ccccc1)c1ccccc1 10.1016/j.bmcl.2013.09.075
156013851 183974 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
CHEMBL4635110 183974 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
76325522 112511 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 480 10 3 8 3.2 CCc1cc(-c2noc(-c3ccnc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3126433 112511 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 480 10 3 8 3.2 CCc1cc(-c2noc(-c3ccnc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
44342331 18188 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 428 16 4 4 4.5 CCCCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL116953 18188 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 428 16 4 4 4.5 CCCCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL1180214 18188 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 428 16 4 4 4.5 CCCCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
162671724 189742 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 567 7 2 7 6.0 O=C(O)C[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4792990 189742 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 567 7 2 7 6.0 O=C(O)C[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
76325532 112537 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccnc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3126605 112537 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccnc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
11675907 18548 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 409 12 4 4 4.3 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181694 18548 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 409 12 4 4 4.3 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL188881 18548 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 409 12 4 4 4.3 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
10883396 10421 45 None -1 4 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2015.11.090
5283560 10421 45 None -1 4 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2015.11.090
911 10421 45 None -1 4 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2015.11.090
CHEMBL225155 10421 45 None -1 4 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2015.11.090
44398049 19950 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 441 13 5 5 3.4 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1190950 19950 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 441 13 5 5 3.4 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL541890 19950 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 441 13 5 5 3.4 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
162652005 187080 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to controlAgonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to control
ChEMBL 361 12 3 3 4.2 CCCCCCCCC1CCc2cc(CCC(N)(CO)CO)ccc2C1 10.1021/acs.jmedchem.6b01433
CHEMBL4750944 187080 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to controlAgonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to control
ChEMBL 361 12 3 3 4.2 CCCCCCCCC1CCc2cc(CCC(N)(CO)CO)ccc2C1 10.1021/acs.jmedchem.6b01433
25110489 78807 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 304 5 0 3 4.3 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1975908 78807 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 304 5 0 3 4.3 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCC2)no1 10.1016/j.bmcl.2013.09.075
10883396 10421 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2005.05.097
5283560 10421 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2005.05.097
911 10421 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2005.05.097
CHEMBL225155 10421 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2005.05.097
10883396 10421 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
5283560 10421 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
911 10421 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
CHEMBL225155 10421 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
72546270 110524 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 440 8 0 5 6.2 CCOc1ccc(-c2cc(C(=O)N(C3CCCCC3)C3CCCCC3)no2)cc1OCC 10.1016/j.bmcl.2013.09.075
CHEMBL3088205 110524 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 440 8 0 5 6.2 CCOc1ccc(-c2cc(C(=O)N(C3CCCCC3)C3CCCCC3)no2)cc1OCC 10.1016/j.bmcl.2013.09.075
46847146 146178 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 7 1 8 4.1 CC(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
CHEMBL3793394 146178 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 7 1 8 4.1 CC(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
44342221 18865 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 352 15 4 4 2.5 CCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL1183918 18865 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 352 15 4 4 2.5 CCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL324358 18865 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 352 15 4 4 2.5 CCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
44342244 71650 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL182164 71650 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL423691 71650 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
44342231 18872 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 408 19 4 4 4.0 CCCCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL1183950 18872 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 408 19 4 4 4.0 CCCCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL325408 18872 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 408 19 4 4 4.0 CCCCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
10023913 18905 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 400 14 4 4 3.7 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL1184130 18905 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 400 14 4 4 3.7 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL334038 18905 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 400 14 4 4 3.7 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
67172256 187953 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2nc(-c4onc(-c5ccccc5)c4C(F)(F)F)oc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4760972 187953 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2nc(-c4onc(-c5ccccc5)c4C(F)(F)F)oc2-3)C1 10.1021/acs.jmedchem.6b01099
11452022 10368 39 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2015.11.090
6996 10368 39 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2015.11.090
CHEMBL366208 10368 39 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2015.11.090
118717795 121612 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 547 9 3 9 2.2 N[C@H](COc1cc(Cl)c(-c2nc(N3CCN(C(=O)C4CCCC4)CC3)no2)cc1F)COP(=O)(O)O 10.1016/j.bmcl.2014.09.003
CHEMBL3341785 121612 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 547 9 3 9 2.2 N[C@H](COc1cc(Cl)c(-c2nc(N3CCN(C(=O)C4CCCC4)CC3)no2)cc1F)COP(=O)(O)O 10.1016/j.bmcl.2014.09.003
17253281 78601 9 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 4 0 3 4.9 CC(C)c1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1968913 78601 9 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 4 0 3 4.9 CC(C)c1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
76318195 112533 0 None - 0 Human 5.0 pEC50 = 5 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 440 10 3 8 2.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
CHEMBL3126601 112533 0 None - 0 Human 5.0 pEC50 = 5 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 440 10 3 8 2.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
10883396 10421 45 None -1 4 Human 10.4 pIC50 = 10.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.02.106
5283560 10421 45 None -1 4 Human 10.4 pIC50 = 10.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.02.106
911 10421 45 None -1 4 Human 10.4 pIC50 = 10.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.02.106
CHEMBL225155 10421 45 None -1 4 Human 10.4 pIC50 = 10.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.02.106
10883396 10421 45 None -1 4 Human 9.6 pIC50 = 9.6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm0492507
5283560 10421 45 None -1 4 Human 9.6 pIC50 = 9.6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm0492507
911 10421 45 None -1 4 Human 9.6 pIC50 = 9.6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm0492507
CHEMBL225155 10421 45 None -1 4 Human 9.6 pIC50 = 9.6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm0492507
44565597 186066 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 436 12 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473156 186066 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 436 12 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
10883396 10421 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counterDisplacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counter
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1039/d1md00357g
5283560 10421 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counterDisplacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counter
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1039/d1md00357g
911 10421 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counterDisplacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counter
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1039/d1md00357g
CHEMBL225155 10421 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counterDisplacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counter
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1039/d1md00357g
10883396 10421 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting methodDisplacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting method
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2017.12.010
5283560 10421 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting methodDisplacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting method
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2017.12.010
911 10421 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting methodDisplacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting method
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2017.12.010
CHEMBL225155 10421 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting methodDisplacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting method
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2017.12.010
10883396 10421 45 None -1 4 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
5283560 10421 45 None -1 4 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
911 10421 45 None -1 4 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
CHEMBL225155 10421 45 None -1 4 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
10150171 174788 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 357 13 3 3 4.0 CCCCCCCCc1ccc(CCC(N)COP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL432067 174788 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 357 13 3 3 4.0 CCCCCCCCc1ccc(CCC(N)COP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
10150171 174788 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 357 13 3 3 4.0 CCCCCCCCc1ccc(CCC(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL432067 174788 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 357 13 3 3 4.0 CCCCCCCCc1ccc(CCC(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
44159280 133709 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655496 133709 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44344390 20269 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 15 3 2 4.5 O=P(O)(O)CCCNCCCCCCCCCCc1ccccc1 10.1016/j.bmcl.2004.04.069
CHEMBL119349 20269 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 15 3 2 4.5 O=P(O)(O)CCCNCCCCCCCCCCc1ccccc1 10.1016/j.bmcl.2004.04.069
10883396 10421 45 None -1 4 Human 9.0 pIC50 = 9.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
5283560 10421 45 None -1 4 Human 9.0 pIC50 = 9.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
911 10421 45 None -1 4 Human 9.0 pIC50 = 9.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
CHEMBL225155 10421 45 None -1 4 Human 9.0 pIC50 = 9.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
10172546 121221 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 15 3 3 4.5 CCCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL333335 121221 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 15 3 3 4.5 CCCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
10193915 20957 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 375 14 3 3 4.2 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1F 10.1016/j.bmcl.2004.04.070
CHEMBL119873 20957 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 375 14 3 3 4.2 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1F 10.1016/j.bmcl.2004.04.070
25059746 133620 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 9 1 3 7.1 CC(C)COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655408 133620 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 9 1 3 7.1 CC(C)COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10215138 20853 0 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 321 15 3 2 4.6 CCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL119760 20853 0 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 321 15 3 2 4.6 CCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44159280 133709 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655496 133709 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762369 133715 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 8 1 5 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ncco1 nan
CHEMBL3655502 133715 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 8 1 5 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ncco1 nan
59762343 133724 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 512 8 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3cccnc3)cc2n1Cc1ccccn1 nan
CHEMBL3655510 133724 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 512 8 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3cccnc3)cc2n1Cc1ccccn1 nan
44565715 187222 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 498 12 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475253 187222 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 498 12 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
137651211 164104 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 339 13 2 2 5.0 CCCCCCCCc1ccc(CNCCCP(C)(=O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL4077381 164104 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 339 13 2 2 5.0 CCCCCCCCc1ccc(CNCCCP(C)(=O)O)cc1 10.1021/acs.jmedchem.6b01575
44565596 196325 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 422 11 4 5 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL514302 196325 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 422 11 4 5 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
11510741 196549 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 452 12 4 6 2.9 COc1ccc(CCCCOc2ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL516035 196549 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 452 12 4 6 2.9 COc1ccc(CCCCOc2ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2009.02.073
44344360 17018 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 339 14 3 3 4.8 CCCCCCCCCc1ccc(CNCCCP(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL1160958 17018 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 339 14 3 3 4.8 CCCCCCCCCc1ccc(CNCCCP(O)O)cc1 10.1016/j.bmcl.2004.04.069
44344338 20154 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 369 15 3 2 4.7 CCCCCCCc1ccc(CCCCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL119257 20154 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 369 15 3 2 4.7 CCCCCCCc1ccc(CCCCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
10173002 174884 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 401 15 3 4 4.4 CCCCCCCCOc1c(C)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL432813 174884 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 401 15 3 4 4.4 CCCCCCCCOc1c(C)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
10195325 91895 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 1 4 5.9 O=C(O)C1CCN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1021/jm0492507
CHEMBL224799 91895 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 1 4 5.9 O=C(O)C1CCN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1021/jm0492507
10174255 91992 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1021/jm0492507
CHEMBL225575 91992 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1021/jm0492507
46885744 14533 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 548 10 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(Br)c1 10.1016/j.bmcl.2010.02.098
CHEMBL1089127 14533 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 548 10 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(Br)c1 10.1016/j.bmcl.2010.02.098
138377599 188218 15 None - 0 Human 6.0 pIC50 = 6 Binding
Immunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assayImmunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assay
ChEMBL 408 5 0 5 5.1 CCC/N=C1\S/C(=C\c2ccc(OC(C)=O)c(C)c2)C(=O)N1c1ccccc1C 10.1021/acsmedchemlett.8b00616
CHEMBL4764124 188218 15 None - 0 Human 6.0 pIC50 = 6 Binding
Immunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assayImmunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assay
ChEMBL 408 5 0 5 5.1 CCC/N=C1\S/C(=C\c2ccc(OC(C)=O)c(C)c2)C(=O)N1c1ccccc1C 10.1021/acsmedchemlett.8b00616
44412232 173099 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 391 6 2 5 4.5 CC(C)Cc1ccc(-c2nc(-c3ccc([C@@H]4CC[C@@H](C(=O)O)N4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.038
CHEMBL427221 173099 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 391 6 2 5 4.5 CC(C)Cc1ccc(-c2nc(-c3ccc([C@@H]4CC[C@@H](C(=O)O)N4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.038
58907658 93345 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 350 13 3 4 3.6 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CCC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315815 93345 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 350 13 3 4 3.6 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CCC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
58907531 93346 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 364 13 3 4 3.9 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)CCC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315816 93346 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 364 13 3 4 3.9 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)CCC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
11501417 93347 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 362 12 3 4 3.7 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)/C=C/C(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315817 93347 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 362 12 3 4 3.7 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)/C=C/C(=O)O)cc1 10.1016/j.bmcl.2012.11.053
11408903 91901 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 475 7 1 4 6.1 Cc1cc(CN2CC(C(=O)O)C2)cc(C)c1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
CHEMBL224853 91901 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 475 7 1 4 6.1 Cc1cc(CN2CC(C(=O)O)C2)cc(C)c1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
11705484 186075 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2cccc(-c3ccccc3)c2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473237 186075 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2cccc(-c3ccccc3)c2)cc1 10.1016/j.bmcl.2009.02.073
44565713 187217 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 495 10 4 6 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3C#N)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475247 187217 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 495 10 4 6 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3C#N)cc2)cc1 10.1016/j.bmcl.2009.02.073
58907649 93344 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 336 12 3 4 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315814 93344 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 336 12 3 4 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
10287091 17373 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 14 4 3 4.1 CCCCCCCCC(O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL117007 17373 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 14 4 3 4.1 CCCCCCCCC(O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
10309271 20130 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 373 14 4 4 3.8 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1O 10.1016/j.bmcl.2004.04.070
CHEMBL119239 20130 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 373 14 4 4 3.8 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1O 10.1016/j.bmcl.2004.04.070
44413349 84414 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 453 6 2 5 5.4 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL208838 84414 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 453 6 2 5 5.4 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
44217417 133208 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 411 9 3 4 4.0 CCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccncc2)cc1 nan
CHEMBL3651719 133208 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 411 9 3 4 4.0 CCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccncc2)cc1 nan
59762441 133696 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 9 1 5 5.7 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CN3CCCC3)n(Cc3ccccn3)c2c1 nan
CHEMBL3655482 133696 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 9 1 5 5.7 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CN3CCCC3)n(Cc3ccccn3)c2c1 nan
59762392 133663 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NCC(C)(C)O3)cc2n1Cc1ccccc1 nan
CHEMBL3655450 133663 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NCC(C)(C)O3)cc2n1Cc1ccccc1 nan
25060001 133727 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 7 1 4 5.8 COC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655513 133727 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 7 1 4 5.8 COC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59504175 133738 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 9 1 4 6.8 CC(C)COC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655525 133738 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 9 1 4 6.8 CC(C)COC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44565621 186093 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 428 11 4 6 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2cccs2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473360 186093 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 428 11 4 6 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2cccs2)cc1 10.1016/j.bmcl.2009.02.073
59762314 133700 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 488 7 1 4 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655487 133700 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 488 7 1 4 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCCC3)cc2n1Cc1ccccn1 nan
10236683 174870 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 319 14 2 2 4.9 CCCCCCCCCc1ccc(CNCCCC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL432632 174870 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 319 14 2 2 4.9 CCCCCCCCCc1ccc(CNCCCC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
137638716 163753 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 305 13 2 2 4.5 CCCCCCCCc1ccc(CNCCCC(=O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL4072987 163753 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 305 13 2 2 4.5 CCCCCCCCc1ccc(CNCCCC(=O)O)cc1 10.1021/acs.jmedchem.6b01575
44233260 133747 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 442 9 1 5 5.3 CCCOc1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655534 133747 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 442 9 1 5 5.3 CCCOc1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44394117 73115 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 17 2 2 6.1 CCCCCCCCCCCCCCC1CCCN1CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL185066 73115 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 17 2 2 6.1 CCCCCCCCCCCCCCC1CCCN1CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
10430549 7834 39 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1021/jm0503244
2929 7834 39 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1021/jm0503244
CHEMBL194419 7834 39 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1021/jm0503244
10249887 77703 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 5 1 5 4.2 CC(C)(C)c1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
CHEMBL195141 77703 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 5 1 5 4.2 CC(C)(C)c1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
9979368 78481 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 417 6 1 5 5.0 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL196534 78481 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 417 6 1 5 5.0 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)C1 10.1021/jm0503244
10430549 7834 39 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1016/j.bmcl.2006.03.090
2929 7834 39 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1016/j.bmcl.2006.03.090
CHEMBL194419 7834 39 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1016/j.bmcl.2006.03.090
44233258 133748 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 456 9 1 5 5.6 CC(C)COc1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655535 133748 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 456 9 1 5 5.6 CC(C)COc1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
10151146 19983 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 425 14 3 3 5.4 CCCCCCCCOc1c(Cl)cc(CNCCCP(=O)(O)O)cc1Cl 10.1016/j.bmcl.2004.04.070
CHEMBL119116 19983 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 425 14 3 3 5.4 CCCCCCCCOc1c(Cl)cc(CNCCCP(=O)(O)O)cc1Cl 10.1016/j.bmcl.2004.04.070
44344210 20579 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 307 15 3 2 4.1 CCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL119562 20579 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 307 15 3 2 4.1 CCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
59762430 133684 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 8 1 5 6.0 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655470 133684 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 8 1 5 6.0 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
59762388 133702 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 8 2 3 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655489 133702 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 8 2 3 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
10216035 17807 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 391 20 3 2 6.5 CCCCCCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL117569 17807 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 391 20 3 2 6.5 CCCCCCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
59762287 133714 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 7 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCOCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655501 133714 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 7 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCOCC3)cc2n1Cc1ccccn1 nan
11743459 147569 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 431 7 1 5 4.4 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(CCC(F)(F)F)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL381872 147569 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 431 7 1 5 4.4 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(CCC(F)(F)F)cc4)n3)cc2)C1 10.1021/jm0503244
44234512 134195 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 8 1 5 5.4 CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659693 134195 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 8 1 5 5.4 CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
10125861 19972 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 16 3 2 5.0 CCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL119110 19972 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 16 3 2 5.0 CCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44344412 20126 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.3 CCCCCCCc1ccc(CCCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL119233 20126 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.3 CCCCCCCc1ccc(CCCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
44232784 133630 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 7 1 4 5.9 CC(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655418 133630 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 7 1 4 5.9 CC(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44232786 133632 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.6 CC(C)C(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655420 133632 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.6 CC(C)C(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10408874 79265 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 403 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(C5CCCC5)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL198976 79265 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 403 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(C5CCCC5)cc4)n3)cc2)C1 10.1021/jm0503244
59504166 133746 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 9 1 4 6.4 CCO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655533 133746 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 9 1 4 6.4 CCO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44233495 134180 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 1 4 7.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(/C=N/OC(C)(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3659678 134180 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 1 4 7.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(/C=N/OC(C)(C)C)cc2n1Cc1ccccc1 nan
25060537 133732 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 9 2 3 6.2 CCCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655519 133732 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 9 2 3 6.2 CCCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44233497 134182 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 4 6.4 CO/N=C(\C)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3659680 134182 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 4 6.4 CO/N=C(\C)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
21455530 16914 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 363 19 3 2 5.6 CCCCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL115738 16914 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 363 19 3 2 5.6 CCCCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
59762339 133668 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 479 8 2 5 5.1 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)O)n(Cc3ccccn3)c2c1 nan
CHEMBL3655455 133668 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 479 8 2 5 5.1 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)O)n(Cc3ccccn3)c2c1 nan
59762277 133690 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3cccnc3)c2c1 nan
CHEMBL3655476 133690 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3cccnc3)c2c1 nan
44234257 134193 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 9 1 4 6.2 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659691 134193 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 9 1 4 6.2 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44413430 145547 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 405 7 2 5 4.7 CC(C)Cc1ccc(-c2nc(-c3ccc([C@H]4C[C@@H](CC(=O)O)CN4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.090
CHEMBL378061 145547 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 405 7 2 5 4.7 CC(C)Cc1ccc(-c2nc(-c3ccc([C@H]4C[C@@H](CC(=O)O)CN4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.090
59762368 133699 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 8 2 4 6.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655485 133699 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 8 2 4 6.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccn1 nan
59762285 133679 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 1 5 7.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ccccc1 nan
CHEMBL3655466 133679 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 1 5 7.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ccccc1 nan
11555202 186510 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 504 10 4 5 4.4 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3Cl)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL474407 186510 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 504 10 4 5 4.4 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3Cl)cc2)cc1 10.1016/j.bmcl.2009.02.073
44234513 133205 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 382 8 3 3 4.1 O=P(O)(O)CCCNCc1ccc(-c2ccccc2)c(-c2ccccc2)n1 nan
CHEMBL3651716 133205 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 382 8 3 3 4.1 O=P(O)(O)CCCNCc1ccc(-c2ccccc2)c(-c2ccccc2)n1 nan
59762273 133656 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 2 5 5.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](CO)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655444 133656 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 2 5 5.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](CO)CO3)cc2n1Cc1ccccc1 nan
59762438 133705 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 8 2 4 6.6 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655492 133705 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 8 2 4 6.6 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
59504167 133217 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 461 6 2 4 5.7 O=C(NCc1ccc(F)c(F)c1)c1c(C2CCCC2)n(Cc2ccccn2)c2ccc(O)cc12 nan
CHEMBL3651727 133217 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 461 6 2 4 5.7 O=C(NCc1ccc(F)c(F)c1)c1c(C2CCCC2)n(Cc2ccccn2)c2ccc(O)cc12 nan
59762397 133650 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 8 1 4 6.6 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
CHEMBL3655438 133650 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 8 1 4 6.6 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
59762381 133688 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 6 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1cccnc1 nan
CHEMBL3655474 133688 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 6 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1cccnc1 nan
44394149 130805 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 377 15 3 3 4.5 CCCCCCCCCCCCCCN1CCC(C(O)P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL363008 130805 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 377 15 3 3 4.5 CCCCCCCCCCCCCCN1CCC(C(O)P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
10308738 17043 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 14 3 3 3.9 CCCCCCCCCc1ccc(CNCC(O)CC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL116140 17043 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 14 3 3 3.9 CCCCCCCCCc1ccc(CNCC(O)CC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
10286857 174883 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 353 14 2 2 5.4 CCCCCCCCCc1ccc(CNCCCP(C)(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL432809 174883 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 353 14 2 2 5.4 CCCCCCCCCc1ccc(CNCCCP(C)(=O)O)cc1 10.1016/j.bmcl.2004.04.069
25060262 133728 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 3 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C(=O)N3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655515 133728 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 3 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C(=O)N3CCCC3)cc2n1Cc1ccccc1 nan
44412416 84972 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 431 6 2 5 5.7 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL210520 84972 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 431 6 2 5 5.7 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
59762431 133673 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 433 6 2 3 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N)cc2n1Cc1ccccc1 nan
CHEMBL3655460 133673 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 433 6 2 3 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N)cc2n1Cc1ccccc1 nan
44233749 134185 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3cccc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659683 134185 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3cccc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762344 133674 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCOC3)cc2n1Cc1ccccc1 nan
CHEMBL3655461 133674 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCOC3)cc2n1Cc1ccccc1 nan
10384596 16908 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL115713 16908 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
10384596 16908 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL115713 16908 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
59762383 133660 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 516 8 1 5 6.0 CC[C@H]1COC(c2ccc3c(C(=O)NCc4cc(F)cc(F)c4)c(C(C)C)n(Cc4ccccn4)c3c2)=N1 nan
CHEMBL3655448 133660 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 516 8 1 5 6.0 CC[C@H]1COC(c2ccc3c(C(=O)NCc4cc(F)cc(F)c4)c(C(C)C)n(Cc4ccccn4)c3c2)=N1 nan
44341276 16878 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL115554 16878 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
10287034 72957 3 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 367 11 2 2 4.7 CCCCCCCCCc1ccc(CN2CCC(P(=O)(O)O)C2)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL184349 72957 3 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 367 11 2 2 4.7 CCCCCCCCCc1ccc(CN2CCC(P(=O)(O)O)C2)cc1 10.1016/j.bmcl.2004.07.049
10287365 17345 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 389 12 3 2 5.1 CCCCCCc1ccc(-c2ccc(CNCCCP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL116981 17345 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 389 12 3 2 5.1 CCCCCCc1ccc(-c2ccc(CNCCCP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2004.04.070
44234516 133207 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 396 8 3 3 4.2 CCc1ccc(-c2ccc(CNCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651718 133207 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 396 8 3 3 4.2 CCc1ccc(-c2ccc(CNCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
44234760 133210 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 397 8 3 4 3.6 CCc1ccc(-c2ccc(CNCCP(=O)(O)O)nc2-c2ccncc2)cc1 nan
CHEMBL3651720 133210 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 397 8 3 4 3.6 CCc1ccc(-c2ccc(CNCCP(=O)(O)O)nc2-c2ccncc2)cc1 nan
59504169 133745 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 455 8 1 5 5.3 CCOC(=O)c1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655532 133745 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 455 8 1 5 5.3 CCOC(=O)c1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762366 133717 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 467 8 1 5 5.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
CHEMBL3655504 133717 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 467 8 1 5 5.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
25059487 133202 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 462 8 1 3 6.4 CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651713 133202 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 462 8 1 3 6.4 CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25059487 133202 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 462 8 1 3 6.4 CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651713 133202 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 462 8 1 3 6.4 CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44234005 134187 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 8 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3)cc2n1Cc1ccccn1 nan
CHEMBL3659685 134187 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 8 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3)cc2n1Cc1ccccn1 nan
44394153 72930 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 363 14 3 3 4.3 CCCCCCCCCCCCCCN1CCC(O)(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL184237 72930 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 363 14 3 3 4.3 CCCCCCCCCCCCCCN1CCC(O)(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
44394169 73457 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 16 2 2 5.7 CCCCCCCCCCCCCCN1CCCC1CCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL185447 73457 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 16 2 2 5.7 CCCCCCCCCCCCCCN1CCCC1CCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
44234763 133213 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 397 8 2 3 4.8 Cc1ccc(-c2ccc(COCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651723 133213 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 397 8 2 3 4.8 Cc1ccc(-c2ccc(COCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
127041987 143406 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 319 11 1 3 3.9 CCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3739878 143406 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 319 11 1 3 3.9 CCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
25060263 133729 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 7 1 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C(=O)N(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655516 133729 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 7 1 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C(=O)N(C)C)cc2n1Cc1ccccc1 nan
44344456 17415 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 NC(CCCCCCCCCCc1ccccc1)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL117031 17415 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 NC(CCCCCCCCCCc1ccccc1)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44344404 18133 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 349 18 3 2 5.2 CCCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL117973 18133 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 349 18 3 2 5.2 CCCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
11725751 19619 5 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
11725751 19619 5 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL118860 19619 5 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL118860 19619 5 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
10149985 20151 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 341 13 3 2 4.2 CCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL119256 20151 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 341 13 3 2 4.2 CCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
44394191 73083 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 381 12 3 2 5.3 CCCCCCCCCc1ccc(C2CCC(CCP(=O)(O)O)N2)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL184879 73083 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 381 12 3 2 5.3 CCCCCCCCCc1ccc(C2CCC(CCP(=O)(O)O)N2)cc1 10.1016/j.bmcl.2004.07.049
44344194 18688 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 321 16 3 2 4.5 CCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL118265 18688 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 321 16 3 2 4.5 CCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44394191 73083 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 381 12 3 2 5.3 CCCCCCCCCc1ccc(C2CCC(CCP(=O)(O)O)N2)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL184879 73083 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 381 12 3 2 5.3 CCCCCCCCCc1ccc(C2CCC(CCP(=O)(O)O)N2)cc1 10.1016/j.bmcl.2004.07.049
44565717 196309 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL514170 196309 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
44565738 196532 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 445 11 4 5 3.8 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL515917 196532 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 445 11 4 5 3.8 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
44565717 196309 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2010.02.098
CHEMBL514170 196309 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2010.02.098
44232785 133631 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 8 1 4 6.3 CCC(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655419 133631 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 8 1 4 6.3 CCC(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762446 133706 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 8 2 3 7.0 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655493 133706 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 8 2 3 7.0 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
10311227 176112 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 493 17 3 4 5.6 CCCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL441826 176112 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 493 17 3 4 5.6 CCCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
11540052 187346 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475405 187346 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
11540052 187346 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
CHEMBL475405 187346 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
10217498 91861 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 481 7 1 4 6.2 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)c(Cl)c2)C1 10.1021/jm0492507
CHEMBL224571 91861 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 481 7 1 4 6.2 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)c(Cl)c2)C1 10.1021/jm0492507
46885742 14473 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 495 10 4 6 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(C#N)c1 10.1016/j.bmcl.2010.02.098
CHEMBL1088819 14473 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 495 10 4 6 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(C#N)c1 10.1016/j.bmcl.2010.02.098
25008420 15236 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 547 9 4 5 5.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)c(C(F)(F)F)c2)c[nH]1 10.1016/j.bmcl.2010.02.098
CHEMBL1093823 15236 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 547 9 4 5 5.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)c(C(F)(F)F)c2)c[nH]1 10.1016/j.bmcl.2010.02.098
25060261 133642 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 448 7 2 3 5.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CO)cc2n1Cc1ccccc1 nan
CHEMBL3655430 133642 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 448 7 2 3 5.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CO)cc2n1Cc1ccccc1 nan
11224984 15489 23 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1095833 15489 23 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
59504164 133216 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 418 6 1 2 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccccc2n1Cc1ccccc1 nan
CHEMBL3651726 133216 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 418 6 1 2 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccccc2n1Cc1ccccc1 nan
11725751 19619 5 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL118860 19619 5 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
10149985 20151 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 341 13 3 2 4.2 CCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL119256 20151 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 341 13 3 2 4.2 CCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
59762348 133669 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 5 5.3 CC(=O)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3655456 133669 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 5 5.3 CC(=O)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
59762396 133722 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 512 8 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3ccccn3)cc2n1Cc1ccccn1 nan
CHEMBL3655509 133722 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 512 8 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3ccccn3)cc2n1Cc1ccccn1 nan
59504168 133741 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 4 6.0 CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655528 133741 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 4 6.0 CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
11683935 186120 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 456 9 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473563 186120 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 456 9 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
44565716 186522 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 493 10 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL474418 186522 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 493 10 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
10127776 17825 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 465 15 3 4 4.9 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL117723 17825 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 465 15 3 4 4.9 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
44413415 145468 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 2 4 6.1 O=C(O)CC1CNC(c2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL377855 145468 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 2 4 6.1 O=C(O)CC1CNC(c2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
10127776 17825 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 465 15 3 4 4.9 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1021/jm0492507
CHEMBL117723 17825 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 465 15 3 4 4.9 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1021/jm0492507
10215259 91882 5 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 331 11 1 2 4.9 CCCCCCCCCc1ccc(CN2CCC(C(=O)O)C2)cc1 10.1021/jm0492507
CHEMBL224703 91882 5 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 331 11 1 2 4.9 CCCCCCCCCc1ccc(CN2CCC(C(=O)O)C2)cc1 10.1021/jm0492507
11248292 150284 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 465 7 1 4 5.7 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)c(F)c2)C1 10.1021/jm0492507
CHEMBL389880 150284 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 465 7 1 4 5.7 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)c(F)c2)C1 10.1021/jm0492507
59762332 133692 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 495 7 1 3 7.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccncc3)cc2n1Cc1ccccc1 nan
CHEMBL3655478 133692 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 495 7 1 3 7.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccncc3)cc2n1Cc1ccccc1 nan
10287034 72957 3 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 367 11 2 2 4.7 CCCCCCCCCc1ccc(CN2CCC(P(=O)(O)O)C2)cc1 10.1021/jm0492507
CHEMBL184349 72957 3 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 367 11 2 2 4.7 CCCCCCCCCc1ccc(CN2CCC(P(=O)(O)O)C2)cc1 10.1021/jm0492507
44394330 72787 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 14 3 3 5.4 CCCCCCCCCCCCCCC1CC(O)(P(C)(=O)O)CCN1 10.1016/j.bmcl.2004.07.049
CHEMBL183688 72787 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 14 3 3 5.4 CCCCCCCCCCCCCCC1CC(O)(P(C)(=O)O)CCN1 10.1016/j.bmcl.2004.07.049
44394247 128994 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 16 3 2 6.0 CCCCCCCCCCCCCCNC1CCCCC1CP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL359762 128994 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 16 3 2 6.0 CCCCCCCCCCCCCCNC1CCCCC1CP(=O)(O)O 10.1016/j.bmcl.2004.07.049
44412364 84878 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL210257 84878 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
127037695 143353 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 333 12 1 3 4.3 CCCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3739440 143353 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 333 12 1 3 4.3 CCCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
59762334 133719 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 586 8 1 7 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3ncc(Br)s3)cc2n1Cc1ncco1 nan
CHEMBL3655506 133719 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 586 8 1 7 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3ncc(Br)s3)cc2n1Cc1ncco1 nan
44233018 133735 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 9 2 3 6.5 CC(C)NCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655522 133735 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 9 2 3 6.5 CC(C)NCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44234515 133206 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 396 8 3 3 4.4 Cc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651717 133206 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 396 8 3 3 4.4 Cc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
91203058 133643 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 461 8 1 4 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN=O)cc2n1Cc1ccccc1 nan
CHEMBL3655431 133643 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 461 8 1 4 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN=O)cc2n1Cc1ccccc1 nan
44232783 133628 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 7 1 4 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(=O)N(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655416 133628 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 7 1 4 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(=O)N(C)C)cc2n1Cc1ccccc1 nan
59762375 133636 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655424 133636 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762301 133639 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3cc(F)cc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655427 133639 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3cc(F)cc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762342 133725 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 498 9 1 5 5.9 CCOC(=O)Cn1c(C(C)C)c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc21 nan
CHEMBL3655511 133725 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 498 9 1 5 5.9 CCOC(=O)Cn1c(C(C)C)c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc21 nan
44233748 134184 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 4 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCNC3)cc2n1Cc1ccccc1 nan
CHEMBL3659682 134184 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 4 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCNC3)cc2n1Cc1ccccc1 nan
59762355 133637 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3cccnc3)c2c1 nan
CHEMBL3655425 133637 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3cccnc3)c2c1 nan
25059999 133625 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 10 1 4 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCCN(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655413 133625 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 10 1 4 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCCN(C)C)cc2n1Cc1ccccc1 nan
59762312 133672 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 463 7 1 4 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc([N+](=O)[O-])cc2n1Cc1ccccc1 nan
CHEMBL3655459 133672 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 463 7 1 4 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc([N+](=O)[O-])cc2n1Cc1ccccc1 nan
59762384 133654 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
CHEMBL3655442 133654 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
44412165 84536 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL209076 84536 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
44565703 196311 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 444 9 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2cccc3ccccc23)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL514189 196311 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 444 9 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2cccc3ccccc23)cc1 10.1016/j.bmcl.2009.02.073
44233019 133736 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 9 2 3 6.1 CCNCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655523 133736 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 9 2 3 6.1 CCNCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10310253 20278 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 435 14 3 3 4.8 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1Br 10.1016/j.bmcl.2004.04.070
CHEMBL119354 20278 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 435 14 3 3 4.8 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1Br 10.1016/j.bmcl.2004.04.070
10172513 16954 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 369 14 3 3 4.3 CCCCCCCCC(=O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL115970 16954 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 369 14 3 3 4.3 CCCCCCCCC(=O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
25059748 133622 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 524 9 1 3 7.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCc3ccccc3)cc2n1Cc1ccccc1 nan
CHEMBL3655410 133622 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 524 9 1 3 7.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCc3ccccc3)cc2n1Cc1ccccc1 nan
44159392 133737 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 10 2 3 6.5 CCCNCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655524 133737 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 10 2 3 6.5 CCCNCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44233496 134181 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 9 1 4 6.8 CCO/N=C(\C)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3659679 134181 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 9 1 4 6.8 CCO/N=C(\C)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762325 133671 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 506 9 1 6 5.5 CO/N=C(/C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3655458 133671 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 506 9 1 6 5.5 CO/N=C(/C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
44394220 73777 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 15 3 2 5.8 CCCCCCCCCCCCCCNC1CCCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL186921 73777 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 15 3 2 5.8 CCCCCCCCCCCCCCNC1CCCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
44565714 186076 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 484 11 4 5 4.1 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473238 186076 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 484 11 4 5 4.1 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
10215741 17785 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 13 3 4 3.5 CCCCCCCOC(=O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL117403 17785 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 13 3 4 3.5 CCCCCCCOC(=O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
10172338 117324 3 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CCC(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL325198 117324 3 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CCC(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
137655932 165736 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CC[C@@H](N)CCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL4095976 165736 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CC[C@@H](N)CCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
59762427 133658 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 506 8 1 6 5.6 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ncco4)c3c2)=N1 nan
CHEMBL3655446 133658 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 506 8 1 6 5.6 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ncco4)c3c2)=N1 nan
10172338 117324 3 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CCC(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL325198 117324 3 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CCC(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
46885743 14474 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 504 10 4 5 4.4 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(Cl)c1 10.1016/j.bmcl.2010.02.098
CHEMBL1088820 14474 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 504 10 4 5 4.4 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(Cl)c1 10.1016/j.bmcl.2010.02.098
44234004 134189 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 10 1 5 5.4 COCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659687 134189 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 10 1 5 5.4 COCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762421 133685 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 474 9 1 5 5.7 CC(C)COc1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655471 133685 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 474 9 1 5 5.7 CC(C)COc1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
57554674 143577 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 399 12 3 4 4.5 CCCCCCCCOc1ccc([C@@H]2CC[C@](N)(COP(=O)(O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3741414 143577 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 399 12 3 4 4.5 CCCCCCCCOc1ccc([C@@H]2CC[C@](N)(COP(=O)(O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
25059486 133619 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 10 1 3 7.2 CCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655407 133619 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 10 1 3 7.2 CCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25160863 133623 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 8 1 3 7.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655411 133623 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 8 1 3 7.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccc1 nan
44234003 134188 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 1 4 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3659686 134188 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 1 4 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
11725751 19619 5 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL118860 19619 5 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.07.049
44344193 121690 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL334213 121690 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44344193 121690 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1021/jm0492507
CHEMBL334213 121690 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1021/jm0492507
44591264 186758 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)c(F)c1 10.1016/j.bmcl.2008.11.072
CHEMBL474688 186758 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)c(F)c1 10.1016/j.bmcl.2008.11.072
44344193 121690 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL334213 121690 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
10363915 141971 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 405 7 1 5 4.6 CCC(C)(C)c1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
CHEMBL372066 141971 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 405 7 1 5 4.6 CCC(C)(C)c1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
44394220 73777 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 15 3 2 5.8 CCCCCCCCCCCCCCNC1CCCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL186921 73777 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 15 3 2 5.8 CCCCCCCCCCCCCCNC1CCCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
59504172 133215 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 460 6 2 3 6.3 O=C(NCc1ccc(F)c(F)c1)c1c(C2CCCC2)n(Cc2ccccc2)c2ccc(O)cc12 nan
CHEMBL3651725 133215 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 460 6 2 3 6.3 O=C(NCc1ccc(F)c(F)c1)c1c(C2CCCC2)n(Cc2ccccc2)c2ccc(O)cc12 nan
44565622 186119 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 428 11 4 5 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCC2CCCCC2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473562 186119 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 428 11 4 5 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCC2CCCCC2)cc1 10.1016/j.bmcl.2009.02.073
44413447 145461 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 431 6 2 5 5.6 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL377828 145461 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 431 6 2 5 5.6 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
25160740 133618 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 434 6 2 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(O)cc2n1Cc1ccccc1 nan
CHEMBL3655406 133618 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 434 6 2 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(O)cc2n1Cc1ccccc1 nan
25059747 133621 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 12 1 3 8.0 CCCCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655409 133621 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 12 1 3 8.0 CCCCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
49787250 133211 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 424 10 3 3 5.0 CCCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651721 133211 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 424 10 3 3 5.0 CCCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
24752909 133218 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 410 9 3 3 4.6 CCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651728 133218 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 410 9 3 3 4.6 CCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
44341466 16786 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@H](N)C[C@@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL114976 16786 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@H](N)C[C@@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
44341291 16909 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL115714 16909 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
44234006 134190 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 4 5.4 C#CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659688 134190 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 4 5.4 C#CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
46885745 15182 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 484 10 4 5 4.0 Cc1cc(NC(=O)[C@@](C)(N)COP(=O)(O)O)ccc1OCCc1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2010.02.098
CHEMBL1093424 15182 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 484 10 4 5 4.0 Cc1cc(NC(=O)[C@@](C)(N)COP(=O)(O)O)ccc1OCCc1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2010.02.098
59762297 133651 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655439 133651 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccc1 nan
25060265 133731 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 2 3 5.8 CCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655518 133731 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 2 3 5.8 CCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
24804606 133214 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 434 6 2 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2cc(O)ccc2n1Cc1ccccc1 nan
CHEMBL3651724 133214 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 434 6 2 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2cc(O)ccc2n1Cc1ccccc1 nan
59762420 133648 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 498 8 1 5 5.8 CC[C@H]1COC(c2ccc3c(C(=O)NCc4cncc(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
CHEMBL3655436 133648 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 498 8 1 5 5.8 CC[C@H]1COC(c2ccc3c(C(=O)NCc4cncc(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
10125882 172363 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 337 14 2 2 4.9 CCCCCCCCCc1ccc(CNCC(F)CC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL424254 172363 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 337 14 2 2 4.9 CCCCCCCCCc1ccc(CNCC(F)CC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
59762303 133638 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 481 8 1 6 5.2 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
CHEMBL3655426 133638 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 481 8 1 6 5.2 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
59762418 133645 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 7 1 4 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NCCO3)cc2n1Cc1ccccc1 nan
CHEMBL3655433 133645 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 7 1 4 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NCCO3)cc2n1Cc1ccccc1 nan
59762298 133680 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655467 133680 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOCC3)cc2n1Cc1ccccc1 nan
59762305 133682 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 519 8 1 5 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655469 133682 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 519 8 1 5 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOCC3)cc2n1Cc1ccccn1 nan
44233017 133733 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 1 3 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655520 133733 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 1 3 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN3CCCC3)cc2n1Cc1ccccc1 nan
10125862 18397 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 14 3 3 3.9 CCCCCCCCCc1ccc(CNCCC(O)C(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL118068 18397 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 14 3 3 3.9 CCCCCCCCCc1ccc(CNCCC(O)C(=O)O)cc1 10.1016/j.bmcl.2004.04.069
44394248 73023 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 361 15 3 2 5.4 CCCCCCCCCCCCCCNC1CCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL184591 73023 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 361 15 3 2 5.4 CCCCCCCCCCCCCCNC1CCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
44565595 186050 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 476 10 4 6 3.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3cccs3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473016 186050 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 476 10 4 6 3.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3cccs3)cc2)cc1 10.1016/j.bmcl.2009.02.073
59762320 133712 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 499 7 1 5 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccnn3C)cc2n1Cc1ccccn1 nan
CHEMBL3655499 133712 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 499 7 1 5 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccnn3C)cc2n1Cc1ccccn1 nan
59762432 133703 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 2 3 7.4 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655490 133703 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 2 3 7.4 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
59762280 133721 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 507 8 1 5 6.6 Cc1cc(Cn2c(C(C)C)c(C(=O)NCc3ccc(F)c(F)c3)c3ccc(OC4CCCC4)cc32)no1 nan
CHEMBL3655508 133721 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 507 8 1 5 6.6 Cc1cc(Cn2c(C(C)C)c(C(=O)NCc3ccc(F)c(F)c3)c3ccc(OC4CCCC4)cc32)no1 nan
44412165 84536 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL209076 84536 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
11503967 14793 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 482 10 4 5 3.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(C(=O)CCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
CHEMBL1090796 14793 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 482 10 4 5 3.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(C(=O)CCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
91433973 133670 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 9 1 6 5.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)N=O)n(Cc3ccccn3)c2c1 nan
CHEMBL3655457 133670 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 9 1 6 5.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)N=O)n(Cc3ccccn3)c2c1 nan
44233016 133633 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 478 9 1 4 6.0 COCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655421 133633 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 478 9 1 4 6.0 COCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10193676 20511 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 2 2 5.2 CCCCCCCCCc1ccc(CNCCC(F)(F)C(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL119516 20511 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 2 2 5.2 CCCCCCCCCc1ccc(CNCCC(F)(F)C(=O)O)cc1 10.1016/j.bmcl.2004.04.069
59762407 133713 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 514 7 1 5 6.7 Cc1noc(C)c1-c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655500 133713 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 514 7 1 5 6.7 Cc1noc(C)c1-c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762390 133665 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 6 4.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C3=NCCO3)n(Cc3ccccn3)c2c1 nan
CHEMBL3655452 133665 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 6 4.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C3=NCCO3)n(Cc3ccccn3)c2c1 nan
59762449 133716 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 467 9 1 5 5.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
CHEMBL3655503 133716 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 467 9 1 5 5.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
25160865 133629 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 7 1 4 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(=O)C(C)(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655417 133629 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 7 1 4 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(=O)C(C)(C)C)cc2n1Cc1ccccc1 nan
25060538 133739 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 10 1 4 7.0 CCCCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655526 133739 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 10 1 4 7.0 CCCCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44344413 117322 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.3 CCCCCCCCc1ccc(CCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL325193 117322 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.3 CCCCCCCCc1ccc(CCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
44394273 71352 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 395 12 3 2 5.6 CCCCCCCCCc1ccc(CN[C@H]2CCC[C@H](P(=O)(O)O)C2)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL181597 71352 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 395 12 3 2 5.6 CCCCCCCCCc1ccc(CN[C@H]2CCC[C@H](P(=O)(O)O)C2)cc1 10.1016/j.bmcl.2004.07.049
10126584 20367 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 391 14 3 3 4.7 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1Cl 10.1016/j.bmcl.2004.04.070
CHEMBL119413 20367 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 391 14 3 3 4.7 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1Cl 10.1016/j.bmcl.2004.04.070
9796603 171100 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 307 14 3 2 4.2 CCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL421234 171100 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 307 14 3 2 4.2 CCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
127037694 143433 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 347 13 1 3 4.7 CCCCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3740062 143433 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 347 13 1 3 4.7 CCCCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
59762318 133659 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
CHEMBL3655447 133659 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
44234761 133212 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 411 9 2 3 5.1 CCc1ccc(-c2ccc(COCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651722 133212 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 411 9 2 3 5.1 CCc1ccc(-c2ccc(COCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
11575787 77407 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 439 6 1 5 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL195014 77407 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 439 6 1 5 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1021/jm0503244
59762422 133691 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 468 8 1 3 7.0 CC(C)Cn1c(C(C)C)c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc21 nan
CHEMBL3655477 133691 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 468 8 1 3 7.0 CC(C)Cn1c(C(C)C)c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc21 nan
44394161 73799 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 16 2 2 6.1 CCCCCCCCCCCCCC1CCCCN1CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL187061 73799 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 16 2 2 6.1 CCCCCCCCCCCCCC1CCCCN1CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
59762398 133694 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 496 7 1 4 6.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccncc3)cc2n1Cc1ccccn1 nan
CHEMBL3655480 133694 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 496 7 1 4 6.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccncc3)cc2n1Cc1ccccn1 nan
44159394 133749 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 472 8 1 4 6.1 CCOC(=O)c1ccc2c(C(=O)NCc3cccc(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655536 133749 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 472 8 1 4 6.1 CCOC(=O)c1ccc2c(C(=O)NCc3cccc(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
11604577 79100 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 439 6 1 5 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc([C@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL198415 79100 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 439 6 1 5 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc([C@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1021/jm0503244
59762399 133647 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 7 1 5 5.4 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655435 133647 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 7 1 5 5.4 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccc1 nan
44233493 133750 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 472 8 1 4 6.1 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)cc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655537 133750 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 472 8 1 4 6.1 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)cc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10174548 19573 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 507 18 3 4 6.0 CCCCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL118815 19573 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 507 18 3 4 6.0 CCCCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
11271470 144362 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 475 8 1 4 6.1 CCc1cc(CN2CC(C(=O)O)C2)ccc1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
CHEMBL375488 144362 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 475 8 1 4 6.1 CCc1cc(CN2CC(C(=O)O)C2)ccc1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
10309462 20404 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 385 14 3 3 4.7 CCCCCCCCOc1c(C)cc(CNCCCP(=O)(O)O)cc1C 10.1016/j.bmcl.2004.04.070
CHEMBL119440 20404 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 385 14 3 3 4.7 CCCCCCCCOc1c(C)cc(CNCCCP(=O)(O)O)cc1C 10.1016/j.bmcl.2004.04.070
59762317 133657 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1cccnc1 nan
CHEMBL3655445 133657 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1cccnc1 nan
59762406 133677 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 2 3 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655464 133677 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 2 3 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
44233494 133751 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.6 CC(C)OC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655538 133751 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.6 CC(C)OC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
46885796 15183 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 538 10 4 5 4.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(C(F)(F)F)c1 10.1016/j.bmcl.2010.02.098
CHEMBL1093429 15183 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 538 10 4 5 4.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(C(F)(F)F)c1 10.1016/j.bmcl.2010.02.098
44344270 116893 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 395 13 3 5 3.9 CCCCCCCc1nc(-c2ccc(CNCCCP(=O)(O)O)cc2)no1 10.1016/j.bmcl.2004.04.070
CHEMBL323617 116893 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 395 13 3 5 3.9 CCCCCCCc1nc(-c2ccc(CNCCCP(=O)(O)O)cc2)no1 10.1016/j.bmcl.2004.04.070
59762335 133652 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 531 9 1 5 5.8 COC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
CHEMBL3655440 133652 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 531 9 1 5 5.8 COC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
44413365 84157 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 467 6 2 5 5.8 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc(C5CCC(F)(F)CC5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL208648 84157 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 467 6 2 5 5.8 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc(C5CCC(F)(F)CC5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
44344446 121599 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 349 17 3 2 5.4 CCCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL334144 121599 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 349 17 3 2 5.4 CCCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
59762347 133646 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NC(C)(C)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655434 133646 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NC(C)(C)CO3)cc2n1Cc1ccccc1 nan
59762321 133661 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 7 1 5 5.4 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
CHEMBL3655449 133661 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 7 1 5 5.4 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
59762323 133681 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 536 8 1 5 6.9 CC(C)c1c(C(=O)NCc2ccc(C(F)(F)F)nc2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655468 133681 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 536 8 1 5 6.9 CC(C)c1c(C(=O)NCc2ccc(C(F)(F)F)nc2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
44413274 145489 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 447 6 2 4 5.7 O=C(O)C1CNC(c2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL377968 145489 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 447 6 2 4 5.7 O=C(O)C1CNC(c2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
59762313 133666 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 463 8 1 5 4.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C=O)n(Cc3ccccn3)c2c1 nan
CHEMBL3655453 133666 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 463 8 1 5 4.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C=O)n(Cc3ccccn3)c2c1 nan
59762322 133649 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@H](C)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655437 133649 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@H](C)CO3)cc2n1Cc1ccccc1 nan
101863648 165266 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 303 10 1 2 4.1 CCCCCCCCc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL4090982 165266 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 303 10 1 2 4.1 CCCCCCCCc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.6b01575
10149721 91872 5 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 317 11 1 2 4.5 CCCCCCCCCc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/jm0492507
CHEMBL224623 91872 5 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 317 11 1 2 4.5 CCCCCCCCCc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/jm0492507
25059488 133203 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 476 9 1 3 6.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651714 133203 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 476 9 1 3 6.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25059488 133203 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 9 1 3 6.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651714 133203 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 9 1 3 6.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762293 133686 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 6 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ccccn1 nan
CHEMBL3655472 133686 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 6 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ccccn1 nan
59762353 133689 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 1 4 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1cccnc1 nan
CHEMBL3655475 133689 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 1 4 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1cccnc1 nan
44234256 134191 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 9 1 4 6.5 CC(C)COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659689 134191 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 9 1 4 6.5 CC(C)COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44394279 73924 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 16 3 2 5.8 CCCCCCCCCCCCCC[C@H]1CC[C@H](CCP(=O)(O)O)N1 10.1016/j.bmcl.2004.07.049
CHEMBL187588 73924 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 16 3 2 5.8 CCCCCCCCCCCCCC[C@H]1CC[C@H](CCP(=O)(O)O)N1 10.1016/j.bmcl.2004.07.049
44591265 186760 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 425 13 4 5 4.1 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2008.11.072
CHEMBL474689 186760 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 425 13 4 5 4.1 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2008.11.072
44591266 186079 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 443 13 4 5 4.2 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1F 10.1016/j.bmcl.2008.11.072
CHEMBL473269 186079 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 443 13 4 5 4.2 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1F 10.1016/j.bmcl.2008.11.072
44591249 187415 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 402 13 4 5 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2008.11.072
CHEMBL475495 187415 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 402 13 4 5 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2008.11.072
44591250 196533 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1F 10.1016/j.bmcl.2008.11.072
CHEMBL515921 196533 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1F 10.1016/j.bmcl.2008.11.072
44565712 196592 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 484 10 4 5 4.0 Cc1ccccc1-c1ccc(CCOc2ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL516380 196592 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 484 10 4 5 4.0 Cc1ccccc1-c1ccc(CCOc2ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2009.02.073
59762319 133698 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 464 7 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc([N+](=O)[O-])cc2n1Cc1ccccn1 nan
CHEMBL3655484 133698 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 464 7 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc([N+](=O)[O-])cc2n1Cc1ccccn1 nan
59762282 133644 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 499 8 2 3 5.4 C#CCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655432 133644 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 499 8 2 3 5.4 C#CCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762349 133676 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 3 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCCC3=O)cc2n1Cc1ccccc1 nan
CHEMBL3655463 133676 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 3 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCCC3=O)cc2n1Cc1ccccc1 nan
59762413 133707 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 469 8 2 3 6.8 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655494 133707 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 469 8 2 3 6.8 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
72555272 133710 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 4 6.1 C=C(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3655497 133710 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 4 6.1 C=C(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
44394211 73937 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 14 2 3 5.4 CCCCCCCCCCCCCCN1CCC(O)(P(C)(=O)O)CC1 10.1016/j.bmcl.2004.07.049
CHEMBL187645 73937 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 14 2 3 5.4 CCCCCCCCCCCCCCN1CCC(O)(P(C)(=O)O)CC1 10.1016/j.bmcl.2004.07.049
10271422 16709 1 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 385 14 4 3 3.8 CCCCCCCCc1ccc(CCC(N)(CO)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL114584 16709 1 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 385 14 4 3 3.8 CCCCCCCCc1ccc(CCC(N)(CO)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
127037696 143585 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 305 10 1 3 3.6 CCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3741496 143585 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 305 10 1 3 3.6 CCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
59762429 133718 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 508 8 1 7 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ncco1 nan
CHEMBL3655505 133718 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 508 8 1 7 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ncco1 nan
10127475 172808 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 447 7 1 4 5.5 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL425563 172808 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 447 7 1 4 5.5 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
10127475 172808 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 447 7 1 4 5.5 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1021/jm0492507
CHEMBL425563 172808 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 447 7 1 4 5.5 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1021/jm0492507
59762336 133720 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 439 6 2 5 5.0 Cc1cc(Cn2c(C(C)C)c(C(=O)NCc3ccc(F)c(F)c3)c3ccc(O)cc32)no1 nan
CHEMBL3655507 133720 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 439 6 2 5 5.0 Cc1cc(Cn2c(C(C)C)c(C(=O)NCc3ccc(F)c(F)c3)c3ccc(O)cc32)no1 nan
54582607 69233 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition of S1P3 receptorInhibition of S1P3 receptor
ChEMBL 375 3 2 3 5.8 Cc1cc(O)cc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 10.1016/j.bmcl.2011.04.097
CHEMBL1779895 69233 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition of S1P3 receptorInhibition of S1P3 receptor
ChEMBL 375 3 2 3 5.8 Cc1cc(O)cc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 10.1016/j.bmcl.2011.04.097
44344298 20316 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 395 13 3 6 3.0 CCCCCCCn1nnc(-c2ccc(CNCCCP(=O)(O)O)cc2)n1 10.1016/j.bmcl.2004.04.070
CHEMBL119382 20316 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 395 13 3 6 3.0 CCCCCCCn1nnc(-c2ccc(CNCCCP(=O)(O)O)cc2)n1 10.1016/j.bmcl.2004.04.070
59762414 133693 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 8 1 5 6.0 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1cccnc1 nan
CHEMBL3655479 133693 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 8 1 5 6.0 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1cccnc1 nan
44159276 133617 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 448 7 1 3 6.0 COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655405 133617 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 448 7 1 3 6.0 COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44234002 134186 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659684 134186 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762364 133711 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 497 7 1 5 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3cncnc3)cc2n1Cc1ccccn1 nan
CHEMBL3655498 133711 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 497 7 1 5 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3cncnc3)cc2n1Cc1ccccn1 nan
10317453 77193 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 377 7 1 5 3.9 CCCc1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
CHEMBL194578 77193 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 377 7 1 5 3.9 CCCc1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
59762338 131195 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 7 1 5 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3nnco3)cc2n1Cc1ccccc1 nan
CHEMBL3639543 131195 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 7 1 5 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3nnco3)cc2n1Cc1ccccc1 nan
10150372 119685 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 14 3 3 4.4 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1C 10.1016/j.bmcl.2004.04.070
CHEMBL331054 119685 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 14 3 3 4.4 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1C 10.1016/j.bmcl.2004.04.070
44565739 185739 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 459 12 4 5 4.2 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL470511 185739 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 459 12 4 5 4.2 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
25059745 133204 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 476 8 1 3 6.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651715 133204 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 476 8 1 3 6.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25059745 133204 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 8 1 3 6.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651715 133204 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 8 1 3 6.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25060000 133626 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3)cc2n1Cc1ccccc1 nan
CHEMBL3655414 133626 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3)cc2n1Cc1ccccc1 nan
44233020 133634 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCO3)cc2n1Cc1ccccc1 nan
CHEMBL3655422 133634 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCO3)cc2n1Cc1ccccc1 nan
24812110 17522 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 373 13 4 4 3.3 CCCCCCCCc1ccc(CCC(N)(CO)OP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL117130 17522 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 373 13 4 4 3.3 CCCCCCCCc1ccc(CCC(N)(CO)OP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
11452022 10368 39 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]S1P from human S1P3R expressed in CHO cell membranesDisplacement of [33P]S1P from human S1P3R expressed in CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100227q
6996 10368 39 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]S1P from human S1P3R expressed in CHO cell membranesDisplacement of [33P]S1P from human S1P3R expressed in CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100227q
CHEMBL366208 10368 39 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]S1P from human S1P3R expressed in CHO cell membranesDisplacement of [33P]S1P from human S1P3R expressed in CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100227q
2924 8421 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm0492507
44398069 8421 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm0492507
9908268 8421 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm0492507
CHEMBL114606 8421 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm0492507
2924 8421 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2004.02.106
44398069 8421 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2004.02.106
9908268 8421 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2004.02.106
CHEMBL114606 8421 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2004.02.106
46905530 17064 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 14 5 6 2.6 CCCCCCCCc1ccc(CCC(N)(CO)CO[PH](O)(O)O)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL1161691 17064 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 14 5 6 2.6 CCCCCCCCc1ccc(CCC(N)(CO)CO[PH](O)(O)O)cc1 10.1016/j.bmcl.2004.07.049
25059749 133624 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 10 1 4 6.0 COCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655412 133624 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 10 1 4 6.0 COCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10173327 17824 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 421 15 3 4 4.7 CCCCCCCCOc1c(Cl)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL117715 17824 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 421 15 3 4 4.7 CCCCCCCCOc1c(Cl)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
9885762 16506 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CCC(N)CC(O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL113344 16506 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CCC(N)CC(O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
11690779 196494 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 442 8 4 5 3.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(Oc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL515603 196494 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 442 8 4 5 3.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(Oc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
59762379 133664 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 9 1 5 5.1 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CN(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655451 133664 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 9 1 5 5.1 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CN(C)C)n(Cc3ccccn3)c2c1 nan
25060264 133730 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 3 6.2 CC(C)NC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655517 133730 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 3 6.2 CC(C)NC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762294 133687 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 435 6 2 4 5.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(O)cc2n1Cc1cccnc1 nan
CHEMBL3655473 133687 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 435 6 2 4 5.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(O)cc2n1Cc1cccnc1 nan
10125714 117294 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 319 13 2 2 4.7 CCCCCCCCc1ccc(CCC(N)CCC(=O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL325050 117294 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 319 13 2 2 4.7 CCCCCCCCc1ccc(CCC(N)CCC(=O)O)cc1 10.1016/j.bmcl.2004.02.106
59762300 133708 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 488 8 2 4 6.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655495 133708 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 488 8 2 4 6.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccn1 nan
44412415 84953 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 419 8 2 5 5.3 CC(C)Cc1ccc(-c2nc(-c3ccc([C@@H]4CC[C@@H](CCC(=O)O)N4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.038
CHEMBL210468 84953 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 419 8 2 5 5.3 CC(C)Cc1ccc(-c2nc(-c3ccc([C@@H]4CC[C@@H](CCC(=O)O)N4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.038
44233747 134183 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 603 8 1 5 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCN(C(=O)OC(C)(C)C)C3)cc2n1Cc1ccccc1 nan
CHEMBL3659681 134183 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 603 8 1 5 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCN(C(=O)OC(C)(C)C)C3)cc2n1Cc1ccccc1 nan
10172545 16397 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.4 CCCCCCCCc1ccc(CCC(N)C(O)CP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL112655 16397 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.4 CCCCCCCCc1ccc(CCC(N)C(O)CP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
59762315 133667 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 465 8 2 5 4.6 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CO)n(Cc3ccccn3)c2c1 nan
CHEMBL3655454 133667 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 465 8 2 5 4.6 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CO)n(Cc3ccccn3)c2c1 nan
59762403 133641 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)cc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655429 133641 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)cc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44413349 84414 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 453 6 2 5 5.4 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL208838 84414 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 453 6 2 5 5.4 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
10271422 16709 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHO cell membranesDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHO cell membranes
ChEMBL 385 14 4 3 3.8 CCCCCCCCc1ccc(CCC(N)(CO)CCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL114584 16709 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHO cell membranesDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHO cell membranes
ChEMBL 385 14 4 3 3.8 CCCCCCCCc1ccc(CCC(N)(CO)CCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
25060002 133635 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 8 1 4 6.2 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655423 133635 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 8 1 4 6.2 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
69228911 133655 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 516 8 1 5 6.0 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccn4)c3c2)=N1 nan
CHEMBL3655443 133655 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 516 8 1 5 6.0 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccn4)c3c2)=N1 nan
59762358 133695 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 4 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCC3)cc2n1Cc1cccnc1 nan
CHEMBL3655481 133695 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 4 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCC3)cc2n1Cc1cccnc1 nan
44394212 73944 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 373 15 2 2 6.5 CCCCCCCCCCCCCC1CCCC(CCP(C)(=O)O)N1 10.1016/j.bmcl.2004.07.049
CHEMBL187692 73944 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 373 15 2 2 6.5 CCCCCCCCCCCCCC1CCCC(CCP(C)(=O)O)N1 10.1016/j.bmcl.2004.07.049
59762417 133704 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 483 8 2 3 7.2 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655491 133704 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 483 8 2 3 7.2 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
59762438 133705 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 8 2 4 6.6 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655492 133705 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 8 2 4 6.6 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
46885797 14802 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 538 10 4 5 4.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1C(F)(F)F 10.1016/j.bmcl.2010.02.098
CHEMBL1090828 14802 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 538 10 4 5 4.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1C(F)(F)F 10.1016/j.bmcl.2010.02.098
44341399 213746 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 724 25 7 5 7.9 CCCCCCCCc1ccc(CCC(N)/C=C/P(=O)(O)O)cc1.CCCCCCCCc1ccc(CCC(N)C(O)CP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL91283 213746 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 724 25 7 5 7.9 CCCCCCCCc1ccc(CCC(N)/C=C/P(=O)(O)O)cc1.CCCCCCCCc1ccc(CCC(N)C(O)CP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
10126736 117265 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 401 16 3 4 4.5 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1OCC 10.1016/j.bmcl.2004.04.070
CHEMBL324820 117265 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 401 16 3 4 4.5 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1OCC 10.1016/j.bmcl.2004.04.070
10288527 91804 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 1 4 5.8 Cc1cc(CN2CC(C(=O)O)C2)ccc1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
CHEMBL224005 91804 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 1 4 5.8 Cc1cc(CN2CC(C(=O)O)C2)ccc1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
44412353 173007 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 435 6 2 5 5.5 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc(C5CCCC5)c(F)c4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL426688 173007 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 435 6 2 5 5.5 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc(C5CCCC5)c(F)c4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
59762425 133697 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 533 9 1 4 5.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C[N+]3(C)CCCC3)n(Cc3ccccn3)c2c1 nan
CHEMBL3655483 133697 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 533 9 1 4 5.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C[N+]3(C)CCCC3)n(Cc3ccccn3)c2c1 nan
10309022 16809 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 13 2 3 4.1 CCCCCCCCc1ccc(CCC(N)CCS(=O)(=O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL115131 16809 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 13 2 3 4.1 CCCCCCCCc1ccc(CCC(N)CCS(=O)(=O)O)cc1 10.1016/j.bmcl.2004.02.106
59762374 133653 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@H](C)CO3)cc2n1Cc1cccnc1 nan
CHEMBL3655441 133653 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@H](C)CO3)cc2n1Cc1cccnc1 nan
44412165 84536 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL209076 84536 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
162650548 186910 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Immunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assayImmunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assay
ChEMBL 366 4 1 4 4.9 CCC/N=C1\S/C(=C\c2ccc(O)c(C)c2)C(=O)N1c1ccccc1C 10.1021/acsmedchemlett.8b00616
CHEMBL4748743 186910 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Immunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assayImmunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assay
ChEMBL 366 4 1 4 4.9 CCC/N=C1\S/C(=C\c2ccc(O)c(C)c2)C(=O)N1c1ccccc1C 10.1021/acsmedchemlett.8b00616
44234259 134192 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 10 1 4 6.6 CCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659690 134192 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 10 1 4 6.6 CCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44394212 73944 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 373 15 2 2 6.5 CCCCCCCCCCCCCC1CCCC(CCP(C)(=O)O)N1 10.1016/j.bmcl.2004.07.049
CHEMBL187692 73944 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 373 15 2 2 6.5 CCCCCCCCCCCCCC1CCCC(CCP(C)(=O)O)N1 10.1016/j.bmcl.2004.07.049
10172354 120563 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 357 14 3 3 4.1 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL332373 120563 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 357 14 3 3 4.1 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
44159278 133627 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 5 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3=O)cc2n1Cc1ccccc1 nan
CHEMBL3655415 133627 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 5 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3=O)cc2n1Cc1ccccc1 nan
9824415 117333 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 437 13 3 4 4.1 CCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL325247 117333 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 437 13 3 4 4.1 CCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
10174181 18041 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity towards human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 479 16 3 4 5.2 CCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL117910 18041 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity towards human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 479 16 3 4 5.2 CCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
10384596 16908 2 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL115713 16908 2 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
44233257 133743 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 468 8 1 5 5.9 CC(C)c1c(C(=O)NCc2cccnc2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655530 133743 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 468 8 1 5 5.9 CC(C)c1c(C(=O)NCc2cccnc2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
59762412 133701 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 8 1 3 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N(C)C3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655488 133701 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 8 1 3 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N(C)C3CCCC3)cc2n1Cc1ccccc1 nan
59762389 133726 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 8 1 6 4.9 COC(=O)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3655512 133726 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 8 1 6 4.9 COC(=O)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
59762299 133640 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 474 8 1 6 4.8 CCOC(=O)c1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655428 133640 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 474 8 1 6 4.8 CCOC(=O)c1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44159393 133742 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 10 1 4 7.0 CC(C)CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655529 133742 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 10 1 4 7.0 CC(C)CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762286 133675 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 3 6.6 CC(C)C(=O)Nc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655462 133675 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 3 6.6 CC(C)C(=O)Nc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762434 133678 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 9 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCc3ncco3)cc2n1Cc1ccccc1 nan
CHEMBL3655465 133678 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 9 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCc3ncco3)cc2n1Cc1ccccc1 nan
44233255 133740 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 8 1 5 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCO3)cc2n1Cc1ccccn1 nan
CHEMBL3655527 133740 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 8 1 5 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCO3)cc2n1Cc1ccccn1 nan
44233256 133744 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 454 8 1 4 5.9 CCOC(=O)c1ccc2c(C(=O)NCc3ccccc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655531 133744 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 454 8 1 4 5.9 CCOC(=O)c1ccc2c(C(=O)NCc3ccccc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44394116 73124 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 349 17 2 2 5.2 CCCCCCCCCCCCCCN(C)CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL185100 73124 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 349 17 2 2 5.2 CCCCCCCCCCCCCCN(C)CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
44234511 134194 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(/C=N/N(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3659692 134194 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(/C=N/N(C)C)cc2n1Cc1ccccn1 nan
10289318 120804 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 513 14 3 3 5.6 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1Br 10.1016/j.bmcl.2004.04.070
CHEMBL332667 120804 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 513 14 3 3 5.6 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1Br 10.1016/j.bmcl.2004.04.070
10287343 19091 0 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 387 15 3 4 4.1 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL118508 19091 0 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 387 15 3 4 4.1 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
44159279 133734 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 3 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655521 133734 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 3 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN(C)C)cc2n1Cc1ccccc1 nan
59495631 164032 0 None -1318 2 Human 6.0 pKi = 6.0 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assayDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assay
ChEMBL 430 8 1 6 5.0 COCc1cc(-c2nc(-c3cccc(OCC(=O)O)c3)no2)ccc1-c1ccccc1C 10.1021/acs.jmedchem.6b01575
CHEMBL4076530 164032 0 None -1318 2 Human 6.0 pKi = 6.0 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assayDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assay
ChEMBL 430 8 1 6 5.0 COCc1cc(-c2nc(-c3cccc(OCC(=O)O)c3)no2)ccc1-c1ccccc1C 10.1021/acs.jmedchem.6b01575
137644547 164818 0 None -758 2 Human 5.7 pKi = 5.7 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assayDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assay
ChEMBL 494 7 1 5 7.0 COCc1cc(-c2nc(-c3ccc(-c4ccc(C(=O)O)c(F)c4)cc3)no2)ccc1-c1ccccc1C 10.1021/acs.jmedchem.6b01575
CHEMBL4085783 164818 0 None -758 2 Human 5.7 pKi = 5.7 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assayDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assay
ChEMBL 494 7 1 5 7.0 COCc1cc(-c2nc(-c3ccc(-c4ccc(C(=O)O)c(F)c4)cc3)no2)ccc1-c1ccccc1C 10.1021/acs.jmedchem.6b01575
11545181 10787 6 None -31 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
2930 10787 6 None -31 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
CHEMBL389033 10787 6 None -31 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
44342175 92295 0 None -10 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL227371 92295 0 None -10 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL422074 92295 0 None -10 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
57699087 110374 0 None -19 2 Human 5.3 pKi = 5.3 Binding
Inhibition of S1P3 receptor (unknown origin)Inhibition of S1P3 receptor (unknown origin)
ChEMBL 362 6 1 6 2.1 CCn1c(OC)nnc1[C@@H](C)NS(=O)(=O)c1ccc(F)c(Cl)c1 10.1016/j.bmcl.2013.09.058
CHEMBL3086532 110374 0 None -19 2 Human 5.3 pKi = 5.3 Binding
Inhibition of S1P3 receptor (unknown origin)Inhibition of S1P3 receptor (unknown origin)
ChEMBL 362 6 1 6 2.1 CCn1c(OC)nnc1[C@@H](C)NS(=O)(=O)c1ccc(F)c(Cl)c1 10.1016/j.bmcl.2013.09.058
11363176 9923 47 None - 0 Human 5.7 pIC50 = 5.7 Binding
In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>
Guide to Pharmacology 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 20446681
5446 9923 47 None - 0 Human 5.7 pIC50 = 5.7 Binding
In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>
Guide to Pharmacology 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 20446681
9320 9923 47 None - 0 Human 5.7 pIC50 = 5.7 Binding
In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>
Guide to Pharmacology 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 20446681
CHEMBL1096146 9923 47 None - 0 Human 5.7 pIC50 = 5.7 Binding
In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>
Guide to Pharmacology 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 20446681
10883396 10421 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10446161
10883396 10421 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17170199
10883396 10421 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 9988698
5283560 10421 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10446161
5283560 10421 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17170199
5283560 10421 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 9988698
911 10421 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10446161
911 10421 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17170199
911 10421 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 9988698
CHEMBL225155 10421 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10446161
CHEMBL225155 10421 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17170199
CHEMBL225155 10421 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 9988698
11588811 10784 45 None -85 2 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 15590668
136212600 10784 45 None -85 2 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 15590668
3324 10784 45 None -85 2 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 15590668
CHEMBL228102 10784 45 None -85 2 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 15590668
11545181 10787 6 None -31 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 17113298
2930 10787 6 None -31 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 17113298
CHEMBL389033 10787 6 None -31 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 17113298
10310 10661 0 None - 1 Human 7.0 pKi = 7.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 4 2 3 5.3 Clc1ccc(cc1)NNC(=Nc1ccc(cc1)Cl)C(=O)C(C)(C)C 20097776
16046248 10661 0 None - 1 Human 7.0 pKi = 7.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 4 2 3 5.3 Clc1ccc(cc1)NNC(=Nc1ccc(cc1)Cl)C(=O)C(C)(C)C 20097776
CHEMBL4303550 10661 0 None - 1 Human 7.0 pKi = 7.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 4 2 3 5.3 Clc1ccc(cc1)NNC(=Nc1ccc(cc1)Cl)C(=O)C(C)(C)C 20097776
6992 10781 0 None -23 5 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 369 11 3 3 4.3 CCCCCCCCc1cccc(c1)C1CC(C1)(N)COP(=O)(O)O 21632869
73755254 10781 0 None -23 5 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 369 11 3 3 4.3 CCCCCCCCc1cccc(c1)C1CC(C1)(N)COP(=O)(O)O 21632869